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Abstract 
A decisive event in the cell‟s life-or-death decision is the mitochondrial outer 
membrane permeabilization (MOMP). The biochemical events responsible for MOMP, 
considered by many investigators the “point-of-no-return” in cell death, are not entirely 
defined. Two major and very distinct mechanisms have been implicated in the control 
of MOMP: i) the action of Bcl-2 family proteins, which can directly engage the outer 
mitochondria membrane (OMM) and induce the opening of pores; and ii) the 
mitochondrial permeability transition pore (PTP), an inner membrane unselective 
channel that induces mitochondria swelling upon long term openings, and eventual 
rupture of the OMM. 
The growing interest in cell death biology, fostered by the relevant contributions of 
yeast to the understanding of basic biological processes, brought the unicellular 
eukaryote Saccharomyces cerevisiae into the scene. Yeast cells lack some of the major 
regulators of apoptosis, such as Bcl-2 family proteins (though one related protein was 
recently identified), but still possess homologues of mitochondrially enclosed pro-
apoptotic factors, as well as orthologues of the molecular components generally 
ascribed to PTP, including the ADP/ATP carrier (AAC) and Porin (Por1). These 
particular features of S. cerevisiae, along with the availability of genetic and molecular 
tools and easy manipulation, provided an excellent opportunity to study Bcl-2 family 
members in a “controlled” environment, or the contribution of the PTP and its 
components to cell death. 
In this work, the particular contribution of AAC‟s thiol goups, its oxidation, Por1, 
and of a possible interaction between both proteins to cell death, using the well-
established model of acetic acid-induced yeast death, was explored. It was observed that 
the cysteine residues of the Aac2p, when this AAC isoform was individually expressed, 
do not contribute to the mechanisms of acetic acid-induced death. This finding indicates 
that the oxidative modifications of Aac2p may not be implicated in the acetic acid-
induced cell death program, at least not those involving thiol crosslinking. This idea is 
supported by the apparent absence of a particular Aac2p oxidation pattern. 
Nevertheless, the AAC was previously demonstrated to be required for acetic acid-
induced cytochrome c release, and its absence promoted the survival of yeast cells. 
Deletion of Por1, on the other hand, decreased the viability of yeast cells treated with 
acetic acid. It was hypothesized that the two proteins could share the same pathway in 
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the regulation of cell death. To test this, cytochrome c release was evaluated in 
mitochondria isolated from Δaac1/2/3, Δpor1 and Δaac1/2/3Δpor1 cells following 
acetic acid treatment. The data obtained suggest that absence of Por1 does not affect 
cytcochrome c release, hence MOMP, during acetic acid induced-death, but it may be 
important for its regulation. When both the AAC and Por1 were absent, yeast 
mitochondria could still release cytochrome c, raising the possibility of an AAC-
independent mechanism. Furthermore, we found both proteins have distinct effects that 
regulate the cellular response to different stresses. Particularly, absence of the AACs 
somehow contributed to increased cell wall resistance and osmotic stress resistance. 
Finally, S. cerevisiae was explored as a model to study mechanistic aspects relative 
to the function of Bcl-2 family proteins. Particularly, we assessed the role of 
sphingolipids, using cells lacking sphingolipid metabolism enzymes, in the action of the 
human pro-apoptotic regulator Bax. We found that absence of Isc1p, an inositol 
phospholipase C that degrades complex sphingolipids into ceramides in yeast, favored 
the viability of yeast cells expressing an active form of Bax. It was further revealed that 
this effect is not associated with changes in the action of Bax; rather, it might be related 
with the cellular consequences of Bax-action. Indeed, a parallel with the effect of Uth1p 
absence in yeast cells expressing Bax suggests that the absence of Isc1p could affect the 
selective degradation of mitochondria by mitophagy, and thus produce a different cell 
death response. 
This work provides new insights into the physiological events underlying the 
contribution of mitochondrial proteins, previously associated with cell death responses, 
and sphingolipid metabolism to cell death induced by acetic acid and Bax, respectively. 
Once again, the yeast S. cerevisiae proved to be an excellent model in the particular 
field of cell life and death research. 
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Resumo  
A permeabilização da membrana mitocondrial externa (MOMP) é considerado o 
evento decisivo para a sobrevivência celular. Os eventos bioquímicos subjacentes a este 
processo, considerado o “ponto sem retorno” na morte celular, não estão ainda 
completamente elucidados. Dois dos principais mecanismos apontados como 
responsáveis pelo controlo deste processo consistem na acção das proteínas da família 
Bcl-2, que podem interactuar directamente com a membrana mitocondrial externa 
induzindo a abertura de poros; e o poro de permeabilidade transitória (PTP), um canal 
não selectivo que ocorre na membrana mitocondrial interna e que, quando aberto por 
longos períodos, induz a tumefacção mitocondrial podendo culminar na eventual 
ruptura da membrana mitocondrial externa. 
O crescente interesse no estudo da morte celular, potenciado pelas contribuições da 
levedura na elucidação de processos celulares fundamentais, despoletou a utilização da 
levedura enquanto modelo para a investigação da morte celular. Os principais 
reguladores da apoptose, nomeadamente as proteínas da família Bcl-2 (à excepção de 
um ortólogo recentemente identificado) não estão presentes na levedura. No entanto, 
este organismo possui ortólogos de vários factores apoptóticos, assim como dos 
constituintes moleculares do PTP, incluindo o transportador de ADP/ATP (AAC) e a 
porina de membrana mitocondrial externa (Por1p). Estas características da levedura S. 
cerevisiae, bem como a disponibilidade de ferramentas genéticas e moleculares aliadas 
a uma fácil manipulação, fazem deste sistema uma excelente ferramenta para o estudo 
da expressão de proteínas da família Bcl-2 num ambiente "controlado", ou do contributo 
do PTP e dos seus componentes para a morte celular. 
Neste trabalho é estudada a contribuição dos grupos tiol da proteína AAC, e da sua 
oxidação assim como do papel das próprias proteínas AAC e Por1p, e uma possível 
interacção entre ambas, para a morte celular induzida por ácido acético. Nas condições 
testadas observou-se que os resíduos de cisteína do Aac2p, expresso como a única 
isoforma do AAC, não contribuem para os mecanismos de morte induzida por ácido 
acético. Este resultado sugere que o programa de morte celular induzido por este 
composto não depende de modificações oxidativas do Aac2p, pelo menos dependentes 
da oxidação de grupos tiol. Esta afirmação é suportada por aparente ausência oxidação 
do Aac2p. No entanto, o AAC já foi previamente descrito como elemento essencial para 
a libertação de citocromo c da mitocôndria durante a morte celular induzida por ácido 
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acético. Para além deste efeito, a deleção do AAC promove igualmente a sobrevivência 
das células de levedura. A ausência do gene POR1, por outro lado, diminui a viabilidade 
deste mutante quando exposto ao tratamento com ácido acético.  
Em relação a uma possível interação do AAC e da porina Por, foi sugerido que as 
duas proteínas poderiam partilhar a mesma via na regulação do processo de morte 
celular em levedura. Para testar esta hipótese, a libertação de citocromo c foi avaliada 
em mitocôndrias isoladas dos mutantes Δaac1/2/3, Δpor1 e Δaac1/2/3Δpor1 após o 
tratamento com ácido acético. Os dados obtidos sugerem que a ausência da proteína 
Por1 não bloqueia a libertação de citocromo c, e consequentemente o MOMP, durante a 
morte induzida por ácido acético mas pode ser importante para a sua regulação. Na 
ausência dos genes AACs e POR1 foi possível observar libertação de citocromo c, o que 
aponta para a existência de um mecanismo alternativo de regulação do MOMP nestas 
condições. Verificou-se também que estas proteínas têm respostas distintas quando 
sujeitas a diferentes stresses celulares. Em particular, a ausência dos AAC contribui, de 
alguma forma, para o aumento da resistência ao stress osmótico e da resistência da 
parede celular. 
Por fim, a levedura S. cerevisiae foi usada como um modelo para estudo das 
proteínas da família Bcl-2. Especificamente, avaliou-se o papel dos esfingolípidos, na 
acção da proteína pro-apoptótica de mamíferos Bax usando estirpes mutadas no 
metabolismo dos esfingolípidos. Foi observado que a ausência da proteína Isc1p, uma 
inositol fosfolipase C que degrada esfingolípidos complexos em ceramidas, favorece a 
viabilidade de células que expressam uma forma activa da Bax. Mostrou-se ainda que 
este efeito parece não estar associado a uma alteração na acção da Bax, podendo, pelo 
contrário, estar relacionado com os defeitos subsequentes à acção desta proteína. Assim, 
e paralelamente ao que está descrito para ausência da proteína Uth1, a remoção do Isc1p 
poderá estar a influenciar a degradação selectiva de mitocôndrias através de um 
processo de mitofagia, conduzindo a um processo diferente na execução da morte 
celular. 
Com este trabalho foi possível aprofundar os conhecimentos sobre os mecanismos 
fisiológicos subjacentes à contribuição de proteínas mitocondriais, anteriormente 
associadas a processos de morte celular, e do metabolismo de esfingolípidos na morte 
celular induzida por ácido acético e Bax, respectivamente. Mais uma vez, a levedura S. 
cerevisiae mostrou-se um excelente modelo para compreensão dos processos de morte 
celular.
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Rego, A., Trindade, D., Chaves, S.R., Manon, S., Costa, V., Sousa, M.J., and Côrte-Real, M. (2013). The 
yeast model system as a tool towards the understanding of apoptosis regulation by sphingolipids. FEMS 
Yeast Res. 
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1. Life and Death 
 
 
“Life is not an exact science, it is an art.”  
Samuel Butler 
 
 
Life is indeed the most extraordinary creation of Nature. Despite the apparent 
delicacy, it was given the power to interact with and change the surrounding world, to 
adapt and evolve through the challenges it is confronted with. Like most elements in 
nature, life has its own antagonist, its complement, which goes by the name of Death. 
Importantly, one cannot be without the other. The balance between these two forces 
represents the very essence of life as we know it, determining the development of 
organisms and defining their lives. 
The notion of regressive changes during development of multicellular organisms 
goes way back in science history, possibly to the time of Aristotle or Galen, and it was 
widely recognized in the early years of the 19
th
 century (nicely reviewed in Clarke and 
Clarke, 1996). However, the association between those changes and the concept of 
naturally occurring cell death had to wait until the establishment of the cell theory by 
Schleiden (1842) and by Schwann (1839). Following the advances in the field of 
microscopy, the discovery of developmental cell death became possible in about 1840. 
Its first realization was published by Carl Vogt in 1842, when words such as “resorbed”, 
“destroyed” and “disappearing” were used to report the elimination of the notochord 
and its replacement by the vertebrae during amphibian metamorphosis. Two years later, 
the work of Prévost and Lebert corroborated the observations of Vogt, again stating that 
the "simple globules" of the notochord are resorbed. By the end of 19
th
 century several 
studies, mostly on insect and amphibian development, have provided enough evidences 
to ensure the continuation and prosperity of cell death investigation.  
Since its very beginning, and throughout the 20
th
 century, the field of cell death 
research has grown considerably, and cell death was found to occur in different 
organisms, from mammals to plants and even in unicellular organisms like yeasts. 
Advances in different scientific areas enabled a deeper look into this biological 
phenomenon, and it was eventually realized that cell death was not just a mere accident 
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from nature. Inevitably, a new concept was born. The term programmed cell death was 
used for the first time in a series of works published in 1964 and 1965 by Lockshin and 
Williams (Lockshin and Williams, 1965). In 1966, Saunders and colleagues observed 
that cell death could be prevented by substances released by other tissues, indicating 
that it is not an inevitable process and that it can be suppressed by signals from other 
cells (Saunders, 1966). Additionally, the finding that inhibitors of RNA and protein 
synthesis were able to inhibit cell death indicated that an active metabolism is necessary 
to carry out this process (Lockshin, 1969; Makman et al., 1971; Martin et al., 1988; 
Tata, 1966). These were the basis of the programmed cell death investigation that 
became a particular subject of interest in the following years (Häcker and Vaux, 1997).  
 
 
2. Programmed Cell Death 
 
The term Programmed Cell Death (PCD) generally defines all forms of death whose 
execution is under genetic control and is carried out in a regulated manner. This requires 
that the process follows a specific, orchestrated sequence of biochemical events, both 
ordered in time and space. Moreover, such process should implicate an advantage for 
the particular organism or cell population. Accordingly, PCD is a normal physiological 
form of cell death that plays a key role in multicellular organisms both during the 
embryonic development and in the maintenance of adult tissues.  
During adult life, PCD is crucial for tissues homeostasis. It also constitutes a defense 
mechanism by which damaged and potentially dangerous cells can be eliminated for the 
benefit of the organism as a whole. This is the case, for instance, of virus-infected cells 
that undergo PCD to prevent the production of new virus particles, thus limiting the 
spread of the pathogen through the host organism. This biological process also 
eliminates cells carrying potentially harmful mutations resulting from DNA damage, an 
essential feature in the prevention of cancer. During development, PCD plays a key role 
by eliminating unwanted cells from a variety of tissues as, for example, the elimination 
of larval tissues during amphibian and insect metamorphosis, the elimination of tissue 
between the digits during the formation of fingers, and in the selection of neurons that 
have made the correct connections with their target cells during the development of the 
mammalian nervous system. 
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Besides its role in the development and homeostasis of cell populations, PCD is also 
a determinant aspect in pathology and aging. In fact, defective control of PCD is 
directly linked to several pathologies including chronic inflammatory and 
neurodegenerative diseases, autoimmunity and neoplasia, among others (Bellamy et al., 
1995; Lockshin and Zakeri, 2001). By the end of the 20
th
 century the interest on PCD 
had increased exponentially among the scientific community, and a great deal of studies 
have focused on the biochemical events that control and promote the cellular demise. 
Current knowledge reveals that the regulation of PCD is mediated by the integrated 
activity of a variety of signaling pathways, some acting to induce cell death and others 
to promote cell survival. The delicate balance between these cellular forces is the 
ultimate power that determines the fate of a cell. 
 
2.1. Apoptosis 
 
Apoptosis is probably the most studied and well understood form of PCD. The term 
apoptosis, resulting from the Greek word used to describe the "dropping off" or "falling 
off" of petals from flowers and leaves from trees, was first proposed by Kerr and his co-
workers to describe a morphologically distinct mechanism of “controlled cell deletion”, 
which plays a complementary but opposite role to mitosis in the regulation of animal 
cell populations or during embryonic development (Kerr et al., 1972). 
At the present time, apoptosis is considered a universal event in the normal 
development and aging of multicellular organisms, acting as a homeostatic mechanism 
that removes damaged cells and contributes to tissue normal development, maintenance 
and renewal (Elmore, 2007). Albeit its importance to the normal functioning of the 
organisms, a defective regulation of apoptosis, is usually connected to serious 
physiological consequences, resulting in the occurrence and progression of several 
different pathologies (Rudin and Thompson, 1997). For example, the inaccurate 
activation of apoptosis is responsible for different neurodegenerative disorders, such as 
Alzheimer‟s disease (Smale et al., 1995) or Huntington‟s disease (Hickey and 
Chesselet, 2003). On the other hand, suppression of apoptosis and the subsequent 
inability to remove potentially dangerous cells is commonly recognized as a 
determinant step in the development of cancers (Evan and Vousden, 2001; Lowe and 
Lin, 2000). This ambiguous feature of apoptosis has placed it under the spotlight of 
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scientific investigation in the last decades, particularly as a result of the increasing 
interest in apoptosis as a therapeutic target (Lockshin and Zakeri, 2007). 
 
2.1.1. Apoptosis: main characteristics, molecular components and 
pathways involved 
Kerr and colleagues generalized the idea that the mechanism of controlled cell 
deletion followed a specific pattern characterized by cell shrinkage, nuclear and 
cytoplasmic condensation, nuclear coalescence and margination of chromatin, and 
fragmentation of the cell and the nucleus into membrane-bound, and ultrastructurally 
well-preserved fragments. These fragments, named apoptotic bodies, were then taken up 
by other cells and rapidly degraded by lysosomal enzymes (Kerr et al., 1972). In 1977, 
using a genomic approach, Sulston and Horvitz demonstrated that ~13% of somatic 
cells in the embryo of Caenorhabditis elegans die predictably, shortly after appearing, 
thus establishing a genetic basis for cell death (Sulston and Horvitz, 1977). By 1982, the 
first genes involved in the control of cell death were revealed (Horvitz et al., 1983). 
Later on, apoptosis was associated to a specific pattern of internucleosomal DNA 
degradation, which provided a simple method of identifying and measuring the amount 
of apoptotic cell death (Arends et al., 1990). 
Apoptosis has been suggested as an active, genetically predetermined and higly 
regulated phenomenon that can be triggered by a variety of environmental stimuli, both 
pathogenic and physiological. These include genotoxic agents (responsible for DNA 
damage), absence of survival factors and the specific activation of death receptors 
(Nagata, 2000). Apoptosis is now widely recognized and accepted as a distinct and 
important mode of programmed cell death, characterized by cell shrinking, chromatin 
condensation (pyknosis), DNA and nuclear fragmentation (karyorrhexis). At the final 
stage of apoptosis, organelles condensate into vesicles and lipid asymmetry is lost, 
resulting in the exposure of phosphatidylserine. Finally, dying cells fragment into small 
apoptotic bodies, thus preventing the uncontrolled release of intracellular components to 
the extracellular milieu, where it could be harmful to the surrounding cells. These 
critical morphological and biochemical changes are generally common to most 
processes of apoptosis, no matter how they were initiated. 
Apoptosis may be mediated by several molecular pathways which respond to 
different stimuli and can be triggered by distinct mechanisms. Nevertheless, many of 
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the molecular regulators of apoptosis are shared among the different pathways that 
eventually intersect at some of point of the process. The best characterized and most 
prominent ones are called the extrinsic and intrinsic pathways, and their common 
regulators include caspases and Bcl-2 family proteins. 
 
 Caspases 
The main effectors of apoptosis are the highly conserved cysteine-dependent 
aspartate-directed proteases, globally known as caspases. Over a dozen caspases have 
been identified in humans and about two-thirds of these have been suggested to function 
in apoptosis (Earnshaw et al., 1999). Based on their substrate preference, extent of 
sequence identity and structural similarities, caspases can usually be divided into two 
different groups: the initiator caspases (that include caspases-2, 8, 9 and 10) and the 
effector/executioners caspases (including caspases-3, 6 and 7) (Fig. 1). 
 
Fig. 1 – Schematic representation of caspase structure and processing. Caspases cleave substrates in a 
highly specific manner after the Asp residue in short tetrapeptid (X-X-X-Asp) motifs. a) Apoptotic 
caspases can be divided into two classes: initiator and executioner caspases. Initiator caspases are 
characterized by their long pro-domains, while the effector caspases possess shorter pro-domains. b). 
Caspases are synthesized as catalytically inactive zymogens. The inactive proteins, also called pro-
caspases, are then activated by proteolytic cleavage of its pro-form. The smaller fragments then dimerise 
to form the active enzyme (from: Tait and Green, 2010).  
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In general, initiator caspases, which act at the apex of the signaling cascade, are 
characterized by their long pro-domains designated Death Effector Domain (DED, in 
caspases-8 and -10) and Caspase Recruitment Domain (CARD, in caspases-2 and -9), 
with more than 90 amino acid residues, while the effector caspases possess shorter pro-
domains with only 20-30 residues (Budihardjo et al., 1999; Chowdhury et al., 2008).  
These proteins, crucial to the execution of the controlled cell death program, are 
synthesized, and exist in cells as catalytically inactive zymogens. The inactive proteins, 
also called pro-caspases, are then activated by proteolytic cleavage of its pro-form, at 
specific aspartate residues. The smaller fragments then dimerise to form the active 
enzyme (Cohen, 1997; Shi, 2002). Besides cleaving several proteins, these enzymes can 
also act upon other caspases activating them and thus initiating a phenomenon known as 
the cascade of caspase activation (Chowdhury et al., 2008).  
Although caspases are not strictly required for the execution of cell death activation 
they might be necessary for the acquisition of typical morphological markers of 
apoptosis (Kroemer and Martin, 2005; Kumar, 2007). Once caspases are initially 
activated, there seems to be an irreversible commitment towards cell death. Regulation 
of caspases is, therefore, vital to determine the cell‟s fate (Lamkanfi et al., 2007). 
 
 Bcl-2 Proteins Family 
Apoptosis is a strictly controlled cellular process with a vast number of regulators. 
Besides caspases, the Bcl-2 protein family, which includes a set of proteins that can 
either promote or prevent cell death, plays a major role in the life-or-death decision that 
determines the fate of a cell (Adams and Cory, 1998, 2007; Chao and Korsmeyer, 1998; 
Cory and Adams, 2002; Nuñez and Clarke, 1994; Reed, 1994). The contribution of Bcl-
2 family proteins to the regulation of apoptosis started to be unveiled when the BCL2 
(B-cell Lymphoma 2) gene product was found to inhibit cell death (McDonnell et al., 
1990; Vaux et al., 1988). Since then, several Bcl-2-related proteins were found, all 
sharing at least one Bcl-2 Homology domain (BH), and classified according to their 
structure and function (Fig. 2).  
Bcl-2, Bcl-xL, Bcl-w, A1 and Mcl1 have four BH domains and constitute the anti-
apoptotic members of the family. The pro-apoptotic members can be separated into 
multidomain promoters of cell death or effector proteins (Bax, Bak and possible Bok), 
and the BH3-only proteins that can act as direct activators (Bid, Bim and Puma), or 
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sensitizer/de-repressor proteins (Bad, Bik, Bmf, Hrk and Noxa). The effector proteins 
were initially described to have only three BH domains (BH1-3), but recent data 
revealed a BH4 domain (Kvansakul et al., 2008). The BH3-only direct activators 
interact with both the anti-apoptotic and the effector proteins, while the sensitizer/de-
repressor members interact with the anti-apoptotic Bcl-2 repertoire exclusively (Chipuk 
et al., 2010). These proteins are responsible for the regulation of Mitochondria Outer 
Membrane Permeabilization (MOMP), an event that enables the release of apoptogenic 
factors, such as cytochrome c (cyt c), from mitochondria into the cytosol, eventually 
leading to the activation of caspases (Jürgensmeier et al., 1998; Kluck et al., 1997). The 
ability of Bcl-2 family proteins to form homo- or heterodimers suggests that there is a 
neutralizing competition between pro- and anti-apoptotic members, so that the ratio 
between the two subsets will determine the cells fate (Gross et al., 1999). These proteins 
are also subjected to posttranslational modifications that affect their function in 
promoting either death or survival of the cell. Phosphorylation/dephosphorylation by 
different kinases/phosphatases are among the regulation mechanisms of Bcl-2 family 
members through posttranslational modifications (for a review see Silva et al., 2011). 
 
Fig. 2 – Schematic representation of the Bcl-2 family of proteins. a) The Bcl-2 family of proteins is 
divided into three groups based on their BH domain organization. The anti-apoptotic members (Bcl-2, 
Bcl-xL, Bcl-w, A1 and Mcl1) have four BH. The pro-apoptotic members can be separated into effector 
proteins (Bax and Bak), which also contain four BH domains, and BH3-only proteins. The BH3-only 
proteins can act as direct activators (Bid, Bim and Puma), or sensitizer/de-repressor proteins (Bad, Bik, 
Bmf, Hrk and Noxa). b) Two models for Bax/Bak activation have been proposed. The indirect activator 
model consideres that competitive interactions of BH3-only with the anti-apoptotic Bcl-2 family members 
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disrupt the association of these proteins with Bax/Bak, which are releasing as activated forms. In the 
direct activator-derepressor model, Bax and Bak are activated via direct interactions with a subset of 
BH3-only proteins termed direct activators. Bcl-2 anti-apoptótic members may inhibit the action of 
activated Bax/Bak or sequester activating BH3-only proteins. A second subset of BH3-only proteins, 
named sensitizors, interacts exclusively with the anti-apoptotic Bcl-2 repertoire to neutralize it. (adapted 
from: Tait and Green, 2010). 
 
Reactive oxygen species in Apoptosis 
Over the past decades, Reactive Oxigen Species (ROS) have become recognized as 
common event in virtually all scenarios of PCD (Simon et al., 2000). Generation of 
oxygen derived free radicals such as superoxide, hydrogen peroxide as well as of other 
ROS, results from the capacity of molecular oxygen to readily accept electrons from 
other molecules. Most of these species are only moderately reactive with other 
biological molecules, but they can originate hydroxyl radicals, which are highly reactive 
and responsible for damages to DNA, lipids and proteins (Davies and Goldberg, 1987; 
Halliwell and Gutteridge, 1990; Schraufstätter et al., 1988). At low/physiological 
concentrations, ROS can act as chemical messengers mediating signaling pathways and 
transcriptional regulation (Huang and Philbert, 1996; Morel and Barouki, 1999; 
Thannickal and Fanburg, 2000), or provide a defense mechanism that can be used by 
cells of the immune system to destroy pathogens (Babior, 1984; Chanock et al., 1994; 
Morel et al., 1991). In excessive concentrations, however, ROS overcome the capacity 
of the cell‟s anti-oxidant defense mechanisms and induces oxidative stress, which might 
eventually lead to cell death (Buttke and Sandstrom, 1994). Several studies show that 
antioxidant agents and the over-activation of cellular defense mechanisms responsible 
for the elimination of ROS are actually capable of delaying or even preventing 
apoptosis (Ferrari et al., 1995; Verhaegen et al., 1995; Watson et al., 1997). Moreover, 
the inhibitory action of some anti-apoptotic proteins, such as Bcl-2, is partially 
associated with protection against oxidative stress (Hockenbery et al., 1993). The 
finding of active forms of cell death in plants and yeast that also involve ROS suggests 
the existence of an ancestral redox-sensitive death signaling pathway that is conserved 
throughout the eukaryotic domain (Levine et al., 1994; Madeo et al., 1999). 
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2.1.2. Apoptotic Pathways 
The cascade of events leading to apoptosis can be sub-divided in activation and 
execution phase. During the activation phase, multiple signaling pathways lead to the 
central control of the cell death machinery and activate it. This is followed by the 
execution stage, in which the activated machinery acts on multiple cellular targets 
eventually promoting the destruction of the cell (Elmore, 2007). Currently, two well-
understood mechanisms of apoptosis activation are documented: the extrinsic and the 
intrinsic apoptotic pathway (Fig. 3).  
 
Fig. 3 – The major signaling pathways leading to cellular apoptosis in mammalians: extrinsic and 
intrinsic pathways. The extrinsic pathway is initiated through the stimulation of the death receptors. 
Association between the death receptor, the adaptor protein and the pro-caspase-8 forms the DISC, 
responsible for caspase-8 activation, and subsequent cascade of caspase activation. The intrinsic pathway 
is activated by internal stimuli and depends on MOMP. MOMP facilitates the release of pro-apoptotic 
proteins to the cytoplasm including cytochrome c that combines with Apaf-1 and pro-caspase 9 to form 
the apoptosome. Activated caspase-9 initiates the activation of other caspases. (image from Renault and 
Chipuk, 2013) 
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Both pathways converge on the same terminal, or execution phase (Hengartner, 
2000). This final phase of apoptosis begins when the execution caspases are activated. 
Executiner caspases (-3, -6 and -7) activate a cytoplasmic endonuclease, which degrades 
nuclear material, as well as proteases that degrade the nuclear and cytoskeletal proteins, 
being responsible for the typical morphological and biochemical changes observed in 
apoptotic cells (Slee et al., 2001). 
 
Extrinsic Pathway 
The extrinsic pathway, also called death membrane receptor pathway, depends of 
transmembrane receptor-mediated interactions. This pathway involves death receptors 
that are members of the Tumor Necrosis Factor (TNF) receptor gene superfamily 
(Locksley et al., 2001), namely the death receptors Fas (also called Apo-1 or CD95), 
Tumor-Necrosis Factor Receptor (TNF-R) and TNF-Related Apoptosis-Inducing 
Ligand (TRAIL). The death receptors are activated by specific extracellular ligands that 
promote clustering of the receptors (Sartorius et al., 2001). The signal transduction into 
the cell is mediated by the cytoplasmic fraction of the death receptors, which contains 
two copies of a conserved domain called the Death Domain – DD. The receptors then 
recruit adaptor proteins such as Fas-Associated Death Domain protein (FADD) and 
TNF-R-Associated Death Domain protein (TRADD), which in turn also have two 
interaction domains: a DD and a Death Effector Domain (DED) (Chinnaiyan et al., 
1995; Hsu et al., 1995). These proteins bind to the death receptors by interactions 
between the DDs, and to the pro-caspases via interactions between the DEDs. 
Association between the extracellular ligand, the death receptor, adaptor protein and the 
pro-caspase forms a complex called the Death Inducer Signaling Complex – DISC 
(Kischkel et al., 1995). The concentration of pro-caspase-8 in the DISC results in its 
cleavage and subsequent activation. Once active, caspase-8 initiates the cascade of 
caspase activation by processing caspases-3, -6 and -7, which will act upon different 
substrates (Chowdhury et al., 2008; Thorburn, 2004). The death receptors can be 
inhibited by a protein called cellular FLICE (FADD-Like IL-1β-Converting Enzyme)-
inhibitory protein, which binds to FADD and caspase-8, rendering them ineffective 
(Krueger et al., 2001). 
Alternatively, the extrinsic apoptotic pathway can be mediated by dependence 
receptors, such as the DCC and the UNC5B, which trigger the apoptotic signal in the 
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absence of their ligand, netrin-1. When DCC is activated, the pro-apoptotic signaling 
proceeds through the assembly of a DRAL- and TUCAN- (or NLRP1-) platform that 
binds and activates caspases-9 (Mille et al., 2009). Activation of UNC5B, triggers the 
apoptotic signal via PP2A-mediated dephosphorylation of DAP kinase, which can direct 
activation of executioner caspases or favor MOMP (Guenebeaud et al., 2010). 
 
Intrinsic Pathway 
The intrinsic pathway, also called mitochondrial pathway, initiates within the cell 
and is triggered by a wide variety of intracellular perturbations such as DNA damage 
(caused by radiation, toxins, hypoxia, hyperthermia, viral infections and free radicals), 
oxidative stress, cytosolic calcium (Ca
2+
) overload or endoplasmic reticulum (ER) stress 
(Kroemer et al., 2007). Independently of the pathways responsible for sensing this 
stresses, all signals converge to the mitochondria and trigger MOMP, an event required 
for the activation of the intrinsic apoptotic pathway (Tait and Green, 2010). The several 
mechanisms underlying MOMP will be discussed in a different section. The MOMP, 
and consequent loss of the mitochondrial membrane potential, facilitates the release of 
several pro-apoptotic proteins into the cytoplasm, such as cytochrome c (cyt c), 
Apoptosis-Inducing Factor (AIF), Endonuclease G (Endo G), Smac/Diablo (Second 
Mitochondria-derived Activator of Caspases/Direct Inhibitor of Apoptosis Protein 
(IAP)-Binding protein with Low Pi) and High Temperature Requirement protein A2 
(HtrA2/Omi) (Cai et al., 1998; Du et al., 2000; Garrido et al., 2006; van Loo et al., 
2002). 
After being released from the mitochondria, cyt c combines with Apoptotic protease 
activating factor-1 (Apaf-1) and deoxyadenosine triphosphate (dATP) to form a protein 
complex known as the apoptosome. This complex, in turn, activates caspase-9 thus 
initiating the cascade of caspase activation and subsequent cellular destruction (Acehan 
et al., 2002). Smac/DIABLO and HtrA2/Omi are reported to promote apoptosis by 
inhibiting the activity of Inhibitors of Apoptosis Proteins (IAPs), which block the 
activity of executing caspases. (van Loo et al., 2002; Schimmer, 2004). AIF and Endo 
G, on the other hand, act in a caspase-independent manner and are translocated to the 
nucleus promoting an extensive DNA degradation (Enari et al., 1998; Joza et al., 2001; 
van Loo et al., 2001).  
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Apart from the release of pro-apoptotic factors, mitochondria membrane 
depolarization and its permeabiliation also induce the loss of cellular homeostasis: ATP 
synthesis stops, redox molecules such as NADH, NADPH and glutathione are oxidized, 
the expression of stress response genes is activated and production of ROS increases 
(Fleury et al., 2002; Kroemer et al., 2007). 
 
2.2. Other Forms of Cell Death 
 
For several years, apoptosis was wrongly assumed as synonymous for PCD. 
However, it must be kept in mind that although apoptosis is an abundant form of cell 
death observed in metazoans, and surely the best characterized one, dying cells may 
follow other forms of PCD, even during development (Chautan et al., 1999). Alternative 
pathways of cellular destruction include programmed necrosis, autophagic cell death 
and mitotic catastrophe as the most morphologically distinctive processes. Yet, unlike 
apoptosis these other forms of PCD are still difficult to distinguish unambiguously and 
remain poorly characterized (Galluzzi et al., 2007). 
The term “autophagic cell death” has been widely used to define scenarios of cell 
death displaying a massive cytoplasmic vacuolization, which often indicates increased 
autophagy (Galluzzi et al., 2007). However, autophagic cell death is far from being a 
consensual terminology for this particular process. On the basis of this conflict resides 
the generalization of the term „autophagic cell death‟ to imply that autophagy actually 
executes the cell demise, when in most scenarios it refers to a cell death program 
accompanied by autophagy (Kroemer and Levine, 2008). In fact, autophagy has been 
implicated as a mediator of cell death during the development of Drosophila 
melanogaster (Berry and Baehrecke, 2007; Denton et al., 2009), and considered 
responsible for the death of certain cancer cells in response to chemotherapeutic agents 
(Grandér et al., 2009), particularly when the apoptotic process is genetically 
compromised (Fazi et al., 2008). Nonetheless, overwhelming evidence suggests that, 
above all, autophagy constitutes a cytoprotective response activated by dying cells in 
the attempt to cope with stress, and its inhibition can actually accelerate cell death 
(Boya et al., 2005; Moreau et al., 2011). In summary, autophagic cell death refers only 
to a cell death process mediated by autophagy that can be prevented by the chemical or 
genetic inhibition of the autophagic machinery (Galluzzi et al., 2012). 
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Until recently, “Necrosis” was the term used to define a merely accidental cell death 
mechanism that was mostly recognized by the absence of typical morphological 
markers of apoptosis or autophagic cell death. Necrotic cells exhibit an increase in cell 
volume (oncosis) that eventually leads to the rupture of the plasma membrane and a 
disorganized dismantling of swollen organelles (Galluzzi et al., 2007). In mammalian 
biology, necrosis is considered a harmful process associated to the pathological loss of 
cells and the promotion of local inflammation (Vakkila and Lotze, 2004). Importantly, 
the inhibition of pathways responsible for apoptosis or autophagy has the ability to 
produce a necrotic phenotype from conditions that would otherwise result in apoptotic 
or autophagic cell death, respectively (Degenhardt et al., 2006; Kroemer and Martin, 
2005). This simple definition of necrosis was radically changed when the receptor 
interacting proteins 1 and 3 (Rip1 and Rip3) were found to be required for the execution 
of necrosis, with the recognition that this form of cell death can occur in a regulated 
manner (He et al., 2009; Hitomi et al., 2008; Zhang et al., 2001). The discovery of 
biochemical pathways involved in the regulation of necrosis brought a new interest in 
this not-so-accidental form of cellular demise, and new concepts such as “Regulated 
Necrosis” or “Necroptosis” were introduced (Christofferson and Yuan, 2010; 
Vandenabeele et al., 2010). 
The term “Mitotic Catastrophe” refers to a special case of cell death triggered by 
aberrant mitosis and occurring either during or shortly after mitosis. It is characterized 
by micro- and multi-nucleation events that precede cell death, and assumed to result 
from a combination of defects in cell cycle checkpoints and cellular damage (Castedo et 
al., 2004; Vakifahmetoglu et al., 2008a). However, the classification of mitotic 
catastrophe as an authentic cell death program is somewhat controversial, particularly 
since apoptotic and necrotic traits have also been detected in cells exhibiting multi-
nucleation (Castedo et al., 2006; Vakifahmetoglu et al., 2008b), and mitotic aberrations 
were associated to cell senescence (Eom et al., 2005; Yun et al., 2009). Presently, 
mitotic catastrophe is considered an oncosuppressive mechanism initiated by 
perturbations of the mitotic apparatus, during the M phase of the cell cycle and 
paralleled by some degree of mitotic arrest, eventually triggering cell death or 
senescence (Galluzzi et al., 2012). 
On the latest communication from the Nomenclature Committee for Cell Death 
(Galluzzi et al., 2012) it was established a biochemical classification for the different 
mechanisms of cell death, including some less-known and less-characterized forms that 
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await further investigations to determine if such processes constitute a truly independent 
form or a particular case of the better-known cell death mechanisms. The different 
modes of PCD mentioned on this communication are summarized in table 1. 
 
Table 1 - Classification of the diferente modes of PCD according to their main biochemical features. 
Mode of cell death Cell death subroutine Main biochemical features 
Caspase-dependent intrinsic 
apoptosis 
Apoptosis 
MOMP 
Irreversible m dissipation 
Caspase-independent intrinsic 
apoptosis 
Release of IMS proteins 
Respiratory chain inhibition 
Extrinsic apoptosis by death 
receptors 
Death receptor signaling 
Caspase-8 (-10) activation 
BID cleavage and MOMP (in type II cells) 
Caspase-3 (-6,-7) activation 
Extrinsic apoptosis by 
dependence receptors 
Dependence receptor signaling 
PP2A activation 
DAPK1 activation 
Caspase-9 activation 
Caspase-3 (-6,-7) activation 
Necroptosis Necrosis 
Death receptor signaling 
Caspase inhibition 
RIP1 and/or RIP3 activation 
Autophagic cell death Autophagy 
MAP1LC3 lipidation 
SQSTM1 degradation 
Mitotic catastrophe Mitotic catastrophe 
Caspase-2 activation (in some instances) 
TP53 or TP73 activation (in some instances) 
Mitotic arrest 
Anoikis Intrinsic Apoptosis (?) 
Downregulation of EGFR 
Inhibition of ERK1 signaling 
Lack of b1-integrin engagement 
Overexpression of BIM 
Caspase-3 (-6,-7) activation 
Cornification (?) 
Activation of transglutaminases 
Caspase-14 activation 
Entosis (?) 
RHO activation 
ROCK1 activation 
Netosis 
Autophagic cell death/ 
Regulated Necrosis (?) 
Caspase inhibition 
NADPH oxidase activation 
NET release (in some instances) 
Parthanatos Regulated Necrosis (?) 
PARP1-mediated PAR accumulation 
Irreversible m dissipation 
ATP and NADH depletion 
PAR binding to AIF and AIF nuclear 
translocation 
Pyroptosis 
Intrinsic Apoptosis/ 
Regulated Necrosis (?) 
Caspase-1 activation 
Caspase-7 activation 
Secretion of IL-1b and IL-18 
Classification of different modalities of PCD according to their biochemical features, and predictede cell death 
subroutine. (?) = predicted or undefined. ATG, autophagy; BCN1, beclin 1; Dcm, mitochondrial transmembrane 
potential; CrmA, cytokine response modifier A; DAPK1, death-associated protein kinase 1; EGFR, epidermal growth 
factor receptor; ERK1, extracellular-regulated kinase 1; IL, interleukin; MAP1LC3, microtubule-associated protein 1 
light chain 3; MOMP, mitochondrial outer membrane permeabilization; NET, neutrophil extracellular trap; PAD4, 
peptidylarginine deiminase 4; PAR, poly(ADP-ribose); PARP1, poly(ADP-ribose) polymerase 1; PP2A, protein 
phosphatase 2A; ROCK1, RHO-associated, coiled-coil containing protein kinase 1; SQSTM1, sequestosome 1; TG, 
transglutaminase; Z-VAD-fmk, N-benzyloxycarbonyl-Val-Ala-Asp-fluoromethylketone; Z-YVAD-fmk, N-
benzyloxycarbonyl-Tyr-Val-Ala-DLAsp-fluoromethylketone. Adapted from Galluzzi et al., 2012; “Molecular 
definitions of cell death subroutines: recommendations of the Nomenclature Committee on Cell Death 2012”. 
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3. Yeast Cell Death 
 
Until recently, apoptosis-like cell death was considered a metazoan-exclusive 
process, and the hypothesis of unicellular organisms, such as yeasts, committing a 
suicide program was considered illogical. Supporting this idea were the facts that, by 
that time, no homologues of the common mammalian apoptosis regulators were found 
in the yeast genome, and the difficulty to ascertain a physiological role to the cellular 
suicide in a unicellular organism. In the last two decades, however, it was found that 
cell death programs are not restricted to multicellular organisms, and can be observed in 
unicellular organisms such as the yeast Saccharomyces cerevisiae. The first evidence 
suggesting the presence of endogenous programmed cell death in yeast was obtained by 
Madeo and his coworkers, who described a cell cycle mutant cdc48
S565G
 of S. cerevisiae 
exhibiting a cell death process that displays typical characteristics of apoptosis (Madeo 
et al., 1997). 
As aforementioned the physiological role of an apoptosis-like program in a 
unicellular organism was initially questioned by the lack of obvious reasons for a 
single-cell organism to commit suicide. However, yeast populations should not be 
interpreted just as a group of partitioned unicellular organisms that do not communicate 
among each other, but rather as a multicellular community of interacting individuals. In 
fact, several microorganisms cluster together, forming multicellular communities like 
colonies or biofilms (Váchová and Palková, 2005). A new concept now suggests that 
the sacrifice of individuals from a population of a unicellular organism can be 
advantageous for the whole population. Thus, it was proposed that a suicide-program in 
unicellular organisms serves an altruistic purpose, whereby unfitted, damaged or old 
cells self-sacrifice for the greater benefit of the population (Büttner et al., 2006; 
Fröhlich and Madeo, 2000).  
As for metazoans, yeast cells undergoing an apoptotic-like cell death show 
characteristic morphological and biochemical markers such as: DNA fragmentation, 
chromatin condensation, exposure of phosphatidylserine on the outer leaflet of the 
plasma membrane (Ludovico et al., 2001; Madeo et al., 1997), mitochondrial 
fragmentation (Fannjiang et al., 2004) and cyt c release from mitochondria (Ludovico et 
al., 2002). The observation of an apoptotic-like program in yeast brought along the 
findings of several yeast orthologues of crucial apoptotic regulators, including caspases 
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(Madeo et al., 2002), AIF (Wissing et al., 2004), Omi/HtrA2 (Fahrenkrog et al., 2004), 
IAP (Walter et al., 2006) and Endo G (Büttner et al., 2007). Like cyt c, yeast Aif1p and 
Nuc1p, orthologues of mammalian AIF and Endo G, respectively, are localized in the 
mitochondria, and are released upon death stimuli. The yeast Nma111p, orthologue of 
Omi/HtrA2, is a serine dependent protease that, unlike its mammalian counterpart, is 
predominantly localized in the nucleus where it remains after a death stimulus 
(Fahrenkrog et al., 2004). A yeast caspase-related protease, Yca1p, has also been 
described as a mediator of yeast cell death, and its requirement for the death process 
depends on the nature of the insult (Liang et al., 2008; Mazzoni and Falcone, 2008). 
Depending on the experimental conditions, Yca1p may act both upstream, in a cyt c-
independent manner (Mazzoni et al., 2005), and downstream of mitochondria, with a 
partially dependence on cyt c (Silva et al., 2005). Yeast Pep4p, an aspartate protease 
orthologue of mammalian cathepsin D, translocates from the vacuole into the cytosol 
during cell death induced by hydrogen peroxide (Mason et al., 2005), actin cytoskeleton 
stabilization (Gourlay and Ayscough, 2006) and acetic acid, being involved in 
mitochondrial degradation (Pereira et al., 2010). Other regulators such as Apaf-1 and of 
most members of the Bcl-2 family proteins, seem to be absent in yeast. Recently, a 
yeast BH3-only protein, the Ybh3p, was identified in yeast. This protein is translocated 
to the mitochondria, after a lethal stimulus, were it seems capable of mediating the 
mitochondrial pathway of cell death (Büttner et al., 2011). 
Several different stimuli were found to induce an apoptotic-like cell death in yeast. 
Defects in several cellular processes such as N-glycosylation, chromatid cohesion, 
mRNA stability, and ubiquitination can trigger this form of cell death in yeast, as do 
DNA damage and replication failure (Carmona-Gutierrez et al., 2010). The apoptotic-
like cell death program can be found during both replicative (Laun et al., 2001) and 
chronological (Fabrizio et al., 2004; Herker et al., 2004) aging, mating and pheromone 
exposure in the absence of the conjugating partner (Madeo and Fröhlich, 2002) and also 
occurs during the development of colonies on solid media (Váchová and Palková, 
2005). Exogenous triggers in the form of chemical or physical stress and other natural 
triggers were also reported to induce an apoptotic-like cell death. These include H2O2 
and acetic acid, the most common exogenous triggers used to induce an apoptotic-like 
yeast cell death (Ludovico et al., 2001; Madeo et al., 1999), ethanol, ceramide, 
hypochlorous acid, high salt concentrations, heavy metals, UV radiation, heat stress, 
and several pharmacological agents. Compounds, which normally constitute nutrients or 
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oligo-elements such as glucose, sorbitol, copper, manganese, and iron, can also trigger 
yeast cell death with apoptotic features when applied at toxic concentrations. The 
apoptotic-like cell death program may also be triggered by toxins from either non-clonal 
enemy strains or by higher eukaryotes in their defense against pathogenic fungi 
(reviewed in (Carmona-Gutierrez et al., 2010). 
The human pro-apoptotic regulator Bax has been found to induce mortality in yeast 
cells (Greenhalf et al., 1996). Indeed, heterologous expression of the human pro-
apoptotic Bax causes growth arrest and cell death in S. cerevisiae, accompanied by 
increased ROS production, and mitochondrial membrane permeabilization with 
subsequent cyt c release (Greenhalf et al., 1996; Kissová et al., 2006; Ligr et al., 1998; 
Polcic and Forte, 2003; Priault et al., 2003a, 2003b; Xu et al., 1999). Although these 
could be considered typical features of an apoptotic program, a study by Kissova and 
colleagues indicates that autophagy, and not an apoptotic-like cell death, is activated in 
Bax induced yeast cell death (Kissová et al., 2006). The contradictory observations 
regarding the mode of Bax-induced cell death in yeast may result from the different 
experimental conditions used. Importantly, certain physiological aspects of the 
functioning of Bcl-2 family proteins seem to be reproducible in yeast, which has been 
significantly used as a “cleaner” model to study mechanistic aspects of mammalian 
apoptotic regulators (Silva et al., 2011). 
 
3.1. Acetic Acid in Yeast Cell Death 
 
Acetic acid (systematically named ethanoic acid; CH3COOH) is a weak organic acid 
commonly used in the food industry as a natural preservative. It can be formed as a 
byproduct of alcoholic fermentation by S. cerevisiae or as a product of the metabolism 
of acetic and lactic acid bacteria. Above a given concentration, acetic acid affects the 
fermentative performance of yeasts, and elevated concentrations induce yeast cell death. 
Its impact on yeast physiology is, therefore, relevant not only for cell research but also 
from a biotechnological perspective. 
Acetic acid entry into the cells depends on the extracellular pH and growth 
conditions according to glucose regulation of its transporters. The anionic form is 
transported by an active transport process that involves a monocarboxylate permease 
encoded by JEN1 (Casal et al., 1999), or a more specific acetate-proton symporter, 
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Ady2p (Paiva et al., 2004). In glucose-repressed yeast cells and at low pH, acetic acid is 
mainly in its undissociated form (pKa is 4.75), and it enters the cell essentially by 
simple diffusion (Casal et al., 1996) and through the aquaglyceroporin Fps1p 
(Mollapour and Piper, 2007). Fps1p is a channel that has an important role in the control 
of acetic acid transport across the plasma membrane, and is regulated by the high 
osmolarity glyecerol (HOG) mitogen-activated protein kinase (MAPK), Hog1p. In the 
presence of acetic acid, Hog1p is activated and phosphorylates Fps1p, targeting this 
channel for degradation in the vacuole. This adaptive response decreases the entry of 
acetic acid into the cell, protecting yeast from its toxic effects (Mollapour and Piper, 
2007). After entering the cells in the undissociated form, and since the intracellular pH 
is usually close to neutrality, acetic acid dissociates into acetate anion and H
+
, which 
leads to intracellular acidification, anion accumulation (if the extracellular pH is lower 
than the intracellular one) (Casal et al., 1996), and inhibition of cellular metabolic 
activity, namely, fermentation (Pampulha and Loureiro-Dias, 2000). Studies on 
enzymatic activities showed that enolase is the glycolitic enzyme most affected by 
acetic acid, leading to alteration of glycolysis (Pampulha and Loureiro-Dias, 2000). 
High concentrations of acetic acid can also compromise the viability of yeast cells 
(Pinto et al., 1989), eventually resulting in yeast cell death (Ludovico et al., 2001).  
In 2001, Ludovico and colleagues characterized the acetic acid-induced cell death in 
S. cerevisiae and identified different processes of cellular demise that were dependent 
on the concentration of acid used in those experiments. Treatment with high 
concentrations of acetic acid was followed by ultrastructural changes typical of necrosis, 
while lower concentrations of acid produced a cell death phenotype sharing some 
features with mammalian apoptosis (Ludovico et al., 2001). Chromatin condensation 
along the nuclear envelope, exposure of phosphatidylserine on the surface of the 
cytoplasmic membrane and DNA strand breaks were observed during acetic acid 
induced cell death (Ludovico et al., 2001).  
In the last decade, acetic acid has been commonly used as an inducer of apoptosis, in 
studies that unravel some of the processes and mechanisms behind this type of cell 
death in yeast. It was demonstrated that yeast undergoes a programmed cell death that 
can be mediated by mitochondria, when exposed to lethal concentrations of acetic acid. 
Acetic acid-treated yeast cells present accumulation of ROS, transient hyperpolarization 
followed by loss of mitochondrial membrane potential, decrease in cytochrome oxidase 
activity, affecting mitochondrial respiration, and release of cyt c (Ludovico et al., 2002). 
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Acetic acid also induces different ultrastructural mitochondrial alterations in yeast, 
including mitochondrial swelling, reduction in cristae number and formation of 
myelinic bodies as well (Ludovico et al., 2003). Apart from cyt c, Aif1p was also found 
to exit mitochondria in response to acetic acid being translocated to the nucleus 
(Wissing et al., 2004). Other mitochondrial proteins also affect the final cell fate, 
including those involved in mitochondrial fission/fusion like Fis1p, Dnm1p, Mdv1p 
(Fannjiang et al., 2004), Ysp2p (Sokolov et al., 2006) Nuc1p, the yeast ortholog of the 
mammalian Endonuclease G (Büttner et al., 2007), and homologues of the putative 
components of mammalian permeability transition pore (PTP), the ADP/ATP carrier 
(AAC) and Por1p (Pereira et al., 2007). Mitochondrial degradation has also been 
associated to yeast cells undergoing apoptosis ((Fannjiang et al., 2004) in a process that 
seems to involve the vacuolar protease Pep4p together with the AAC proteins (Pereira 
et al., 2010).  
The metacaspase Yca1p is activated in cells undergoing acetic acid-induced 
apoptosis in a growth phase dependent manner (Pereira et al., 2007). Nevertheless, in 
the absence of this Yca1p cells were still able to undergo apoptosis, although at lower 
rate than wild-type cells, which suggest that a caspase-independent pathway may also 
exist in yeast (Guaragnella et al., 2006). Besides Yca1p, the protease Kex1p, already 
known to participate in PCD caused by defective N-glycosylation, was also associated 
to the active cell death program induced by acetic acid (Hauptmann et al., 2006). The 
study of the yeast protein expression profile during acetic acid-induced apoptosis 
allowed the observation of alterations in the levels of proteins directly or indirectly 
linked with the target of rapamycin (TOR) pathway (Almeida et al., 2009). 
In spite of great efforts, many of the players involved in acetic acid induced yeast 
cell death and the exact mechanisms by which this process is executed remain 
unknown. A major challenge in the future will be to understand how yeast cells signal 
and execute death programs and how different molecular components might interact to 
decide the cell‟s fate. 
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4. Mitochondria in Cell Death 
 
Until the final years of the 20
th
 century mitochondria (a term derived from the Greek 
words “mitos” meaning threads and “chondros” to mean granule (Benda, 1898)) were 
considered to have one major purpose within cells: energy production. This perspective 
of purely metabolic mitochondria suffered a dramatic change with the discovery of 
another crucial biological function of mitochondria: the control of cell death. 
Progressively, different fields of cell research, including mitochondria bioenergetics and 
cell death, were revitalized, and our understanding of cellular physiology evolved under 
the premise that mitochondria are pluripotent organelles controlling life and death of 
eukaryotic cells. 
 
4.1. Physiology of Mitochondria 
 
Mitochondria are peculiar organelles with distinctive structural and biochemical 
properties, and frequently designated as the cell‟s power plants due to their critical role 
in the generation of metabolic energy in eukaryotic cells. Indeed, mitochondria are 
responsible for most of the useful energy derived from the breakdown of carbohydrates 
and fatty acids, which is converted to ATP by the process of oxidative phosphorylation. 
Structurally, mitochondria are defined by a double-membrane system, consisting of 
an inner (IMM) and an outer mitochondrial membranes (OMM), separated by an 
intermembrane space (IMS). The inner membrane has a larger surface area and forms 
numerous hollow flattened or tubular structures designated by the name of cristae and 
invaginate into the interior of the organelle, called matrix, which contains the 
mitochondrial genetic system as well as the enzymes responsible for central reactions of 
oxidative metabolism (Frey and Mannella, 2000). The inner membrane invaginations 
form a functionally distinct compartment of the IMS: the cristal lumen. Indeed, it is in 
the cristae membranes that the different complexes from the electron transport chain are 
found. Accordingly, it is estimated that 85% to 97% of the cyt c resides within the 
cristal lumen, with the remainder localized in the IMS (Bernardi et al., 1999; Scorrano 
et al., 1999). Cytochrome c is electrostatically associated with cytochrome c reductase 
and cytochrome oxidase, and is also associated with the anionic phospholipid 
cardiolipin, an important component of the IMM with an asymmetrical distribution 
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across the lipid bilayer. The F0F1 ATP synthase is also concentrated in the cristae of the 
IMM, facing the matrix. The cristae joins the rest of the inner membrane in dynamic 
structures designated crista junctions (Perkins et al., 1997), that under stress conditions 
can actually “close” cristae and cut the communication with the remaining IMS 
(Mannella et al., 2001). 
The two membranes from mitochondria have considerably different properties. 
Under physiological conditions, the IMM is nearly impermeable to solutes and ions, 
which allows the respiratory chain complexes (I to IV) to build up the proton gradient 
required for oxidative phosphorylation (Mitchell and Moyle, 1965a, 1965b). The charge 
imbalance generated by the chemical prtoton gradient across the IMM constitutes the 
basis of the inner mitochondrial membrane potential (ΔΨm). The movement of protons, 
back into the matrix, through the F0F1 ATP synthase drives the syntheses of ATP from 
ADP and inorganic phosphate. As a nearly impermeable barrier, the IMM possesses a 
series of highly selective ion channels and transporters required to ensure the exchange 
of metabolites between the matrix and cytosol. The energy required for these transports 
can be provided by the electrochemical gradient. Transient loss of the ΔΨm may occur 
in physiological circumstances through the “flickering” of one or several IMM pores, 
(Zoratti and Szabò, 1995). Long-lasting or permanent ΔΨm dissipation has major 
consequences for mitochondrial function and is often associated with cell death 
(Marchetti et al., 1996). 
The OMM, in contrast to its interior partner, is considered freely permeable to 
solutes and small molecules (< 1 kDa). This leaky behavior of the OMM is generally 
ascribed to the presence of a very abundant protein, the Voltage-Dependent Anion 
Channel (VADC), which promotes the flux of metabolites between the cytosol and the 
IMS. The permeability of the OMM is a tightly regulated process not only in normal 
“life” but also during cellular death, when different signals converge into the OMM to 
determine the fate of the cell (Kroemer and Reed, 2000). 
The IMM and OMM interact with each other at the contact sites, where the two 
membranes are closely juxtaposed. This contact sites are dynamic structures that might 
provide a platform for functional or structural interactions between proteins of the IMM 
and OMM (Kottke et al., 1988). A fairly known example is the interaction between 
VDAC, in the OMM, and the Adenine Nucleotide Translocator (ANT) in the IMM, two 
proteins that can form complexes in vitro, and are co-purified with cytosolic hexokinase 
and the benzodiazepine receptor (Brdiczka et al., 2006; McEnery, 1992). These 
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interactions at contact sites might facilitate the exchange of metabolites between the 
matrix and the cytosol, as well as the import of proteins to mitochondria (Adams et al., 
1989). Additionally, contact sites were proposed to mediate the process of mitochondria 
membrane permeabilization during cell death, providing physical support for the 
formation of a Permeability Transition Pore (Beutner et al., 1996; Crompton et al., 
2002). 
Mitochondria, crucial organelles for cellular bioenergetics, also contain several 
crucial regulators of the cell death programs, creating an authentic switch between 
normal life and a resolute death. 
 
4.2. Mitochondria Membrane Permeabilization 
 
As in normal cellular life, the permeability of the OMM is tightly regulated during 
the cell death. Mitochondria outer membrane permeabilization (MOMP) is probably the 
most significant biochemical event in the mitochondrial pathway of apoptosis enabling 
the release of several apoptotic factors, normally confined to mitochondria within the 
IMS (Liu et al., 1996). Considered by some as the “point of no return” in the cascade of 
events that promotes cell death, inappropriate regulation of MOMP has major 
consequences for health and disease (Green and Reed, 1998).  
The biochemical and biophysical mechanisms underlying MOMP are complex, 
distinct and in some cases debatable, probably involving the coordination of several 
independent steps (Tait and Green, 2010). In response to intracellular stress signals, pro- 
and anti-apoptotic signals are generated and converge at mitochondria. When a death 
signal prevails, the OMM loses its integrity and becomes permeable to soluble IMS 
proteins, namely the pro-apoptotic proteins cyt c, Smac/DIABLO, Omi/HTRA2, AIF 
and Endo G. Along with the release of mitochondrial proteins, MOMP leads to 
uncoupling of the respiratory chain, which results in increased ROS production and the 
dissipation of the ΔΨm, interrupting ATP production and ΔΨm-deriven transport 
activities (Kroemer et al., 2007). Once MOMP has occurred, caspases are activated in 
the cytosol, through the association of cyt c with Apaf1 and dATP, to form the 
apoptosome and activate caspases-9, as referred above (Li et al., 1997; Zhou and Ling, 
1997). When this pathway is inhibited, a caspases-independent cell death (CIDC) 
program, which probably involves ROS production, mitochondrial dysfunction and IMS 
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proteins such as AIF and Endo G, ensures the execution of cell destruction (Chipuk and 
Green, 2005). 
 MOMP can be triggered directly at the OMM by the action of pro-apoptotic 
members of the Bcl-2 family, such as Bax and Bak, which have the ability to form pores 
(von Ahsen et al., 2000; Kluck et al., 1997). Apart from the contribution of 
proteinaceous channels involving the Bcl-2 family members, the formation of lipidic 
pores in OMM may constitute another model for MOMP (Siskind et al., 2005), and 
recent evidences suggest that these mechanisms may actually collaborate in the 
permeabilization of mitochondria during cell death (Ganesan et al., 2010) (Fig. 4). 
Alternatively, MOMP can be triggered at the IMM, as a “secondary” effect of 
Mitochondria Permeability Transition (MPT); a phenomenon consisting of an abrupt 
increase in the permeability of the IMM to water and small solutes (Kroemer et al., 
2007). The different proposed mechanisms accounting for MOMP are discussed in the 
following sections. 
 
4.2.1. Bax/Bak-mediated MOMP 
As discussed in a previous section, the Bcl-2 family proteins are central regulators of 
apoptosis in multicellular organisms. Bax and Bak are the direct effectors of apoptosis 
acting downstream of other Bcl-2 family members to induce MOMP, and cells lacking 
both proteins fail to undergo MOMP and apoptosis in response to different intrinsic 
apoptotic stimuli (Wei et al., 2001). The exact molecular mechanisms underlying 
Bax/Bak mediated permeabilization, however, remain a matter of debate. 
In healthy cells, Bax is mostly cytosolic, where it awaits for activation signals that 
trigger its translocation to mitochondria and subsequent activation (Hsu et al., 1997).  
Bak, on the other hand, has a constitutive mitochondrial localization. Upon apoptotic 
stimulation, Bax and Bak can be activated by direct interaction with truncated Bid 
(tBid) in a process that involves extensive conformational changes, required for both 
translocation/insertion of Bax and the homo-oligomerization of Bak and Bax (Eskes et 
al., 2000; Hsu et al., 1997; Wei et al., 2000). These conformational changes are a critical 
and complex step on the activation of Bak and particularly Bax, whose relocation to 
mitochondria is required but may not be sufficient to induce its permeabilizing activity 
(Renault et al., 2012; Westphal et al., 2011). Indeed, the ability of Bax or Bak to 
oligomerize is apparently associated to the abilty of both proteins to induce MOMP, 
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suggesting that this event is also required to activate the apoptotic activity of these 
proteins (Dewson et al., 2008; George et al., 2007). 
In a classical model of Bax activation, tBid has been demonstrated to associate with 
membranes where it interacts with Bax, promoting its insertion and subsequent 
oligomerization in a coordinated sequence of events that culminate in membrane 
permeabilization. Anti-apoptotic members such as Bcl-xL can prevent Bax activation by 
inhibiting its association with tBid (Lovell et al., 2008). Other BH3-only proteins, such 
as Bim and Puma can also interact directly with Bax and Bak to promote MOMP, and 
the absence of these two regulators prevents ER stress-induced Bax/Bak activation 
(Kim et al., 2009). A model for Bak activation by tBid, proposes that the association 
between both proteins exposes the BH3 domain of Bak allowing symmetrical Bak 
dimers to form through reciprocal BH3 domain-interactions. The resulting homodimers 
of Bak might then interact via their α6 helices, close to the BH1 domain, to form high-
order Bak homo-oligomers that promote MOMP (Dewson et al., 2008, 2009) (Fig. 4). 
An identical process is predicted to mediate the formation of Bax homo-oligomers, 
which also depends on the BH3 and BH1 domains of Bax (George et al., 2007). The 
exact number of Bax or Bak molecules that must oligomerize to successfully induce 
MOMP remains uncertain. The mechanisms by which high-order oligomers of Bax or 
Bak promote MOMP also remain unclear, although it is believed to depend on the 
formation of proteinaceous channels or on the destabilization of lipid membranes to 
form lipidic pores (Fig. 4) (Tait and Green, 2010). 
The structural similarities with bacterial pore-forming toxins were an early 
suggestion that Bax and Bak could insert in OMM and form pores (Muchmore et al., 
1996; Petros et al., 2004; Suzuki et al., 2000). In fact, several studies demonstrated that 
Bcl-2 family proteins are capable of forming pores in artificial membranes, a feature 
that is not exclusive to the pro-apoptotic members (Antonsson et al., 1997; Schendel et 
al., 1997). Indeed, Bid and Bax were able to produce membrane openings in 
reconstituted vesicles in a process that was inhibited by Bcl-xL and required cardiolipin, 
thus suggesting that a BH3/Bax/lipid interaction might be enough to permeabilize 
membranes (Kuwana et al., 2002). Patch clamping experiments on isolated 
mitochondria, and using tBID to induce MOMP, revealed that Bax or Bak must be 
present to enable the formation of a cyt c-translocating OMM channel (Martinez-
Caballero et al., 2009). The stepwise increase in the conductance of this channel, with 
similar kinetics to MOMP, is consistent with pore assembly by sequential recruitment of 
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activated Bax or Bax homodimers (Martinez-Caballero et al., 2009). Furthermore, the 
link between Bax/Bak oligomerization and their ability to promote MOMP (Antonsson 
et al., 2000; Dejean et al., 2005), supports the hypothesis that Bax/Bak oligomers form 
proteinaceous pores large enough to allow the release of cyt c (≈ 12.5 kDa), but not of a 
higher molecular weight protein having similar physico-chemical properties, such as 
hemoglobin tetramer (63 kDa) (Dejean et al., 2005). This evidences support the 
hypothesis of MOMP mediated by Bax or Bak pores, and a proteinaceous pore implies 
that Bax/Bak could form a “ring-like” structure fully spanning OMM (or artificial 
membranes) (Martinez-Caballero et al., 2009). 
 
Fig. 4 – Bax/Bak activation and pore formation. Activated BH3-only proteins, such as tBid, bind to 
Bax/Bak inducing extensive conformational changes that are required for their activation. Exposure of the 
BH3 domain and hydrophobic cleft of Bax/Bak drives the formation of dimmers between symmetrical 
Bax/Bak moledules, through BH3 domain-cleft interactions. During activation, a dimer-dimer interaction 
surface also is exposed, allowing high-order oligomers to form. MOMP might result from the formation 
of proteinaceous channels by Bax/Bak oligomers (bottom left image), or from the formation of lipidic 
pores (bottom right image) resulting form lipid membrane destabilization by Bax/Bak oligomers. (image 
from: Tait and Green, 2010). 
 
An alternative to the model of pores formed by Bax or Bak, is the regulation of 
existing mitochondrial channels by these proteins. In this model, instead of forming 
pores by themselves, Bax and Bak would regulate the opening of mitochondrial 
channels, such as the mitochondrial permeability transition pore complex (which will be 
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discussed below), to mediate MOMP. This cooperation is supported by 
electrophysiological studies with purified recombinant Bax and purified ANT or 
VDAC, two proposed members of the PTP (Green and Kroemer, 2004). Indeed, a Bax-
VDAC interaction has been described (Pastorino et al., 2002), and different models 
supporting a direct collaboration between Bax and VDAC in the control of 
mitochondrial cyt c release were proposed (Banerjee and Ghosh, 2004; Shimizu et al., 
1999, 2000). Meanwhile, Bid, but not Bax, has been demonstrated to regulate VDAC 
channels (Rostovtseva et al., 2004), and evidences obtained from the genetic 
manipulation of mice clearly rule out a possible contribution of VDAC for Bax-
mediated MOMP (Baines et al., 2007). Other studies support a regulatory role of 
VDAC2 in the action of Bak (Cheng et al., 2003; Roy et al., 2009). Similarly, Bax has 
been co-purified with ANT suggesting a possible interaction between both proteins that 
was previously proposed to form a channel that could facilitate cyt c release (Brenner et 
al., 2000; Marzo et al., 1998a). In fact, Bax and ANT can physically interact and 
efficiently form pores in reconstituted liposomes or planar lipid bilayers (Belzacq et al., 
2002). Using the genetic manipulation of mice, once again, it has been demonstrated 
that inactivation of two ANT isoforms (ANT1 and ANT2) had no significant 
consequences for cell death in response to various inducers, and ANTs were considered 
dispensible for mitochondrial cyt c release (Kokoszka et al., 2004). Shortly after this 
particular work, however, a novel isoform of murine ANT was identified (Rodić et al., 
2005). The contribution of cyclophilin D (Cyp-D), a proposed element of the PTP, for 
cell death was also tested. Cyp-D-less cells were found to undergo normal apoptosis 
with no signifficant impact on cyt c release, which constitutes another evidence 
supporting that Bax does not seem to require the PTP components to induce MOMP 
(Baines et al., 2005; Nakagawa et al., 2005; Schinzel et al., 2005). Yeast has also been 
used as a biological model to study the functioning of Bax and its putative collaboration 
with mitochondrial proteins, providing evidence that Bax is able to release cyt c without 
the collaboration of the PTP or any similar system (Priault et al., 2003b). A work with a 
cell-free system actually revealed that the only requirements for Bax-induce membrane 
permeabilization seem to be the activation by Bid and a specific lipid mileu (Kuwana et 
al., 2002). Instead, two distinct mechanisms leading to cyt c release, Bax-dependent and 
-independent, may participate in specific processes leading to cell death and eventually 
coexisting in special circumstances (Eskes et al., 1998). 
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4.2.2. Contribution of Lipidic Pores 
An alternative model of MOMP proposes the formation of lipidic pores, catalysed 
and/or stabilized by Bax/Bak oligomers. In this model, activated Bax or Bak act directly 
by destabilizing the lipid bilayer structure of the OMM, promoting membrane bending 
and the eventual formation of pores large enough to allow release of cytochrome c from 
mitochondria (Basañez et al., 1999, 2002; Hardwick and Polster, 2002). Accordingly, 
Bax-induced pores have been described as large round holes with diameters of 25–100 
nm, with smooth edges at least partially framed by lipids (Qian et al., 2008; Schafer et 
al., 2009). 
For a long time, the mitochondria-specific phospholipid cardiolipin 
(diphosphatidylglycerol) has been a candidate of choice for this model. Indeed, it is able 
to form inverted micelles structures (hexagonal phase HII) that reorganize the lipid 
bilayers around contact sites between the outer and inner membranes and change 
membrane permeability properties (Schug and Gottlieb, 2009). Furthermore, it is well-
documented that cardiolipin is absolutely required for the mitochondrial localization of 
the BH3-only protein tBid (Lutter et al., 2000), which itself favours the oligomerization 
of Bax (Eskes et al., 2000). However, other experiments showed that cardiolipin is not 
required for Bax pore-forming activity, and might be more likely involved in the 
detachment of cytochrome c (and other apoptogenic factors) from the outer face of the 
inner mitochondrial membrane (Gonzalvez et al., 2005a; Kagan et al., 2005). It is 
noteworthy that the utilization of cardiolipin synthase-less yeast mutants has been very 
useful for these studies (Gonzalvez et al., 2005b; Iverson et al., 2004). 
Experiments performed by the groups of Siskind and Colombini delivered significant 
support for the role of ceramide-formed channels in Bcl-2 family proteins-induced 
MOMP. Indeed, in vitro experiments have demonstrated that physiological 
concentrations of ceramides are capable of forming large stable pores in membranes, an 
ability that seems to be specific of ceramide since its natural occurring precursor, 
dihydroceramide (lacking the 4–5 trans double bound present in ceramide), does not 
present this biochemical feature (Siskind and Colombini, 2000). These ceramide 
channels increase the permeability of planar lipid bilayers and of the OMM enabling the 
release of IMS proteins with an estimated molecular weight cut-off of 60 kDa (Siskind 
et al., 2002). Experiments on isolated mitochondria have demonstrated that cytochrome 
c can pass through these channels. Unrelated proteins of the IMS having a comparable 
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size, such as adenylate kinase (≈ 17 kDa) are also released, but matricial proteins such 
as fumarase (≈ 53 kDa) are not. Other apoptogenic factors of the IMS known to be 
released during apoptosis, such as Smac/Diablo (≈ 53 kDa for the dimer), Omi/HtrA2 (≈ 
48 kDa) and endonuclease G (≈ 28 kDa) might potentially pass through ceramide 
channels. Only AIF (≈ 61 kDa) has a size bigger than the cut-off of these channels. 
Interestingly, the cut-off of ceramide channels is about the same as the one of Bax 
channels (≈ 60 kDa). Moreover, it was demonstrated that Bax and ceramide can act 
synergistically in channel formation, in way that activated Bax would favour the growth 
of ceramide channels up to a maximal/optimal size determined by the structure of this 
pro-apoptotic regulator (Ganesan et al., 2010). 
Ceramides are definitely molecules of interest, particularly since several different 
studies have implicated ceramide in mitochondria-mediated apoptosis (Pettus et al., 
2002). First, cellular ceramide levels increase prior to the activation of the 
mitochondrial pathway of apoptosis (Rodriguez-Lafrasse et al., 2001). Second, 
ceramide has been shown to interact with and inhibit components of the mitochondrial 
respiratory chain in isolated mitochondria (Gudz et al., 1997), to increase ROS 
production in whole cells (France-Lanord et al., 1997) and isolated mitochondria 
(García-Ruiz et al., 1997), to induce mitochondrial depolarization and dysfunction 
(Hearps et al., 2002), and to facilitate the release of pro-apoptotic proteins (Di Paola et 
al., 2004; Zhang et al., 2008). Third, the discovery that mitochondria contain the 
enzymes involved in ceramide synthesis and the observation that several agents such as 
TNF, UV radiation and Fas increase the levels of ceramide in isolated mitochondria, 
confirmed that apoptosis occurs via an increase in mitochondrial ceramide levels 
(Siskind et al., 2005). Together, this evidences support a model of MOMP resulting 
from lipid channels induced and regulated by the action of Bcl-2 family proteins. 
 
4.2.3. Contribution of the IMM for MOMP 
One of the earlier mechanisms proposed to induce MMP is the formation of a 
mitochondrial pore designated PTP. Permeability transition defines the sudden increase 
in permeability of the IMM, which allows the passage of solutes and metabolites up to 
1.5 kDa, caused by the reversible opening of a voltage-dependent and high-conductance 
channel (≈ 2.3 nm diameter) (Crompton and Costi, 1988; Crompton et al., 1987a). 
Opening of the PTP can induce several physiological changes including the dissipation 
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of ΔΨm, resulting from the loss of IMM impermeability, and a massive swelling of the 
matrix, due to the osmotic-driven entering of water, which may leads to the rupture of 
the OMM and release of IMS proteins into the cytosol (Crompton et al., 1999; 
Halestrap, 1999). Mitochondrial permeability transition (MPT) has been described to 
occur under conditions of elevated matrix Ca
2+
 concentrations, and is sensitized by 
oxidative stress, high phosphate (Pi) concentrations and depletion of adenine 
nucleotides, although it can also be modulated by a series of substances, which change 
the Ca
2+
 sensitivity of the pore (Bernardi et al., 1999; Crompton and Costi, 1988; 
Crompton et al., 1987, 1987; Halestrap et al., 2002; Haworth and Hunter, 1979; Hunter 
and Haworth, 1979) the numerous efforts to define its molecular composition, the 
structure of the PTP remains indefinable. Several proteins normally participating in 
different metabolic functions have been proposed as either components or regulators of 
the PTP.  The core components initially ascribed to the mammalian PTP included the 
ANT, VDAC and Cyp-D (Crompton et al., 1998; Halestrap et al., 1997), all of which 
are highly conserved among eukaryotic organisms. Other proteins such as the cytosolic 
hexokinase, the matricial creatine kinase or the OMM TSPO (a.k.a. Bz receptor) were at 
some point associated to PTP formation (Zamzami et al., 2001). Several models have 
also been proposed each introducing new elements, such as the inorganic phosphate 
carrier or the F0F1 ATPase into the history of the PTP (Bernardi, 2013; Halestrap, 
2010; Siemen and Ziemer, 2013).  
Mitochondrial unselective channels are not exclusive to mammalian cells, but rather 
widely distributed in many species, exhibiting both similarities and differences in their 
regulation and physiological role (Uribe-Carvajal et al., 2011). One such example is 
Yeast Unselective Mitochondrial Channel (YMUC) (Azzolin et al., 2010). 
 
Adenine Nucleotide Translocator – ANT 
The ADP/ATP carrier (AAC) is the most abundant member of the Mitochondrial 
Carrier Family (MCF), which consists of a set of proteins responsible for approximately 
20 different transport functions involved in the fluxes of metabolites through the IMM. 
These mitochondrial carriers are implicated in energy-generating pathways, amino acid 
synthesis and degradation, and also in mitochondrial DNA replication (Nury et al., 
2006). The AAC exchanges cytosolic ADP for ATP produced in mitochondria, and 
seems to be indispensible to this organelle. 
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The involvement of ANT in the mitochondrial PTP is based on the effects that 
different ANT-interacting compounds produce on MPT (Halestrap, 2009). Indeed, PTP 
opening is stimulated by adenine nucleotide depletion and carboxyatractyloside (CAT), 
a specific ANT ligand, and inhibited by ATP, ADP and bongkekric acid (BKA), another 
ligand of the ANT that locks the translocator in a different conformation from that 
induced by CAT. These compounds act by changing the Ca
2+
 sensitivity of 
mitochondrial PTP. An interaction between the ANT and Cyp-D was also found 
(Crompton et al., 1998; Woodfield et al., 1998). 
The ANT has also been implicated in MPT as a target for oxidative stress and thiol 
reagents, two inducers of PTP opening that reduce the ability of adenine nucleotides to 
inhibit PT (Halestrap et al., 1997). This effect resulted from the cross-linking of Cys160 
with Cys 257 of the ANT and could be reproduced by eosin 5-maleimide, which only 
modifies Cys 160 (McStay et al., 2002). Additionally, the increased matrix Ca
2+
 
concentrations can induce the „c‟ conformation of the ANT (with the ATP binding site 
facing the cytsol), suggesting it could contain the Ca
2+
 triggering site of the PTP 
(Halestrap, 1987; Pebay-Peyroula et al., 2003). 
Experiments with reconstituted bovine ANT or the translocator from Neuspora 
crassa demonstrated the ability of these proteins to form non-specific channels induced 
by Ca
2+
 (Brustovetsky et al., 2002; Halestrap and Brenner, 2003). In the case of 
NcANT, opened pore probability was increased by oxidative stress at high membrane 
potential, in a cyclophilin-dependent manner. Studies using mice that were genetically 
inactivated for two ANT isoforms revealed that mitochondria could still undergo a CsA-
sensitive permeability transition which was less sensitive to Ca
2+
 than wild-type 
mitochondria, and insensitive to ligands of the ANT such as ADP, CAT and BKA 
(Kokoszka et al., 2004). Another ANT isoform was found shortly after in mice, which 
could account for the presence of some ANT in the manipulated mice mitochondria 
(Rodić et al., 2005). Still this would unlikely account for the observed adenine 
nucleotide-insensitive MPTP opening. Similarly the AAC, a S. cerevisiae homologue of 
mammalian ANT, is not required for yeast mitochondria to undergo MPT (Ballarin and 
Sorgato, 1995). Such evidences suggested that the ANT is not an indispensable 
component of the mitochondrial PTP, instead it might contribute with regulatory 
functions. 
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Voltage-Dependent Anion Chanel – VDAC 
VDAC (also called porin) is a small (≈30 kDa) highly-conserved protein that 
presumably exists in the OMM of all eukaryotic organisms. Its main function as an 
OMM channel is to facilitate and regulate the flow of metabolites between the cytosol 
and the mitochondrial IMS. To do so, VDAC forms a pore with an estimated internal 
diameter of 2.5 nm. 
VDAC was included in the PTP history after being co-purified in a complex with 
ANT, under specific conditions (McEnery, 1992). Later, VDAC was also found to bind 
ANT and Cyp-D from detergent-solubilized mitochondria (Crompton et al., 1998). 
However, genetically manipulated mice mitochondria, lacking the all three isoforms of 
VDAC, still exhibited MPT thus suggesting that VDACs are not essential components 
of the PTP. In S. cerevisiae the VDAC homologue, Porin1 (Por1p), also seems 
dispensable for the formation of YMUC (Lohret and Kinnally, 1995), nevertheless the 
absence of this porin changed the physiological properties of YMUC, suggesting a 
possible regulatory role (Gutierrez-Aguilar et al., 2007; Lohret and Kinnally, 1995). 
 
Other PTP components/models 
The involvement of Cyp-D in the PTP originates from the observation that 
submicromolar concentrations of the immunosuppressant drug cyclosporine A (CsA) 
could inhibit MPT, a critical finding for the elucidation of the molecular mechanism of 
the pore (Crompton et al., 1998). The mitochondrial Cyp-D was subsequently identified 
as a ≈ 18 kDa nuclear encoded cycliphilin isoform (Connern and Halestrap, 1992; 
Griffiths and Halestrap, 1991). Several CsA analogues, and other compounds, bind 
Cyp-D and inhibit PTP opening (Waldmeier et al., 2002). Mitochondria from mice in 
which Cyp-D was genetically inactivated no longer exhibited a CsA-sensitive PTP, and 
required a much higher Ca
2+
 loading to undergo permeability transition (Baines et al., 
2005; Basso et al., 2005). These findings reveal an important role of Cyp-D in the 
regulation of MPT, probably by facilitating a Ca
2+
-triggered conformational change in a 
membrane protein component of the PTP. 
Pi is a long-known inducer of mitochondria swelling (Azzi and Azzone, 1965; 
Crompton et al., 1988), a process that, more recently, has been proposed to involve the 
inorganic phosphate carrier (PiC) as the pore‟s Cyp-D binding component or the 
channel itself (Alcalá et al., 2007; Leung et al., 2008; Varanyuwatana and Halestrap, 
 General Introduction 
34 
 
2012). In the model of PiC as a member of the PTP, pore opening would be favored by 
Ca
2+
 and Cyp-D binding, possibly involving the formation of a heterodimer with the 
ANT (Leung et al., 2008). Contrasting reports on the ability of Pi to activate or inhibit 
the PTP, however, originated some skepticism around this model (Basso et al., 2008; 
Herick et al., 1997). 
An alternative and distinct model, proposes that PTP could be formed by the 
aggregation of misfolded integral membrane proteins damaged by stress, rather than 
being formed by specific proteins (He and Lemasters, 2002; Kowaltowski et al., 2001). 
In this model, PTP opening would be blocked by chaperone-like proteins, including 
CyP-D, modulated by Ca
2+
 and CsA, and occur when the protein aggregates exceeded 
the available chaperones (He and Lemasters, 2002). The involvement of the ANT and 
PiC would merely reflect the abundance of these proteins in the IMM and their 
susceptibility to oxidative damage. Yet, this model does not seem to account for typical 
features of the PTP such as the absolute Ca
2+
 requirement or the regulation by voltage, 
pH or adenine nucleotides, as well as a defined diameter. 
Recently, a new protein was brought into the picture and the PTP proposed to be 
constituted by dimers of the FOF1 ATP synthase (Giorgio et al., 2013). In fact, Cyp-D is 
able to bind the lateral stalk of the FOF1 ATP synthase in a process that requires Pi and 
partially inhibits its enzymatic activity. CsA could stimulate this activity suggesting that 
it blocked Cyp-D binding to the enzyme (Giorgio et al., 2009). Cyp-D is proposed to 
form an electrostatic interaction with the OSCP subunit of FOF1 ATP synthase, more 
precisely in a region over-lapping with helices 3 and 4 of this component (Giorgio et al., 
2013). Importantly this is also the binding site of Bz-423, an inhibitor of the FOF1 ATP 
synthase (Johnson et al., 2005), subsequently found to sensitize PTP opening to Ca
2+
, an 
effect that is opposed by Pi-dependent Cyp-D binding to OSCP (Giorgio et al., 2013). 
Moreover, decreased amounts of OSCP affected the Ca2+ dependence of the pore, 
suggesting the FOF1 ATP synthase as good candidate for PTP component. 
 
4.3. Mitochondrial morphology and cell death 
 
Another possible contribution of mitochondria to cell death may rely on their 
dynamic behaviour, as mitochondria continually fuse and divide to yield a dynamic 
interconnected network that spreads throughout the cell. Massive fission of the 
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mitochondrial network is a frequent event observed in apoptotic cells, with 
mitochondria changing from a thread organization into small, round and numerous 
grain-like organelles during apoptosis (reviewed in Youle and Karbowski, 2005). This 
event can be preceded by an elongation and hyperfusion of mitochondria, a process that 
is interpreted as a cell defence mechanism (Tondera et al., 2009). The physiological 
relevance of mitochondrial fragmentation for the apoptotic cell death program, however, 
is controversial issue (Landes and Martinou, 2011). 
 Importantly, changes in the dynamics of mitochondria morphology are actually able 
to modulate cell death. Inhibition of Drp1p and Fis1p, two proteins necessary for 
mitochondrial fission, is able to delay or even prevent apoptosis (Frank et al., 2001; Lee 
et al., 2004), while overexpression of Fis1p has been demonstrated to promote cell 
death (James et al., 2003). Conversely, overexpression of Mfn1 and Mfn2 mitofusins 
prevents apoptosis (Sugioka et al., 2004) while the loss of Opa1, a dynamin-related 
mitochondrial GTPase required for mitochondrial fusion, induces fragmentation of 
mitochondria, cyt c release and apoptosis (Olichon et al., 2003). Similar relations 
between mitochondrial morphology and cell death are also found in C. elegans and 
yeast (Fannjiang et al., 2004; Jagasia et al., 2005). 
As for mammals, yeast proteins involved in mitochondria morphology can also 
modulate cell death. Accordingly, deletion of the fission proteins Dnm1p, homologue of 
mammalian Drp1p, and Mvd1p delays the fragmentation of the mitochondrial network 
and promotes cell survival following a death stimulus or in ageing cells (Fannjiang et 
al., 2004; Scheckhuber et al., 2007). Dnm1p-mediated mitochondrial fragmentation and 
yeast cell death can be prevented by the human anti-apoptotic proteins Bcl-2 and Bcl-xL 
(Fannjiang et al., 2004). Other proteins associated with cell death in yeast can also 
contribute to mitochondrial morphology. This is the case for Yca1p (yeast caspase 1), a 
Ca
2+
-dependent cysteine protease whose deletion has been associated to a decrease in 
mitochondria fission and increased survival in response to different death stimuli 
(Mazzoni et al., 2005).  Two mitochondrial proteins named yeast suicide protein 1 and 
2, Ysp1p and Ysp2p, have also been identified as necessary elements for mitochondrial 
fission associated to amiodarone-induced cell death in yeast (Pozniakovsky et al., 2005; 
Sokolov et al., 2006). 
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5. Sphingolipid Metabolism and Cell Death 
 
5.1. Sphingolipid Metabolism 
 
Sphingolipids are a class of lipids composed typically by an 18-carbon amino alcohol 
backbone, the sphingosine long-chain base, attached to one long-chain fatty acid and, in 
most cases, to a polar head group. Modifications in the type of sphingosine long-chain, 
fatty acid and polar head group are what give rise to the vast family of sphingolipids 
(Hannun and Obeid, 2011; Ozbayraktar and Ulgen, 2009). 
In mammalian cells, the sphingolipid metabolic pathway displays a complex network 
of reactions resulting in the formation of a multitude of sphingolipids in which ceramide 
can be considered a metabolic hub, occupying a central position in sphingolipid 
biosynthesis and catabolism. In fact, sphingolipid metabolism comprises a de novo 
biosynthesis pathway as well as a sphingolipid turnover pathway (Fig 5).  
 
Fig. 5 – Overview of mammalian (left) and yeast (right) sphingolipid metabolism. Ceramide, which 
occupies a central position in the sphingolipid network, can be generated by de novo syntesis or by the 
turnover of complex sphingolipids. The pathways and constituents underlying the metabolism of 
sphingolipids are highly conserved in yeast (image from Rego et al., 2013).   
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Sphingolipid biosynthesis is initiated in the ER with the condensation of serine and 
palmitoyl-CoA, a reaction catalyzed by a serine palmitoyltransferase, to yield 3-keto-
dihydrosphingosine. In turn, a 3-ketodihydrosphingosine reductase reduces 3-keto-
dihydrosphingosine to dihydrosphingosine, which is subsequently acylated to 
dihydroceramide by the action of one of six distinct ceramide synthases. 
Dihydroceramide can be desaturated by dihydroceramide desaturase to form ceramide. 
In the following sphingolipid biosynthetic reactions, ceramide is used to generate 
complex sphingolipids such as glucosylceramide, galactosylceramide and 
sphingomyelin. Sphingomyelin, the most abundant complex sphingolipid, is produced 
by transferring a phosphocholine headgroup from phosphatidylcholine to ceramide 
through the action of sphingomyelin synthase. Ceramide can also be glycosylated by 
glucosyl or galactosyl ceramide synthases thus generating glucosylceramide and 
galactosylceramide, respectively, or can be phosphorylated to form ceramide-1-
phosphate.  
An alternative important source of ceramide is provided by the turnover of complex 
sphingolipids. The conversion of glucosylceramide and galactosylceramide to ceramide 
occurs predominantly through hydrolysis of the monosaccharide residues from these 
lipids by the action of specific hydrolases. The catabolism of sphingomyelin into 
ceramide is catalyzed by one of the acid, neutral or alkaline shingomyelinases (SMases). 
The yielded ceramide can be broken down by ceramidases leading to the formation of 
sphingosine, which in turn can be phosphorylated to sphingosine-1-phosphate. The 
sphingosine-1-phosphate can be recycled into the biosynthestic pathway or instead it 
can be irreversibly cleaved to ethanolamine phosphate and hexadecenal, thus exiting the 
sphingolipids metabolism (for a review see Bartke and Hannun, 2009; Gault et al., 
2010; Hannun and Obeid, 2008).  
The pathways and constituents underlying the metabolism of sphingolipids are 
highly conserved in yeast (Fig 5). Phytoceramide and dihydroceramide are assumed to 
be the yeast counterparts of mammalian ceramides. The steps to the generation of 
dihydroceramide in yeast are identical to what was described for mammalian cells. 
Phytoceramide, the yeast ceramide counterpart, is generated by the hydroxylation of 
dihydrosphingosine to form phytosphingosine, which is subsequently acylated. 
Phytoceramide and dihydroceramide are first converted into inositol 
phosphorylceramide, by the transfer of a phosphorylinositol group to ceramide, and then 
mannosylated to form mannosylinositol phosphorylceramide. The final step in yeast 
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sphingolipid synthesis is the formation of mannosyldiinositol phosphorylceramide, the 
most abundant complex lipid in this organism.  As in mammalian cells, yeast ceramides 
can also be produced by the catabolism of the complex sphingolipids. This reaction is 
catalyzed by the inositol phosphosphingolipid phospholipase C (Isc1p), which has 
phospholipase-C-type activity and hydrolyses the polar head groups from complex 
sphingolipids, releasing dihydroceramide and phytoceramide. (for a review see Dickson, 
2010; Rego et al., 2013). 
 
5.2. Sphingolipids in cell death signalling 
 
First discovered by Johann Thudichumin in the 1870s, sphingolipids represent the 
second major class of lipids constituents of membranes in eukaryotes, and for a long 
time, they were considered to be merely structural components of the biological 
membranes. However, intensive research on sphingolipids‟ metabolism and function 
has revealed that they can act as bioactive molecules in a variety of signaling pathways, 
controlling diverse cellular processes such as differentiation (Okazaki et al., 1989), 
senescence (Venable et al., 1995), proliferation (Adam et al., 2002), cell cycle 
progression (Cowart and Obeid, 2007), mitogenesis, inflammation (Lamour and 
Chalfant, 2005), migration and angiogenesis (Hannun and Obeid, 2008), necrosis (Hetz 
et al., 2002), and apoptosis (Obeid et al., 1993). In fact, a vast number of scientific 
works were published in the last decades connecting the dynamic equilibrium of the 
levels of sphingolipids, particularly ceramide, sphingosine and sphingosine-1-
phosphate, to the processes of PCD, particularly apoptosis. In mammalian cells, the 
increase of ceramide and sphingosine levels has been shown to induce cell growth arrest 
and apoptosis, whereas the increase of sphingosine-1-phosphate levels promotes cell 
proliferation and inhibits apoptosis (Futerman and Hannun, 2004).  
The increase of ceramide levels during apoptosis was observed in response to several 
stimuli such as different chemotherapeutic agents (Quintans et al., 1994), cytokines 
(TNF-α; IL-1b and FasL) (Dressler et al., 1992; Gulbins et al., 1995; Mathias et al., 
1993), environmental stresses (like heat shock, oxidative stress, ionizing and UV 
radiation and growth factor withdrawal (Chang et al., 1995; Obeid et al., 1993), and 
other agents of stress, injury or infection (HIV or bacteria) (Grassmé et al., 2003; De 
Simone et al., 1996). Generation of ceramide after these stimuli can occur either by de 
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novo synthesis (slow accumulation) and/or by complex sphingolipids turnover (fast 
accumulation) (Zhang et al., 2009). The elevation of ceramide levels, by inducing the 
endogenous expression of ceramide metabolic enzymes or through direct exogenous 
delivery, has also been reported to induce apoptosis (Veldman et al., 1998; Zhang et al., 
1997).  Ceramide-induced apoptosis is a very specific process since dihydroceramide, 
the natural precursor of ceramide, is not able to induce apoptosis, and the blockage of 
ceramide generation is able to prevent cell death mediated by pro-apoptotic agents 
(Bielawska et al., 1993; Obeid et al., 1993) (Fig. 6). 
The effects of ceramide in apoptosis appear to be mediated by diverse pathways 
including: protein kinases and phosphatases, such as ceramide-activated protein kinase 
(CAPK), protein kinase C (PKC), mitogen-activated protein kinases (MAPKs) and 
ceramide-activated protein phosphatases (CAPPs), or through the interaction with 
caspases and mitochondria (Hannun and Obeid, 2008; Mathias et al., 1998; Nikolova-
Karakashian and Rozenova, 2010). Indeed, ceramide-mediated cell death seems to 
depend, at least in part, on the activation of PP1 and PP2A CAPPs, promoting their 
phosphorylation and consequent inactivation of AKT/PKB, an important element in the 
regulation of cell survival (Chalfant et al., 1999). It has also been proposed that 
ceramide regulates PKC ζ (Bourbon et al., 2000; Lozano et al., 1994), Kinase 
Suppressor of Ras (KSR) (Zhang et al., 1997), JNK pathway (Nica et al., 2008; Verheij 
et al., 1996; Westwick et al., 1995), and p38 (Willaime et al., 2001) by significantly 
changing the phosphorylation levels of various key substrates. Another binding target 
for ceramide is the endossomal acidic aspartate protease cathepsin D, which directly 
affects the regulation of MOMP by Bcl-2 family proteins (Heinrich et al., 2004). 
Ceramides have also direct effects on mitochondrial function, thus interfering with 
its role in mitochondria-mediated apoptosis. For instance, ceramide inhibits components 
of the mitochondrial respiratory chain in isolated mitochondria (Gudz et al., 1997), 
induces mitochondrial dysfunction (Hearps et al., 2002) and the release of pro-apoptotic 
proteins (Di Paola et al., 2004; Zhang et al., 2008), and increases the production of ROS 
in isolated mitochondria (García-Ruiz et al., 1997). Additionally, it was also described 
that cellular ceramide levels increase prior to the activation of the mitochondrial 
pathway of apoptosis (Rodriguez-Lafrasse et al., 2001), as do the mitochondrial 
ceramide levels (Siskind et al., 2005). 
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Fig. 6 – Ceramide signaling in Apoptosis. Different stimuli, including environmental stresses, 
citokines and diverse chemotherapeutic agents, induce ceramide generation through de novo synthesis or 
breakdown of complex sphingolipids. Generated ceramide accumulates and activates a series of proteins 
responsible for multiple signaling events, thus amplifying the scope of ceramide signaling. Downstream 
targets of ceramide include: ceramide-activated protein kinases (CAPKs), ceramide-activated protein 
phosphatases (CAPPs), Protein Kinase C (PKC) and mitogen-activated protein kinases (MAPKs).  
Ceramide mediated signaling events target several players directly or indirectly involved in the control of 
apoptosis including Bcl-2 family proteins and mitochondria (image from Rego et al., 2013). 
 
These overwhelming and increasing evidences place sphingolipids in the front line of 
the cellular battle for life and death. Through signaling events or direct interference in 
mitochondria, ceramide in particular, and sphingolipids in general might truly have the 
power to change the balance and decide the cellular fate. The intersection of 
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sphingolipid metabolism with the Bcl-2 family function, key regulators of MOMP and 
cell death, will be discussed in the following sections. 
 
5.2.1. Sphingolipids and Bcl-2 family proteins in the regulation of MOMP 
The concept of cooperation between ceramides and Bcl-2 family members during 
MOMP arises from the observation that anti-apoptotic proteins Bcl-2 and Bcl-xL are 
capable of preventing ceramide-induced cytochrome c release from mitochondria (see 
for example (Geley et al., 1997; Ghafourifar et al., 1999; Wiesner et al., 1997), although 
the specific molecular mechanisms regulating these actions remain unclear. It has been 
shown that Bcl-2 and Bcl-xL can inhibit ceramide-induced apoptosis by direct action on 
ceramide generation, reducing or even preventing its accumulation (Sawada et al., 2000; 
Tepper et al., 1999). Recently, it has been demonstrated that the pro-apoptotic protein 
Bak is required for long-chain ceramide generation during irradiation-induced 
apoptosis, a mechanism that seems to depend on post-translational modifications of 
ceramide synthase (Siskind et al., 2010). Due to the complexity of sphingolipid 
metabolism (Hannun and Obeid, 2008), the mechanisms regulating the role of Bcl-2 
family members in ceramide-induced apoptosis may rely on the different metabolic 
pathways and subcellular locations regarding ceramide generation, involving a complex 
interplay between sphingolipid metabolism proteins and Bcl-2 family members. 
Nonetheless, it has also been established that over-expression of either Bcl-2 or Bcl-
xL can protect different cell lines against ceramide-induced apoptosis without 
preventing ceramide generation and/or accumulation (Allouche et al., 1997; Wiesner et 
al., 1997; Zhang et al., 1997). These findings suggest that inhibition of ceramide-
induced apoptosis by anti-apoptotic Bcl-2 proteins occurs downstream of ceramide 
generation. In fact, addition of ceramide analogues to isolated mitochondria induces 
cytochrome c release, but this process is completely prevented by preincubation of 
mitochondria with Bcl-2 (Ghafourifar et al., 1999).  
The formation of protein-permeable ceramide channels in the OMM does not require 
Bcl-2 family proteins; however, both human Bcl-xL and CED-9 (a Bcl-2 homologue 
from C. elegans) are capable of disassembling ceramide channels in mitochondria 
isolated from rat liver and yeast (Siskind et al., 2008). The same phenomenon is 
observed in the defined system of planar phospholipid membranes, suggesting that 
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channel disassembly might involve a direct interaction with the anti-apoptotic Bcl-2 
members (Siskind et al., 2008). 
Ceramide also collaborates with pro-apoptotic members of the Bcl-2 family, since it 
has been reported to induce a Bax-dependent cell death process in a variety of cell lines 
(von Haefen et al., 2002; Kim et al., 2001; Sawada et al., 2000). In fact, Bax 
translocates to mitochondria of cells undergoing ceramide-mediated apoptosis (Kim et 
al., 2001), and a direct interaction between ceramide and Bax has been demonstrated in 
isolated yeast mitochondria and planar phospholipid membranes, revealing that these 
molecules act synergistically on mitochondria to induce MOMP (Ganesan et al., 2010). 
An in vitro experiment with bacterial SMase-treated mitochondria showed that 
generation of ceramide in this organelle might be sufficient to induce Bax translocation 
to mitochondria (Birbes et al., 2005). Recent studies have identified ceramide-enriched 
detergent-resistant microdomains in the mitochondrial membrane, with which Bax 
preferentially associates (Martínez-Abundis et al., 2009). Additionally, Bax isolated 
from these mitochondrial ceramide-rich domains (MCRDs), which are virtually non-
existent in healthy cells, is in the form of high-molecular weight oligomers compatible 
with pore formation, while the non-MCRD membranes contain the monomeric form of 
Bax exclusively (Lee et al., 2011). A deeper look into the relation between 
sphingolipids and the pro-apoptotic Bcl-2 family members revealed that mitochondrial 
ceramide serves as precursor of sphingosine-1-phosphate and hexadecenal, which 
cooperate specifically with Bak and Bax, respectively (Chipuk et al., 2012). Indeed, 
overexpression of mouse sphingomyelin synthase-1, altering sphingolipid metabolism 
to favour SM accumulation, was able to decrease the sensitivity of yeast cells to the 
action of Bax (Yang et al., 2006). Such observations support the idea that ceramide 
accumulation in the OMM of apoptotic cells creates a specific micro-environment that 
might be essential for the action of pro-apoptotic Bcl-2 proteins. 
 
5.2.2. Sphingolipids and phosphoregulation of Bcl-2 family members  
The collaboration between sphingolipids and Bcl-2 family members is not limited to 
the direct interaction of ceramide and these apoptotic regulators in the mitochondrial 
membrane. Ceramide, like other sphingolipids, can act as a signalling molecule in a 
variety of physiological responses, and several proteins have been shown to interact 
with ceramide both in vitro and in cells (Hannun and Obeid, 2008). In fact, protein 
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phosphatases 1 (PP1) and 2A (PP2A) are stereospecific ceramide-activated protein 
phosphatases (CAPP) that can bind to ceramide in vitro (Chalfant et al., 1999, 2004), 
and mediate two distinct ceramide signalling pathways. In cancer cells, exogenously 
added or de novo generated ceramide induced dephosphorylation of Serine/Arginine-
rich (SR) proteins (Chalfant et al., 2001), known modulators of mRNA splicing and 
specific substrates of PP1 (Mermoud et al., 1994). Consistently, ceramide has been 
shown to regulate the alternative splicing of Bcl-x and caspase-9 mRNA (Boise et al., 
1993; Srinivasula et al., 1999) through a PP1-dependent mechanism (Chalfant et al., 
2002). Treatment of lung cancer cells with ceramide, or ceramide-inducing agents, 
downregulates the mRNA levels of the anti-apoptotic proteins Bcl-xL and caspase-9b, 
and increases the levels of the pro-apoptotic forms Bcl-xS and caspase-9 (Chalfant et al., 
2002). Ceramide is also a specific activator of PP2A (Dobrowsky and Hannun, 1992, 
1993), a protein that directly interacts with Bcl-2 to dephosphorylate this anti-apoptotic 
regulator at serine 70 and promote its binding to p53, therefore inhibiting Bcl-2‟s 
survival functions (Deng and Ma, 1998; Deng et al., 2009; Ruvolo et al., 1999). PP2A is 
able to regulate the phosphorylation state of Bax in response to ceramide as well, since 
it co-localizes and interacts with Bax in intact cells, and directly dephosphorylates it in 
vitro (Xin and Deng, 2006). Ceramide-induced Bax dephosphorylation causes a 
conformational change that promotes the insertion and oligomerization of Bax in the 
OMM, and also disrupts the Bcl-2/Bax association to liberate Bax from the 
heterodimeric complex (Xin and Deng, 2006). Additionally, PP2A activates the pro-
apoptotic function of Bad, in a mechanism that involves dissociation of Bad from 14-3-
3 proteins (Chiang et al., 2001), a family of multifunctional phosphoserine binding 
molecules that can serve as effectors of survival signalling (Tzivion and Avruch, 2002). 
The 14-3-3 protein associates with Bad, facilitating the phosphorylation of Ser155 by 
survival promoting kinases, and thus controlling Bad‟s pro-apoptotic activity (Datta et 
al., 2000). 
Other targets for ceramide mediated-dephosphorylation include for example the 
retinoblastoma gene product RB, PKCα (Lee et al., 1996) and protein kinase B (PKB or 
AKT) (Schubert et al., 2000). The serine/threonine protein kinase AKT is recruited to 
the plasma membrane and activated through PI(3)K signalling in response to various 
growth factors (Burgering and Coffer, 1995). AKT is considered a central player in the 
regulation of metabolism, mobility, transcription, cell-cycle progression and cell 
survival (Fayard et al., 2005). The pro-survival role of AKT is associated, at least in 
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part, with the inhibition of apoptosis (Dudek et al., 1997; Kauffmann-Zeh et al., 1997), 
and once activated this kinase interacts with different proteins, acting both upstream and 
downstream from MOMP (Franke et al., 2003). Among other cellular targets, AKT is 
able to regulate the action of both anti- and pro-apoptotic Bcl-2 family members. The 
first evidence of this relation emerged from the observation that growth factor activation 
of the PI(3)K/AKT signalling pathway induces phosphorylation of Bad, and that AKT is 
actually able to phosphorylate this pro-apoptotic regulator both in vitro and in vivo, thus 
promoting cell survival (Datta et al., 1997; del Peso et al., 1997). Since then, several 
studies have reported a role of AKT in the regulation of other Bcl-2 family proteins 
such as Bcl-2 (Pugazhenthi et al., 2000), Bcl-xL (Jones et al., 2000) Bax (Gardai et al., 
2004), Bak and Bik (Kennedy et al., 1999). Interestingly, downregulation of PI(3)K 
activity by stress-induced ceramide results in the inhibition of AKT and decreased 
phosphorylation of Bad (Zundel and Giaccia, 1998), indicating that the action of AKT is 
negatively regulated by this sphingolipid. The regulation of AKT by ceramide might 
comprise two independent mechanisms: blockage of AKT translocation to the plasma 
membrane, and stimulation of AKT dephosphorylation (Stratford et al., 2004). 
Experiments in rat adipocytes revealed that PP2A is the primary regulator of AKT 
dephosphorylation, establishing a direct pathway for ceramide to control AKT activity 
(Resjö et al., 2002). Another key element involved in ceramide-mediated AKT 
inactivation is the atypical PKC isoform ζ, which associates with AKT in vivo and acts 
as negative regulator of this kinase (Doornbos et al., 1999). Ceramide can specifically 
bind PKCζ and has been shown to activate this kinase in vitro, and in vivo by treating 
cells with exogenous SMase (Bourbon et al., 2000; Lozano et al., 1994), a process that 
involves recruitment and phosphorylation of PKCζ within structured lipid 
microdomians (Fox et al., 2007). Ceramide-activated PKCζ increasingly associates with 
AKT, leading to diminished AKT activation and consequent growth arrest (Bourbon et 
al., 2002).  PKCζ phosphorylates AKT at Thr34 inhibiting its ability to bind to 
phosphatidylinositol 3,4,5-triphosphate (PIP3) at the plasma membrane, thereby 
disrupting AKT activation by PI(3)K signalling (Powell et al., 2003). Curiously, PKCζ 
can also promote cell survival through the inhibition of acid SMase in response to UV-
C irradiation (Charruyer et al., 2007) and the phosphorylation of Bax at Ser184, 
sequestering Bax in cytoplasm  (Xin et al., 2007). Such observations establish a new 
mechanism for the regulation of cell death by sphingolipids that comprises an interplay 
between ceramide, PI(3)K/AKT signalling and Bcl-2 family members. 
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Another direct effector of ceramide is the lysosomal aspartyl protease cathepsin D. 
Endosomal ceramide, resulting from the activity of an acid SMase, binds to and 
promotes the autocatalytic proteolysis of procathepsin D to originate its enzymatically 
active isoforms (Heinrich et al., 1999). Remarkably, cathepsin D colocalizes with the 
BH3-only protein Bid in HeLa cells, and directly cleaves this apoptotic regulator in 
vitro (Heinrich et al., 2004). Stimulation of acid SMase activity by TNF-α or 
chemotherapeutic drugs leads to the accumulation of endosomal and lysosomal 
ceramide, which in turn enhances the cathepsin D-mediated cleavage of Bid, activating 
it to promote the insertion of Bax in the OMM and trigger the mitochondrial pathway of 
apoptosis (Heinrich et al., 2004). 
Other sphingolipids can also participate in the regulation of Bcl-2 family proteins. 
Sphingosine, which unlike ceramide is not exclusively confined to membrane fractions, 
is able to activate sphingosine dependent kinases (SDK) such as SDK1 – a caspase-
cleaved fragment of PKCδ (Hamaguchi et al., 2003; Megidish et al., 1998) – and PKA, 
both of which phosphorylate a serine residue at the interface of the dimeric 14-3-3 
proteins. This reaction results in disruption of dimeric 14-3-3 into the monomeric form, 
potentially modulating several biological functions (Woodcock et al., 2003). Indeed, 14-
3-3 proteins have been shown to block apoptosis (Xing et al., 2000) in a process that 
involves the inhibition of Bad (Masters et al., 2001). Therefore, sphingosine-induced 
monomerization of 14-3-3 protein may promote an apoptotic pathway via disruption of 
14-3-3‟s anti-apoptotic function. Additionally, sphingosine can also activate 3-
Phosphoinositide-Dependent Kinase 1 (PDK1), a kinase acting upstream of AKT (King 
et al., 2000). Another sphingolipid, sphigosine-1-phosphate, generally associated with 
pro-survival effects, enhances activation of the PI(3)K/AKT pathway with an associated 
up-regulation of the anti-apoptotic Bcl-2 and down-regulation of the pro-apoptotic Bim 
(Limaye et al., 2005).  
 
5.2.3. Sphingolipids and the heterologous expression of Bcl-2 family 
members in yeast  
Generation of ceramide in response to different stresses has also been observed in 
yeasts, suggesting that ceramide signalling is an “old” response conserved from yeasts 
to mammals (Jenkins et al., 1997; Mathias et al., 1998). Interestingly, addition of 
ceramide to the yeast Saccharomyces cerevisiae induces a cell cycle arrest in G1 phase, 
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an effect partially mediated by a ceramide-activated protein phosphatase (Nickels and 
Broach, 1996). Recent developments on the putative role of ceramide in yeast cell death 
implicate mitochondria and the organization of the plasma membrane as targets for 
ceramide action and consequent loss of viability (Carmona-Gutierrez et al., 2011; 
Pacheco et al., 2013; Rego et al., 2012). These evidences argue in favour of exploring 
yeast as a model to understand the basis of ceramides‟ cytotoxicity  
In vitro experiments with isolated yeast mitochondria have been a useful tool to show 
the regulation of ceramide channel by recombinant Bcl-2 family proteins (Siskind et al., 
2008). However, in vivo experiments in yeast would be an interesting alternative to gain 
more insights in the mechanistic support of this process. Although yeast does not 
contain a family of Bcl-2-like proteins, only one putative member being described so far 
(Büttner et al., 2011), the heterologous expression of pro-apoptotic Bax or Bak in yeast 
is able to induce MOMP (Marzo et al., 1998b; Priault et al., 1999), eventually leading to 
growth arrest and death. For that reason, yeast has been used to identify proteins capable 
of suppressing the growth-inhibitory effects of Bax (Yang et al., 2006). This study 
reported the involvement of sphingolipid metabolism in the effects of Bax and showed 
that mouse sphingomyelin synthase 1 (SMS1) expression can prevent Bax-mediated cell 
death as well as the effects of several stresses, namely hydrogen peroxide, osmotic 
stress, elevated temperature and exogenous ceramides. Different mutants of Bcl-2 
family proteins can be expressed in yeast, and they resume the properties expected from 
experiments in mammalian cells (see for example Arokium et al., 2004; Cartron et al., 
2005). 
The availability of yeast mutants deleted for genes encoding enzymes involved in 
ceramide metabolism offers the opportunity to test the effects of these enzymes on the 
capacity of Bax, and other Bcl-2 family members, to interact with OMM and to regulate 
MOMP. For example, one might expect that a yeast mutant with low ceramides content 
might be less sensitive to Bax-induced permeabilization of the OMM to cytochrome c. 
Conversely, a lower expression of Bcl-2/Bcl-xL would be required to disassemble 
ceramide channels and prevent the release of cytochrome c induced by a yeast cell death 
stimulus such as acetic acid (Pereira et al., 2007). Combining the utilization of ceramide 
metabolism mutants with Bcl-2 proteins might provide a powerful system to accurately 
define the molecular determinants underlying their interactions during cell death.  
Numerous kinases and phosphatases are conserved between yeast and mammals. 
Several yeast kinases, such as Sch9p, the yeast potential homolog of AKT (Fabrizio et 
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al., 2001), are able to phosphorylate Bax (Simonyan et al., unpublished data). 
Alternatively, mammalian kinases and phosphatases can be expressed in yeast, keep 
their function, and eventually compensate the genetic absence of the endogenous yeast 
homologs. The heterologous co-expression of mammalian kinases/phosphatases of 
interest with Bcl-2 family members in yeast mutants for ceramide metabolism might be 
a sophisticated and powerful tool to investigate the connection between ceramides, 
kinases/phosphatases signalling pathways and the capacity of Bcl-2 family proteins to 
regulate MOMP. As an example, one can envisage the heterologous expression of AKT 
and Bax in ceramide metabolism mutant strains as a tool to investigate how the 
ceramide-regulation of the kinase may have consequences on Bax ability to promote 
MOMP. 
Together, the reports mentioned in the last sections and the promise from future 
experimentation, provide a nice perspective on what might be the intricate network of 
cellular events that connects sphingolipids, Bcl-2 family proteins and mitochondria in 
the regulation of cell death. 
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6. Scope of the thesis 
 
The yeast S. cerevisiae, while easy-to-manipulate and genetically defined model, has 
been widely and successfully used to study different aspects of cell death biology, either 
through the heterologous expression of know regulators from mammalian cell death 
programs, or through the examination of possibly conserved cell death mechanisms 
mediating the response of yeast cells to different stress stimuli (Priault et al., 2003; 
Carmona-Gutierrez et al., 2010). On this work, and once more, we explore the potential 
of yeast to investigate distinct processes involved in cell death, through a set of different 
physiological and biochemical assays. Accordingly, the following chapters of this thesis 
will describe the knowledge and experimental approaches used to: i) evaluate the role of 
Aac2p cysteine residues, and Aac2p oxidation in the acetic acid-induced apoptotic-like 
death of S. cerevisiae ii) assess the role of the AAC and Por1 in acetic acid-induced 
MOMP, during yeast cell death; iii) and study the influence of sphingolipid metabolism 
in the action of structurally and functionally different forms of Bax, as well as in the 
pro-apoptotic activity of Bcl-xL. The observations documented during our 
experimentations are presented and discussed in light of contemporary knowledge, 
followed by the major conclusions and future perspectives into what may follow in each 
particular subject. 
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1. Introduction 
 
Mitochondrial outer membrane permeabilization (MOMP) is considered a crucial 
event in the intrinsic mammalian apoptotic pathway, enabling the release of apoptogenic 
molecules, such as cytochrome c (cyt c), from mitochondria to the cytosol (Tait and 
Green, 2010). In spite of its importance for apoptosis, the molecular mechanisms 
responsible for MOMP are still a matter of debate. Different mechanisms underlying 
such mitochondrial events have been suggested involving the pro-apoptotic members of 
the Bcl-2 protein family, putative components of the permeability transition pore (PTP) 
and the formation of ceramide channels, all of which might be involved in a complex 
interplay that determines the fate of a cell (Desagher and Martinou, 2000; Siskind, 
2005). 
In mammals, the formation of a mitochondrial pore designated PTP, which induces 
mitochondria swelling and subsequent rupture of the outer mitochondrial membrane 
(OMM), is considered a key step in mitochondria permeabilization and cell death 
(Kroemer and Reed, 2000). Mitochondrial PTP is a non-specific pore that allows the 
passage of virtually any molecule with a molecular mass inferior to 1500 Da, occurring 
in the inner mitochondrial membrane (IMM) under conditions of elevated matrix Ca
2+
 
concentrations, especially when this is accompanied by oxidative stress and depletion of 
adenine nucleotides (Halestrap et al., 2002). The exact molecular composition of the 
PTP is not entirely defined, although it is generally accepted that opening of PTP 
implicates a multicomponent protein complex (PTPC) and not a single protein (Siemen 
and Ziemer, 2013). PTPC assembly is thought to occur at the contact sites of the inner 
and outer mitochondrial membranes (Beutner et al., 1996), and several different proteins 
have been considered as either structural or regulatory components of the pore. The first 
candidates included the voltage-dependent anion channel (VDAC) in the OMM (Szabo 
et al., 1993; Szabo and Zoratti, 1993), the adenine nucleotide translocator (ANT) in the 
IMM (Halestrap and Davidson, 1990), and cyclophylin D (CyP-D) in the matrix 
(Griffiths and Halestrap, 1991; Halestrap and Davidson, 1990). Other proteins such as 
hexokinase (Beutner et al., 1998; Beutner et al., 1996), the translocator protein TSPO 
(a.k.a. peripheral benzodiazepine (Bz) receptor) (Hirsch et al., 1998) and Bcl-2 family 
members (Marzo et al., 1998; Zamzami and Kroemer, 2001) have been proposed to 
participate in the PTPC assembly and/or regulation. This original model of PTPC has 
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evolved. While the contribution of some proteins to the PTPC was questioned, new 
elements were introduced as possible members of the pore. In 2008, the mitochondrial 
phosphate (Pi) carrier was brought into this issue and suggested as an important 
component of the PTPC, an hypothesis based on the interactions of the carrier with 
CyP-D and the ANT (Leung et al., 2008). Recently, Giorgio and colleagues observed 
that purified dimers of the F1F0 ATP synthase reconstituted into lipid bilayers where 
able to trigger the opening of a channel with a conductance identical to that of the PTP, 
and thus proposing a new model for the pore (Giorgio et al., 2013). 
The hypothesis of ANT‟s involvement in the PTP probably arose from the 
observation that Ca
2+
-induced MOMP can be modulated by ligands of the ANT, such as 
the ANT‟s inhibitors atractyloside and bongkrekic acid or its own substrate ADP 
(Haworth and Hunter, 1979; Hunter and Haworth, 1979). Supporting this idea, a highly 
purified and functional ANT was incorporated in, and successfully permeabilized 
asolectin/cardiolipin vesicles in the presence of Ca
2+
 (Ruck et al., 1998). This effect was 
inhibited by ADP, promoted by atractyloside and insensitive to cyclosporine A (which 
binds to CyP-D), driving the authors to conclude that ANT itself is capable of adopting 
a pore-like structure under conditions known to induce PTP opening (Ruck et al., 1998). 
The concept of the ANT as a core component of the PTP was seriously questioned when 
Kokoszka and colleagues observed that mouse liver mitochondria lacking the two 
isoforms of ANT could still undergo PT induced by different promoters of cell death 
(Kokoszka et al., 2004). Under such experimental conditions, PTP opening simply 
required higher concentrations of Ca
2+
, and could no longer be regulated by the ANT 
ligands (Kokoszka et al., 2004). Meanwhile, a novel ANT gene, ANT4, was identified is 
mouse stem cells casting some doubts on the idea that the ANT would be irrelevant for 
PTP opening (Rodic et al., 2005). It seems reasonable to assume that, even if it is not a 
core component of the PTP, the ANT might play important regulatory functions in some 
scenarios of cell death. 
The ADP/ATP carrier (AAC), a yeast orthologue of mammalian ANT, has been 
identified as a necessary element to MOMP, and consequent release of cyt c, during cell 
death induced by acetic acid  in yeast (Pereira et al., 2007). Absence of AAC proteins 
increases the resistance of Saccharomyces cerevisiae to acetic acid, yet the biochemical 
events underlying such process remain poorly understood (Pereira et al., 2007). 
Deletion of Aac2p, the major isoform of the AAC expressed under derepressed 
conditions (Kolarov et al., 1990), is associated with a massive reduction in cyt c content 
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and respiration (Gawaz et al., 1990). The role of Aac2p in acetic acid-induced cell 
death, however, does not depend on the carrier‟s capacity to translocate adenine 
nucleotides since op1, a mutated form of Aac2p affected on its transport activity, was 
still able to promote MOMP (Pereira et al., 2007). Opening of the PTP has been 
associated with several distinct mechanisms including the chemical modification of 
PTPC proteins, such as protein oxidation. ADP/ATP translocases are known to be 
sensitive to oxidative stress, especially in the thiol groups of cysteine residues (McStay 
et al., 2002). Thiol reagents and oxidative stress, known inducers of MPT, are able to 
modify thiol groups in the ANT (Halestrap et al., 1997), and the cross-linking of ANT 
thiols has been proposed as a mechanism capable of inducing PTP opening (Costantini 
et al., 2000). In yeast, it has been proposed that ROS-mediated Aac2p modifications are 
responsible for reduced proliferation rates of S. cerevisiae cells in response to an over-
activation of RAS/protein kinase A (PKA) signaling (Hlavata et al., 2008). Such effect 
was independent of the ADP/ATP transport activity, leading the authors to suggest that 
oxidative modifications to the Aac2p might contribute to a PTP-like function in yeast 
mitochondria. 
The present work aimed to understand whether oxidative modifications of the Aac2p 
may contribute to MOMP and consequent release of cyt c, during acetic acid induced 
programmed cell death (PCD) in S. cerevisiae. For such purpose, S. cerevisiae strain 
JL1-3, lacking the three isoforms of the AAC (AAC1, 2 and 3), was transformed with 
two different copies of the AAC2 gene, a wild-type (wt) and a cysteine-less AAC2 (CL), 
in which the 4 cysteine residues were replaced by alanines. Different aspects of the 
acetic acid-induced cell death including survival, plasma membrane integrity, ROS 
production and mitochondrial membrane potential, were evaluated. Data collected 
during this study suggest that the cysteines in the Aac2p are not responsible, per se, for 
promoting a biochemical change capable of leading the Aac2p to a PTP-like function in 
yeast mitochondria. Moreover, the mechanisms involved in acetic acid-induced cell 
death do not seem to depend on the oxidation of the Aac2p. 
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2. Materials and Methods 
 
2.1. Yeast strains, plasmids and growth conditions 
The yeast strains and plasmids used in this study are listed in Table 1: 
 
Table 2 – List of strains used in the experiments described further ahead. 
Name Strain/Plasmid Source/Reference 
Δaac1/2/3 
JL1-3 (MATa, ade2, his3, leu2, trp1, ura3, can1, 
aac1::LEU2, aac2::HIS3, aac3::URA3) 
Kissova et al., 2000 
Aac2 wt JL1-3 + pYES-Ppic2-aac2 This study 
Aac2 CL JL1-3 + pYES-Ppic2-aac2-cystein-less This study 
Aac2 wt-V5-His6 JL1-3 + pYES-Ppic2-aac2-V5-His6 This study 
Aac2 CL-V5-His6 JL1-3 + pYES-Ppic2-aac2-cystein-less-V5-His6 This study 
His6-Aac2 JL1-3 + pYES-Ppic2-His6-aac2 This study 
 
Saccharomyces cerevisiae JL1-3 (MATa, ade2, his3, leu2, trp1, ura3, can1, 
Δaac1::LEU2, Δaac2::HIS3, Δaac3::URA3), which is a derivative of W303-1B lacking 
the three isoforms of the AAC (AAC1, AAC2 and AAC3) (Kissova et al., 2000), was 
transformed with the plasmids pYES-Ppic2-aac2, pYES-Ppic2-aac2-CL (cysteine-less) 
and pYES-Ppic2-His6-aac2, kindly provided by Doctor Edmund Kunji, to originate a 
strain expressing a normal form of the Aac2p (wt), a cysteine less form of the carrier 
(CL) or a His6 tagged Aac2p protein (His6-Aac2p) respectively. JL1-3 was also 
transformed with plasmids pYES-Ppic2-aac2-V5-His6 and pYES-Ppic2-aac2-cystein-
less-V5-His6. To construct the Aac2-V5-His6, a mutated sequences of the AAC2 wt 
and CL gene were amplified by PCR, using a set of primers designed to change the stop 
codon for a serine (TAA into TCA) and to include the restriction sites NhoI and XhoI at 
both ends of the mutated gene. This fragment was digested and then inserted into the 
pYES3-Ppic2 plasmid which carries the sequences of the V5 epitote and His6 tag 
followed by a stop codon. The resulting construction consisted of the AAC2 or AAC2 
cystein-less sequence with a V5-His6 double tag attached to its C-terminal. All plasmids 
were amplified in E. coli XL-Blue, extracted using a Sigma GenElute
TM
 Plasmid 
extraction kit and verified by sequencing. Transformation of S. cerevisiae cells with the 
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above mentioned plasmids was done by lithium acetate general protocol (Ito et al., 
1983). Transformed cells were selected and kept in SC-glucose –W selective medium 
(0.175% YNB, 2% Glucose, 0.5% (NH4)2SO4, (2% agar for solid medium)) 
supplemented with adenine (final concentration of 40 mg/L) and without tryptophan. 
All strains were pre-grown in SC-glucose –W at 30°C, 200 rpm. 
 
2.2. Acetic acid treatment 
S. cerevisiae cells were grown until exponential growth phase (O.D.640 = 0.8 – 1.0; 
30 ᵒC, 200 rpm) in synthetic minimal medium with 2% glucose or 2% galactose as 
carbon sources, supplemented with adenine (40 mg/L). The cultures were collected and 
resuspended to a final concentration of 10
7 
cells per mL in fresh medium adjusted to pH 
3.0 with HCl and containing 160 or 180 mM acetic acid. Incubation took place for 180 
min at 30 °C as previously described. At different time points, samples were collected 
from these cultures and diluted to 10
-4
 cell/mL.  40µL from the diluted suspensions were 
inoculated onto YPDA medium (2% glucose, 1% yeast extract, 1% bactopeptone and 
2% agar) and colony forming units (c.f.u.) were counted after 48 h incubation at 30 °C. 
The percentage of viable cells was estimated considering 100% survival the number of 
c.f.u. obtained at time zero. 
 
2.3. PI exclusion, DiOC6 Staining and ROS production 
Propidium Iodide (PI) exclusion, DiOC6(3) staining and ROS production were 
monitored by flow cytometry analysis. The membrane integrity of Aac2 wt and CL 
strains was assessed by PI (Sigma) exclusion. Cells were harvested at different time 
points during acetic acid treatment (160 mM), washed and resuspended in PBS (137 
mM NaCl; 2.7 mM KCl; 100 mM Na2HPO4; 2 mM KH2PO4; pH 7.4) containing PI (4 
μg/ml). The samples were incubated for 10 minutes at room temperature in the dark 
before analysis. The fluorescent probe 3,3′dihexyloxacarbocyanine iodide (DiOC6(3)) 
(Invitrogen) was used to evaluate how acetic acid influences the mitochondrial potential 
in Aac2 wt and CL mutants. 2x10
6
 acetic acid-treated cells were harvested, washed, and 
resuspended in a buffer (10 mM MES; 0.1mM MgCl2; 2% (wt/v) glucose, adjusted to 
pH 6 with Ca(OH)2) containing DiOC6(3) (1 nM) and PI (4 μg/ml). Cells were analyzed 
by flow cytometry after 30 minutes of incubation at room temperature and protected 
from light. To study ROS production, 1x10
6
 Aac2 wt and CL cells were collected, 
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resuspended in PBS in the presence of DHE (2 μg/ml) and incubated for 30 minutes at 
30 °C, in the dark. Samples were analyzed by flow cytometry.  
Flow cytometry analysis was performed in an Epics® XLTM (BeckmanCoulter) 
flow cytometer equipped with an argon-ion laser emitting a 488 nm beam at 15 mW. 
Red fluorescence, emitted by DHE and PI, was collected through FL-3 (605/635 nm) 
and FL-4 (660/700 nm) sensors, respectively. Green fluorescence emitted by DiOC6(3) 
was collected through FL-1 (505/545 nm) sensor. The obtained data were further 
analyzed by WinMDI 2.8 software or Flowing Software version 2.5.0. 
 
2.4. Mitochondrial isolation and Western-blot analysis 
Mitochondria isolation was performed by differential centrifugation, after enzymatic 
digestion of the cell wall with zymoliase, essentially as previously described by Daum 
and colleagues (Daum et al., 1982). Some minor modifications were introduced to the 
protocol; spheroplasts were suspended in sorbitol 0.5 M, Tris/HCl pH 7.5 20 mM, 
EDTA 1 mM, and a Dounce homogenizer was used to obtain an even suspension. 
Assessment of cyt c release from mitochondria was performed by Western-blotting. 
Protein lysates were precipitated with 0.3 M trichloroacetic acid (TCA), solubilized in 
Laemmli buffer (2% SDS), separated on 12.5% SDS-PAGE gels and then blotted into 
polyvinylidene fluoride (PVDF) membranes (hybond-P; Amersham). Membranes were 
blocked with 5% non-fat milk in phosphate buffered saline (PBS) containing 0.05% 
Tween 20, for at least 1 h at room temperature. Membranes were then incubated 
overnight at 4 °C with primary antibodies: mouse monoclonal anti yeast 
phosphoglycerate kinase (PGK1) antibody (1:5000, Molecular Probes), mouse 
monoclonal anti yeast porin (POR1) antibody (1:5000, Molecular Probes), rabbit 
polyclonal anti yeast cytochrome c (CYC1) antibody (1:1000, custom-made by 
Millegen), rabbit polyclonal anti yeast F1F0 ATP synthase subunit β (ATP2) antibody 
(1:30000, homemade by Jean Velours, IBGC, Bordeaux - France), mouse monoclonal 
anti yeast cytochrome c oxidase subunit II (COX2) antibody (1:5000, Molecular 
Probes), rabbit polyclonal anti yeast translocase of outer mitochondrial membrane 40 
(TOM40) antibody (1:2000, home made by Carla Koehler, UCLA, Los Angeles - USA), 
mouse monoclonal anti V5 epitope antibody (1:5000, Invitrogen), rabbit polyclonal anti 
His6 Tag antibody (1:5000, Bethyl Laboratories, Inc). Membranes were incubated for 1 
h at room temperature with secondary antibodies against mouse or rabbit IgGs 
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(1:10000), coupled to horse radish peroxidase (Jackson Laboratories) and revealed by 
chemiluminescence (ECL+Amersham). Protein quantifications were performed by the 
Lowry method, using Folin-Ciocalteau‟s reagent (Lowry et al., 1951). For total protein 
extracts approximately 2x10
6
 cells were collected, suspended in 500 µL of water and 
disrupted with 50 µL of a mixture of 3.5% β-mercaptoethanol in 2 M NaOH, for 15 
minutes on ice. Proteins were precipitated with 50 µL of 3 M TCA for 15 min on ice 
and deposited by a rapid centrifugation. The resulting pellet was washed with acetone, 
and resuspended in Laemmli buffer for SDS-PAGE (Laemmli, 1970). Membrane 
blotting and developing was performed as described above. 
 
2.5. Redox Spectrophotometry 
Cytochrome content of whole cells was measured by differential redox 
spectrophotometry. Cells were collected during exponential growth, and concentrated in 
a cellular suspension of 2 mL at ≈ 40 O.D.640nm. The concentrated cell suspension was 
divided by two cuvettes and analyzed in a double beam spectrophotometer, Varian Cary 
4000. The reference cuvette was oxidized with hydrogen peroxide (H2O2), and the 
sample cuvette reduced with sodium dithionite. Spectra were acquired between 500 and 
650 nm and cytochromes c+c1, b and a+a3 were quantified by the O.D. differences, 550 
nm minus 540 nm, 561 nm minus 575 nm, and 603 nm minus 630 nm, respectively, 
with molar extinction coefficient of 18000, 18000 and 24000 M
-1
, respectively. 
 
2.6. Immunoprecipitation of His6-Aac2p 
Immunoprecipitation of the His6-Aac2p was performed using Pierce Protein A/G 
Plus Agarose from the Pierce Classic IP Kit (Thermo Scientific). All steps from this 
protocol were executed at 4°C, unless otherwise indicated. Briefly, mitochondria from 
His6-Aac2 control and acetic acid-treated cells were isolated as described above and 2 
mg of mitochondrial protein were transferred to an IP column and solubilized in 500 µL 
of cold IP Lysis/Wash Buffer (0.025M Tris, 0.15M NaCl, 0.001M EDTA, 1% NP-40 
(tergitol), 5% glycerol, pH 7.4), for 30 minutes with gentle mixing. To prepare the 
immune complex 1 µg of anti-His6 antibody was added, and the mixture incubated 
overnight at 4°C. Pierce Protein A/G Agarose resin was added to the antibody/lysate 
sample, and mixture was incubated with gentle end-over-end mixing for 6 hours, to 
allow the capture of the immune complex. The column was placed in a collection tube 
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and centrifuged for 60 seconds at 1000 x g. The resin was washed three times with 200 
µL of cold IP Lysis/Wash Buffer, and once with 100μL of 1X Conditioning Buffer 
(Pierce Classic IP Kit). To elute the captured proteins, 50μL of Elution Buffer (pH 2.8, 
Pierce Classic IP Kit) were added to the resin and the mixture incubated for 10 minutes 
at room temperature, before centrifugation. 
Samples of purified His6-Aac2p and mitochondria from control and acetic-acid 
treated cells were separated by SDS-PAGE, blotted and probed with the anti-His6 
antibody. The remaining samples of purified His6-Aac2p were used for OxyBlot 
determinations. 
 
2.7. Detection of protein oxidation by OxyBlot 
For OxyBlot determinations, samples of purified His6-Aac2p and mitochondria from 
control and acetic-acid treated cells were prepared according to manufacturer‟s 
instructions (OxyBlot™ Protein Oxidation Detection Kit, Millipore). Shortly, 30 µg of 
mitochondrial protein or 10 µL of purified His6-Aac2p were denaturated with 6% SDS 
and derivatized with 10 or 20 µL of 1 x 2,4-Dinitrophenylhydrazine (DNPH) solution, 
respectively. A control reaction was performed for the mitochondrial samples by adding 
10 µL of 1 x Derivatization-Control solution to a second protein solution (30 µg of 
mitochondrial protein denaturated with 6% SDS). Samples were incubated at room 
temperature for 15 minutes, and the reaction stopped by the addition of 7.5 or 15 µL of 
Neutralization Solution to the mitochondrial or purified protein samples, respectively. 
Samples were loaded onto a polyacrylamide gel, electrophoretically separated and 
blotted onto a PVDF membrane. The membrane was incubated in Blocking/Dilution 
Buffer (1% BSA in PBS-T) for 1 hour with gentle shaking. 1° Antibody (anti-DNP) was 
diluted 1:150 in Blocking/Dilution Buffer, added to the membrane and incubated for 1 
hour at room temperature under agitation. The membrane was rinsed twice with 1 x 
PBS-T, and then washed in 1 x PBS-T once for 15 minutes and twice for 5 minutes. A 
horseradish peroxidase-conjugated secondary Antibody was diluted 1:300, added to 
membrane and incubated for 1 hour at room temperature with gentle shaking. The 
washing steps described previously were repeated before revealing the membrane by 
chemiluminescence (ECL+Amersham) with a G-Box imaging system (Syngene). 
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3. Results 
 
3.1. Acetic acid tolerance of Aac2p-wt and Aac2-cysteine-less mutants 
A recent study from our group has identified the Aac2p as an important element in 
MMP, and consequent release of cyt c, during yeast cell death. In the absence of AAC 
proteins, yeast cells exhibit increased resistance to acetic acid-induced death, a 
phenotype that is not related to the impairment of oxidative phosphorylation (Pereira et 
al., 2007). This observation emphasizes the important role of mitochondria in yeast cell 
death.  
 
Fig. 1 – (A) Stereoview of the structural model of the yeast ADP/ATP carrier, AAC2, presented in 
Bamber et al., 2007. Trans-membrane (TM) α-helices (H1, H2, H3, H4, H5 and H6) are numbered 
according to their order of appearance in the sequence. Two matrix helices are also identified by h12 and 
h56, the numbers corresponding to the two TM α-helices they connect. The four cysteines of the AAC2 
are encircled and represented as van der Waals spheres. (B) Aminoacid sequence of the S. cerevisiae 
AAC2. Each one of the four cysteine residues, Cys
73
, Cys
244
, Cys
271
 and Cys
288
, identified by black 
arrows, were replaced by alanines to produce the cysteine-less AAC2. 
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To understand whether oxidative modifications are contributing to the role of Aac2p 
in MMP, S. cerevisiae strains carrying either a wt or a cysteine-less (CL) Aac2p, in 
which all four cysteine residues were replaced by alanine residues (Fig. 1A and B), were 
studied in response to acetic acid. The CL mutant of yeast Aac2p functions like the 
native (wt) form of the carrier, with the native conformation in the mitochondrial 
membrane, and an initial velocity of ADP uptake to mitochondria as high as 84% that of 
a wt Aac2p, showing that these cysteines are not required for adenine nucleotide 
transport (Bamber et al., 2007a; Bamber et al., 2007b; Hatanaka et al., 2001). Aac2 wt 
and CL cultures grown in glucose or galactose as carbon sources were treated with 160 
mM acetic acid, and the viability was evaluated by c.f.u. counting. In both cases, no 
significant differences were observed between the survival profile of wt and CL mutants 
(Fig. 2A). The platting efficiency of both strains decreases progressively with the 
exposure to acetic acid, reaching values of approximately 40% after 120 min of 
incubation in glucose medium (Fig. 2A).  Growth and treatment in the presence of 
galactose as the sole carbon source, contributes to an increased toxicity of acetic acid, 
reaching levels as low as 10% survival after 120 min (Fig. 2A). The following 
experiments, characterizing the death process in the Aac2 wt and CL strains, were 
performed in galactose medium since it is less effective in the repression of the 
respiratory metabolism and allows the cells to possess a higher mitochondrial mass 
(Herrero et al., 1985). 
To characterize the mechanisms responsible for acetic acid-induced cell death in 
Aac2 wt and CL strains, the preservation of plasma membrane integrity, commonly used 
as an indicator of cell viability and a tool to differentiate necrotic, apoptotic and normal 
cells in PCD assays, was evaluated by propidium iodide (PI) exclusion. The plasma 
membrane is impermeable to PI, a fluorescent molecule and an intercalating agent that 
can bind to double stranded nucleic acids and is generally excluded from healthy cells. 
Aac2 wt and CL cells collected during the acetic acid treatment were incubated with PI, 
and analysed by flow cytometry. The amount of PI positive cells, i.e. cells which have 
lost their plasma membrane integrity, increased along with the exposure to acetic acid in 
both cell types (Fig. 2B). This increase, however, does not match the loss of cell 
viability observed by c.f.u. counting indicating that not all dying cells have lost plasma 
membrane integrity, or that this event is delayed when compared to loss of plating 
efficiency. Interestingly, CL cells display a tendency to accumulate less PI than wt cells, 
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particularly upon a longer exposure to acetic acid (Fig. 2B), suggesting that the Aac2 
cysteine-less mutation may result in a different cellular response to this death stimulus. 
 
Fig. 2 – Cell death of Aac2 wt and Aac2 CL cell cultures during acetic acid treatment. A) Survival 
curve of cell cultures pre-grown in synthetic minimal medium, pH 3.0, with galactose (A – left panel) or 
glucose (A – right panel) as the sole carbon source and treated in the same medium with acetic acid (160 
mM). Viability was determined by c.f.u. counts at the indicated time points (100 % survival corresponds 
to the total c.f.u. number at time zero). Both strains are more sensitive to acetic acid when galactose was 
used. Still, loss of cell viability occurs at identical rates for both strains in the two tested scenarios. B) 
Loss of plasma membrane integrity was assessed by PI staining in both Aac2 wt and Aac2 CL strains. 
Acetic acid-treated cells were collected at indicated time points, resuspended in PBS and incubated with 
PI (4 µg/mL), for 10 minutes in the dark, prior to flow cytometric analysis. Loss of plasma membrane 
integrity enhances with increasing time of exposure to acetic acid in both strains. Upon longer exposures 
(180 min) a difference between both strains is observed (P<0.001). Data represent mean ± SD of at least 3 
independent experiments. 
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3.2. ΔΨm and ROS production in Aac2p-mediated MOMP 
As a central player in PCD, mitochondria are subjected to several changes in their 
structure and biochemical properties, some of which are universally recognized as 
hallmarks of the different scenarios of cell death. In healthy cells, the IMM acts as a 
nearly impermeable barrier to all ions, allowing the respiratory chain complexes to build 
up the proton gradient required for oxidative phosphorylation (Mitchell and Moyle, 
1965).  The charge imbalance resulting from the generation of this gradient across the 
IMM constitutes the inner mitochondrial membrane potential (ΔΨm). Since the 
disruption of ΔΨm will affect ATP synthesis, its maintenance is vital for cellular 
bioenergetics (Mitchell and Moyle, 1965). Long-lasting or permanent loss of ΔΨm is 
commonly associated with cell death and the opening of a PTP (Zamzami et al., 1995). 
As observed in some scenarios of mammalian apoptosis, the ΔΨm of S. cerevisae also 
dissipates upon yeast exposure to a death stimulus, such as toxic concentrations of 
acetic acid (Ludovico et al., 2002). For the Δaac1/2/3 strain, a possible relation between 
ΔΨm and the increased resistance to acetic acid has been proposed, considering that the 
ΔΨm dissipation profile from this mutant differs from that of wt cells (Pereira et al., 
2010). ΔΨm can be estimated by the capacity of mitochondria to incorporate the 
lipophilic cationic fluorescent probe DiOC6(3) assessed by flow cytometry (Petit et al., 
1990). This probe can freely enter the cell and is concentrated in the cytoplasm driven 
by the plasma membrane potential (ΔΨp). It then enters mitochondria driven by ΔΨm 
and accumulates on the inner surface of IMM. Since the relative cell volume affects the 
fluorescence measurements without revealing a real difference in ΔΨm, all the 
cytometric data were expressed as a ratio (R) between the mean of green fluorescence 
intensity (FL-1 channel) and the mean of frontal scatter (FS), in an attempt to normalize 
the fuorescence intensity for the relative cell volume. Additionally, the determinations 
of ΔΨm in Aac2 wt and CL cells collected during acetic acid treatment were monitored 
in the cell population with preserved plasma membrane integrity, i.e. PI-negative cells. 
Fluorescence values were also normalized to time zero. The results suggest that ΔΨm of 
both wt and CL drops shortly after exposure to acetic acid (≈ 30 min) (Fig. 3A). This 
effect is apparently transient, since the ΔΨm of both cell types seems to recover after 1 
hour of treatment. When comparing wt and CL cells, no significant differences were 
observed regarding the ΔΨm dissipation profile. 
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Fig. 3 – Cell death markers of Aac2 wt and Aac2 CL strains in response to 160 mM of acetic acid for 
180 min in medium containing galactose. A) Variation of the mitochondrial membrane potential of Aac2 
wt and Aac2 CL cells treated with acetic acid, assessed by flow cytometry using the fluorescent probe 
DiOC6(3). Cells were incubated in DiOC6(3) buffer containing 1 nM of DiOC6(3), for 30 minutes in the 
dark. Fluorescence at time zero was considered as 100%. Membrane potential changes were identical in 
both wt and CL cells. B) Accumulation of ROS in acetic acid-treated cells was evaluated by DHE 
staining. Cells were collected and incubated in PBS containing 2 µg/mL of DHE, for 30 minutes in the 
dark, prior to flow cytometric analysis. ROS accumulation occurs progressively in both strains. No 
statistical difference is observed. C) Cytochrome c detection by Western blot in mitochondria and 
corresponding cytosolic fractions obtained from Aac2 wt and Aac2 CL cells treated with acetic acid. 
Mitochondria from cells without any treatment were used as control. The same amount of mitochondrial 
and post-mitochondrial protein was loaded into the gel. Porin (Por1p) from the outer mitochondrial 
membrane and the cytosolic phosphoglycerate kinase (Pgk1p) were also evaluated as control for 
mitochondria and cytosolic fractions, respectively. Upon treatment with acetic acid cyt c is released from 
mitochondria into the cytosol. Such phenomenon was similarly observed in both strains. Data from A and 
B panels represent mean ± SD of at least 3 independent experiments. In panel C one representative 
experiment is shown. For flow cytometry assays a minimum of 35,000 cells were counted in an Epics XL 
Flow Cytometer. 
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Another common feature to numerous scenarios of PCD is the accumulation of ROS 
(Simon et al., 2000), and acetic acid-induced death has also been associated with ROS 
production by yeast cells (Ludovico et al., 2002; Pereira et al., 2007). The exact role of 
ROS in this process, however, remains undefined. To study ROS accumulation in Aac2 
wt and CL strains, acetic acid-treated cells were stained with DHE, a probe that can 
react with superoxide and other oxidants to generate oxidative red fluorescent products 
(Zhao et al., 2003). The fluorescence resulting from oxidation of DHE was then 
quantified by flow cytometry. The overall result indicates that there is no significant 
difference in ROS accumulation between wt and CL cells treated with acetic acid (Fig. 
3B). In both mutants, red fluorescence increases considerably with the exposure to the 
acid, showing a 5-fold greater intensity after just 1 hour of treatment. Superoxide 
production increases for another hour, until it finally stabilizes. This observation 
indicates that the cysteine-less form of the Aac2p is not affecting the 
production/accumulation of ROS during acetic acid-induced yeast cell death. 
 
3.3. Cytochrome c release from Aac2 wt and CL mitochondria 
Cyt c release from mitochondria during MOMP, is probably one of the most decisive 
events during programmed cell death. Once the OMM is permeabilized, several 
apoptogenic factors, including cyt c, are released into the cytosol, triggering a sequence 
of biochemical events ultimately leading to cell death (Kluck et al., 1997; Liu et al., 
1996; Yang et al., 1997). In yeast cells, cyt c release from mitochondria was first 
reported by Manon and colleagues in a strain expressing the human pro-apoptotic 
protein Bax (Manon et al., 1997). Since then, mitochondrial release of cyt c has been 
found in different scenarios of yeast cell death, including acetic acid-induced death 
(Ludovico et al., 2002). Interestingly, the absence of AAC proteins impairs MOMP and 
cyt c release in S. cerevisiae cells treated with acetic acid, revealing an essential role of 
the AAC in this particular process (Pereira et al., 2007). 
In order to test if the cysteine residues of the Aac2p, and a possible thiol 
crosslinking, are responsible for the Aac2p-dependent acetic acid-induced cyt c release, 
mitochondria from wt and CL cells were prepared before and after treatment with acetic 
acid. Mitochondria isolation was performed by differential centrifugation, after 
enzymatic digestion of the cell wall with zymoliase and cell disruption with a Dounce 
homogenizer. Cyt c release in both cell types was analysed by Western-blot using 
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specific antibodies to detect cyt c in the mitochondrial extracts and the corresponding 
post-mitochondrial fractions. As shown in Fig. 3C, cyt c was released from 
mitochondria of wt cells after exposure to acetic acid, which is in agreement with 
previous descriptions from our group (Ludovico et al., 2002; Pereira et al., 2007). This 
observation is supported by the appearance of cyt c in the post-mitochondrial fraction of 
treated cells, contrasting with the cyt c-free fraction of untreated cells (Fig. 3C). As for 
CL mutant, the result was similar to the one of wt strain, displaying a drop in cyt c 
content of mitochondria from treated cells, and an increase in its post-mitochondrial 
fraction (Fig. 3C). These observations suggest that the cysteine residues of Aac2p, and 
therefore the possibility of a PTP-like function mediated by thiol crosslinking, are not 
associated to the role of this carrier in acetic acid-induced MOMP. 
 
3.4. Characterization of the Aac2 wt- and CL-V5-His6 mutants 
To understand if oxidative modifications are capable of shifting the Aac2p into a 
structure/function that can mediate MOMP, two V5-His6 double tagged Aac2p (wt and 
CL) were constructed. The goal was to isolate these proteins from cells treated with 
acetic acid, and search for carbonylated amino acid residues. Yeast strains carrying the 
tagged proteins, Aac2 wt-V5-His6 or Aac2 CL-V5-His6, were tested for their 
respiratory ability in order to estimate the impact from the tag in the capacity of Aac2 wt 
and CL to transport adenine nucleotides. Both wt-V5-His6 and CL-V5-His6 have 
impaired respiration as shown by the lack of growth on YPGA medium (2% glycerol) 
(Fig. 4A), indicating that the physiological role of the Aac2p is compromised in these 
constructions. In parallel, these strains were treated with acetic acid (160 mM) and the 
survival, assessed by c.f.u. counting, was compared with that of the untagged wt and CL 
strains. Interestingly, the V5-His6 double tagged strains exhibit an increased resistance 
to acetic acid when compared with the untagged wt and CL (Fig. 4B). To test if this 
increased resistance is related to the inhibition of acetic acid-induced cyt c release in the 
wt-V5-His6 and CL-V5-His6 mutants, and to confirm the mitochondrial localization of 
the tagged proteins, mitochondria were isolated from both cell types after exposure to 
acetic acid (160 mM for 3h). Using an anti-V5 antibody, the wt-V5-His6 and CL-V5-
His6 forms of the carrier were detected in the obtained mitochondrial fractions at the 
expected size, suggesting a correct addressing of these proteins to mitochondria (Fig. 
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4C). Surprisingly, no cyt c was detected in any sample, including the ones of untreated 
mitochondria (Fig. 4C).  
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Fig. 4 – Characterization of JL1-3 strain carrying a V5-His6 double tagged Aac2 wt or Aac2 CL. A) 
Growth of W303 (1), JL 1-3 (2), Aac2 wt (3), Aac2 wt-V5-His6 (4 and 5), Aac2 CL-V5-His6 (6 and 7) 
and Aac2 CL (8) in Glucose (left panel) or Glycerol (right panel).  Aac2 wt-V5-His6 and Aac2 CL-V5-
His6 strains were not able to grow on medium containing glycerol as carbon source. B) Survival of Aac2 
wt-V5-His6 and Aac2 CL-V5-His6 cell cultures during acetic acid treatment in synthetic minimal 
medium with galactose. Exponential cells were treated with 160 mM acetic acid for 180 min and viability 
determined by c.f.u. counts (100 % survival corresponds to the total c.f.u. number at time zero, values 
represent % c.f.u. after 180 minutes). Aac2 wt-V5-His6 strain was more resistance to acetic acid treatment 
then Aac2 wt (p<0.01). C) Western Blot analysis of mitochondria extracted from Aac2 wt-V5-His6 and 
Aac2 CL-V5-His6 cells before and after exposure to acetic acid (160 mM, 3 hours) (left panel). Cyt c and 
Aac2-V5-His6 proteins were detected using anti-cyt c and anti-V5 antibodies, respectively. Por1p and 
Pgk1p were used as controls. The same amount of mitochondrial and post-mitochondrial protein was 
loaded into the gel. No cyt c was detected for both strains. An identical result was obtained for total 
extracts of Aac2 wt-V5-His6 and Aac2 CL-V5-His6 cells (right panel). One representative experiment is 
shown, on each panel. D) Cytochrome content of Aac2 wt and Aac2 wt-V5-His6 cells assessed by redox 
spectrum analysis. Cytochrome quantities were calculated considering the maximum and minimum 
absorbance values for each cytochrome, (ΔO.D.550nm – ΔO.D.540nm) for cyt c and (ΔO.D.561nm – 
ΔO.D.575nm) for cyt b, respectively, per mg of dry weight. Aac2 wt-V5-His6 exhibits a lower cyt c+c1 
content when compared to Aac2 wt. 
 
The same phenomenon was observed in total protein extracts from wt-V5-His6 and 
CL-V5-His6 cells (Fig. 4C), indicating that for some reason cyt c appears to be absent in 
these mutants. To clear out this possibility, the cytochrome content in the presence of a 
tagged and untagged Aac2p was compared by redox spectrophotometry. Cells from wt 
and wt-V5-His6 strains were collected during exponential growth, concentrated and 
divided into two cuvettes, to prepare an oxidized or reference sample and a reduced 
sample. When compared to the Aac2 wt, cells expressing the tagged carrier presented a 
remarkably low content of cyt c, resulting in a lower cyt c/cyt b ratio as well (Fig. 4D). 
Such evidence suggests that the insertion of the V5-His6 double tag in the C-terminal of 
Aac2p not only compromised the physiological role of the carrier but also resulted in 
the loss of cyt c cellular content. 
 
3.5. Immunoprecipitation of His6-Aac2 
Since the insertion of a V5-His6 double tag at the C-terminal of Aac2p affected its 
normal function, even resulting in the loss of cyt c in wt-V5-His6 and CL-V5-His6 cells, 
a new construction consisting of a six-histidine tag attached to the N-terminal of Aac2p 
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was used to immunoprecipitate the carrier. Cells containing the His6-Aac2p, were 
collected before and after acetic acid treatment (160 mM for 3h), and mitochondria were 
isolated as described above. The presence of His6-Aac2p in the mitochondrial samples 
was confirmed by WB using an anti-His6 antibody.  
 
Fig. 5 – Effect of acetic acid treatment on mitochondria extracted from His6-Aac2 cells. A) Detection 
of His6-Aac2p in total extracts and mitochondria isolated from control and acetic acid treated cells, by 
Western Blot using an anti-His6 antibody. 50 µg of protein were loaded into the gel. The His6-Aac2p 
content in mitochondria from acetic acid-treated cells is considerably lower than that of control 
mitochondria. B) Mitochondria protein profile of control and acetic acid treated cells revealed by 
coomassie staining. Some mitochondrial proteins appear to be degraded and/or downregulated in cells 
exposed to acetic acid, as may be concluded by the absence or smoothness of some bands. Other proteins 
are expressed or upregulated under these conditions, resulting in the appearance or increased thickness of 
some bands. C) Detection of different mitochondrial proteins in mitochondria extracts from control and 
acetic acid treated His6-Aac2 cells. Both IMM proteins (His6-Aac2p, Cox2p, Atp2p) and OMM proteins 
(Por1p and Tom40p) are degraded or downregulated after exposure to acetic acid. For each panel, one 
representative experiment is shown. 
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Although an equivalent amount of protein from both control and acetic acid treated 
mitochondria was loaded into the polyacrylamide gel and blotted, mitochondria from 
acetic acid-treated cells have clearly less His6-Aac2p than those isolated from control 
cells (Fig. 5A). In fact, acetic acid exposure induces drastic changes in the 
mitochondrial protein profile, as observed by Coomassie staining of mitochondrial 
extracts from control and acetic acid-treated cells (Fig. 5B). IMM proteins such as 
Cox2p and Atp2 and OMM proteins such as Por1p and Tom40p seem to be degraded 
and/or down regulated during acetic acid treatment, suggesting that mitochondrial 
proteins are targeted by acetic acid (Fig. 5C). To immunoprecipitate the His6-Aac2p, 2 
mg of mitochondrial protein isolated from control and acetic-acid treated cells were 
solubilized and incubated over-night with an Anti-His6 antibody. The immune complex 
was captured with Pierce Protein A/G Plus Agarose (Thermo Scientific) and the protein 
recovered by low-pH elution. The presence of His6-Aac2p in the purified samples was 
verified by Western-Blotting (Fig. 6A). 
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Fig. 6 – Immunoprecipitation of His6-Aac2p. A) Western Blot detection of His6-Aac2 in purified and 
mitochondrial samples from control cells and cells exposed to acetic acid. B) Oxyblot determination of 
protein carbonylation in His6-Aac2p purified samples and mitochondria extracted from control and acetic 
acid-treated cells. Control and acetic acid-treated samples were derivatized with DNPH. A control with 
Derivatization Control Solution (DCS) was performed for the mitochondrial samples. 
 
To find out if acetic acid is able to induce the oxidation of Aac2p, the carbonylation 
state of purified His6-Aac2p from control and acetic acid-treated cells was evaluated 
using an OxyBlot kit (Milipore). Samples of purified His6-Aac2p and mitochondria 
extracts were derivatized with a DNPH solution, according to manufacturer‟s 
instructions, separated in a polyacrylamide gel, blotted into a PVDF membrane and the 
carbonyl groups detected with the provided antibodies. When comparing the protein 
oxidation profile of control and acetic acid-treated mitochondria, it seems that acetic 
acid was responsible for an increased oxidation of some proteins (Fig. 6B). This result, 
however, must take into consideration the fact that acetic acid is responsible for a 
considerable change in the mitochondrial protein profile of treated cells, as mentioned 
above. While some proteins might actually be more oxidized after acetic acid-treatment, 
others are degraded or even down- or up-regulated. As for the purified His6-Aac2p 
protein sample, no particular differences were observed (Fig. 6B). 
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4. Discussion 
 
Since Crompton and Costi hypothesized the involvement of MPT in cell death 
almost 3 decades ago (Crompton and Costi, 1988), many different investigators have 
focused on studying the mechanisms responsible for this phenomenon. MPT is now 
attributed to the opening of a proteinaceous pore in the IMM, whose scaffold structure 
was originally thought to rely on the dynamic interactions between VDAC, ANT and 
CyP-D. Several studies support a role of the ANT in PTP opening, but its exact 
contribution for PCD is somewhat blurry (Leung and Halestrap, 2008). MOMP has also 
been associated to yeast cell death induced by acetic acid (Ludovico et al., 2002). 
Pereira and colleagues have demonstrated that AAC proteins, the yeast orthologues of 
mammalian ANTs, are required for stability and release of cyt c during acetic acid-
induced cell death in S. cerevisiae (Pereira et al., 2007). Additionally, oxidative stress 
has been proposed as a possible trigger of the Aac2-mediated mitochondrial 
permeabilization (Hlavata et al., 2008). To understand if the role of Aac2p in acetic acid 
induced-MOMP is controlled by oxidative modifications to this carrier, yeast strains 
lacking the three isoforms of the AAC (AAC1, 2 and 3) were transformed with a normal 
(Aac2 wt) or a cysteine-less Aac2p (Aac2 CL), and different aspects of cell death were 
tested. 
Our data clearly indicate that the absence of cysteine residues from the Aac2p has no 
effect in the resistance of S. cerevisiae cells to acetic acid, as observed by the survival 
profile of the Aac2 wt and Aac2 CL strains. The plating efficiency of both strains 
decreases progressively and similarly upon exposure to acetic acid, an effect that is 
aggravated when cells were pre-grown in medium with galactose, instead of glucose, as 
the sole carbon source and suspended in the same medium to assess acetic acid-induced 
cell death. Mitochondria play a central role in acetic acid induced death, and 
mitochondrial proteins/function seem to be determinant for the capacity of S. cerevisiae 
to cope with the toxic effect of the acid (Sousa et al., 2013; accepted for publication). 
Some mitochondrial proteins protected while others sensitised cells to acetic acid 
induced cell death. In this particular case, both strains have altered mitochondria which 
may affect their resistance to acetic acid. The higher mitochondrial mass of cells grown 
in the presence of galactose as the sole carbon source (Herrero et al., 1985) may 
therefore represent an increase in a cellular target for acetic acid. Accordingly, 
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heterologous expression of the human pro-apoptotic regulator Bax in S. cerevisiae 
demonstrated that Bax is more efficient to kill yeast cells grown on mannose, a 
fermentable but not repressive carbon source, than on glucose grown cells (Priault et al., 
1999). This is in contrast to the higher resistance of S. cerevisiae W303-1A stationary 
cells relative to exponential cells grown in YEPD medium containing glucose 
(Ludovico et al., 2002). The differences in the used medium composition and culture 
stage as well as in strains with expression plasmids may underlie these apparent 
opposite results. 
Other features of cell death were also evaluated and compared between both strains, 
including plasma membrane integrity, ΔΨm, cyt c release from mitochondria and ROS 
accumulation. The evaluation of plasma membrane integrity by PI exclusion revealed a 
lower accumulation of PI in Aac2 CL cells, particularly upon prolonged exposure to 
acetic acid. Since there are no differences in the survival profile, such effect could 
indicate that the apoptotic-like cell death and subsequent secondary necrosis is delayed 
in Aac2 CL strain. Considering the importance of Aac2p in such process, it is possible 
that the absence of cysteine residues could modulate, but not prevent, the physiological 
role of this carrier during cell death. Further assays of cell survival for longer acetic acid 
treatments, and assessment of cell death markers, are required to elucidate this 
hypothesis. A similar delay in the loss of plasma membrane integrity has already been 
observed by Pereira and colleagues in Δaac1/2/3 cells, although it was accompanied by 
an increased resistance to acetic acid as well as a delay in the occurrence of other 
cellular events associated with acetic acid-induced death (Pereira et al., 2007). 
During cell death, opening of PTP induces the dissipation of mitochondrial ΔΨm 
(Marchetti et al., 1996), an event associated to a matrix remodelling that might facilitate 
the release of cyt c from mitochondrial intra cristae space, its exposure to the IMS and 
subsequent release (Gottlieb et al., 2003). Under optimal experimental conditions, an 
increase in DiOC6(3) fluorescence intensity could represent a mitochondrial 
hyperpolarization since more polarized mitochondria would accumulate more cationic 
probe. On the other hand, mitochondrial depolarization would reduce the capacity of 
mitochondria to retain the fluorescent probe, hence resulting in decreased fluorescence 
intensity. Still, one must also consider the limitations and conditionings that are intrinsic 
to this approach in order to ensure a meaningful interpretation of the results obtained. 
Ultimately, the amount of dye loaded into mitochondria will depend on several factors 
including; the concentration of dye in the medium, ΔΨp, ΔΨm, mitochondrial size or 
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mass and loading/equilibrium time (Perry et al., 2011). All these variables should be 
controlled or accounted for, in order to enable a proper interpretation of the obtained 
results. For instance, optimizing the correlation between cell fluorescence and the 
magnitude of ΔΨm might require the use of ultra-low concentrations of DiOC6(3) and 
the lowest possible dye/cell ratio, thus avoiding unspecific staining (Rottenberg and 
Wu, 1998; Wilson et al., 1985). Creating an artificial ΔΨm, for instance with a 
valinomycin-induced K
+
 diffusional potential, should allow such optimization. Also, 
changes in mitochondrial mass affect accumulation of the probe and the fluorescence 
signal must therefore be normalized for this cell parameter so that the changes in 
fluorescence only reflect changes in ΔΨm. Previous works, using either rhodamine 123 
(Rh123) (Ludovico et al., 2002) or DiOC6(3) (Pereira et al., 2007) have addressed this 
issue and proposed the normalization of the fluorescence signal by calculating the ratio 
between the green fluorescence (FL1, log) and the relative size (FS, log) to correct for 
changes in mitochondrial mass. Both studies report that wild-type yeast cells undergo a 
transient hyperpolarization followed by progressive depolarization, during acetic acid 
treatment. Our results suggest that ΔΨm of Aac2 wt and CL cells slightly drops during 
the first 30 minutes of acetic acid treatment. After this initial period, the fluorescence 
intensity increases in both strains, reaching values higher than those recorded for time 
zero. The distinct evolution of ΔΨm observed during our experiments could be a 
consequence of the genetic manipulation performed on the studied strains, which lack 
AAC1 and AAC3, and express AAC2 exclusively. In fact, deletion of the three AAC 
isoforms also produces an altered ΔΨm phenotype in response to acetic acid (Pereira et 
al., 2007). 
Production of ROS during acetic acid-induced cell death in Aac2 wt and CL strains 
was also evaluated. ROS play an important physiological role, particularly in signal 
transduction events associated to vital cell functions. However, uncontrolled ROS 
production or inappropriate anti-oxidant defence mechanisms may result in serious 
damages to the cell‟s biomolecules (Simon et al., 2000). As for mammalian cells, ROS 
accumulation is also considered a common event in most scenarios of yeast cell death 
(Ludovico et al., 2005). The exact role of ROS during PCD in yeast is not defined and 
conflicting observations suggest that ROS accumulation does not always correlate with 
loss of viability (Trancíková et al., 2004). Indeed, Pereira and colleagues observed that 
the increased resistance of Δaac1/2/3 strain to acetic acid was not accompanied by 
diminished ROS production/accumulation, even though other cellular events associated 
Assessment of oxidative modifications of the AAC2p and its contribution to mitochondria membrane 
permeabilization in yeast 
 
94 
 
to yeast PCD were also delayed in this particular mutant (Pereira et al., 2007). The 
accumulation of ROS in Aac2 wt and CL strains increases steadily and equally after 
exposure to acetic acid, reaching what appears to be a threshold (approx. 80% of the 
cells with red fluorescence) after 2 hours of treatment. Since it was not possible to 
observe any statistically significant differences, it is logical to assume that the absence 
of cysteine residues from the Aac2p had no impact on ROS generation during acetic 
acid treatment. Such result is in agreement with the previous observation that the role of 
AAC proteins in acetic acid-induced death seems to be independent from ROS 
accumulation (Pereira et al., 2007), which in turn might be a consequence of acetic acid-
induced mitochondrial dysfunction. 
One final feature of yeast cell death evaluated in Aac2 wt and CL strains was the 
release of cyt c from mitochondria. As for mammalian cells, cyt c can be translocated 
from mitochondria to the cytosol of yeast cells undergoing death induced by different 
stimuli, including the heterologous expression of the pro-apoptotic protein Bax, absence 
of the histone chaperone ASF1/CIA1; acetic acid or H2O2 (Ludovico et al., 2002; Manon 
et al., 1997; Pereira et al., 2007; Yamaki et al., 2001). The exact role of cyt c release in 
S. cerevisiae cell death, however, remains to be clarified. Immunodetection of cyt c in 
mitochondrial and post-mitochondrial fractions isolated from Aac2 wt and CL cells 
revealed an acetic acid-induced cyt c release from mitochondria of both strains. The 
decrease on mitochondrial cyt c was accompanied by an equivalent enrichment of this 
protein in the corresponding post-mitochondrial fractions, indicating that both wt and 
CL forms of the Aac2p were able to restore the AAC-mediated MMP on a Δaac1/2/3 
background. Considering the obtained results, it is reasonable to say that even if the 
cysteine residues of the Aac2p were being targeted and modified by ROS, they do not 
contribute to the role of Aac2p in MOMP during acetic acid-induced cell death. It is 
possible that other protein modifications could be responsible for this particular feature 
of the Aac2p in cell death. 
To understand if acetic acid is able to promote changes in the Aac2 protein structure, 
an experiment was devised in order to isolate this carrier before and after acetic acid 
treatment, and to study eventual protein modifications. The idea was to purify the Aac2 
wt and CL proteins using a V5-His6 double tag attached to the C-terminus of these 
carriers. Unexpectedly, the presence of this double tag produced an Aac2p that has lost 
its ability to translocate adenine nucleotides, judging by the lack of growth in non-
fermentable carbon sources. Additionally, both wt- and CL-V5-His6 tagged Aac2p lead 
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to an increased resistance of S. cerevisiae to acetic acid. A similar resistance phenotype 
has previously been reported for respiratory deficient mutants such as ρ0, Δatp10 and 
Δcyc3 (Ludovico et al., 2002). Yet, the resistance phenotype of Δaac1/2/3 mutant, 
which also lacks the ability to grow on non-fermentable carbon sources, is not related to 
its respiratory deficiency since the presence of a mutated form of Aac2p with reduced 
respiration capacity (Gawaz et al., 1990), is able to reverse this resistance phenotype 
(Pereira et al., 2007). As the role of the AAC in yeast cell death is not dependent on its 
carrier activity, we wondered if the presence of a double tag in Aac2p could affect the 
protein‟s structure disturbing its role in MMP. This hypothesis was tested by the 
evaluation of cyt c release form Aac2 wt-V5-His6 and CL-V5-His6 mitochondria during 
acetic acid treatment, only to find out that apparently there is no cyt c present in these 
strains. The Aac2 wt-V5-His6 and CL-V5-His6 constructions were addressed to 
mitochondria and had the expected size, but for some reason cyt c was absent or 
significantly reduced in these mitochondria, possibly degraded. This absence/reduction 
was confirmed by immunodetection of cyt c, in total and mitochondrial extracts, and 
also by redox spectrophotometry in the case of Aac2 wt-V5-His6. One possible 
explanation resides in the implications of a C-terminus tag for the Aac2 protein‟s 
biochemistry, with consequences to mitochondrial bioenergetics and function as well as 
to other mitochondrial proteins. It is possible that a C-terminus tagged Aac2p, although 
normally produced and imported to mitochondria, may not be properly inserted and/or 
folded into the IMM, an idea that has previously been suggested (Fiore et al., 2000). 
 The import of Aac2p into mitochondria depends on the cooperation of its three 
modules (each containing a pair of membrane-spanning domains), and their interaction 
with the receptor protein Tom70p, which then transfers the Aac2 precursor to the TOM 
import complex (Wiedemann et al., 2001). Removal of the first (N-terminal) and third 
(C-terminal) modules strongly impairs the stable accumulation of Aac2 precursor in the 
TOM complex (Wiedemann et al., 2001). Although neither the N- or C-terminus are 
required for initiation of the protein transfer to the IMM (Wiedemann et al., 2001), the 
third module is able to stall the translocation arresting the precursor at the TOM 
complex, presumably a mechanism to prevent misfolding and aggregation of the 
precursor in the IMS (Endres et al., 1999). The import and insertion in IMM, which 
requires several members of the TIM import machinery, depends on ΔΨm and is 
regulated by a signal contained in the C-terminal part of the Aac2p (Endres et al., 1999). 
The presence of a C-terminus V5-His6 double tag could be enough to affect such a 
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delicate process, eventually causing inappropriate insertion or folding of the carrier. It 
should be mentioned, however, that a covalent tandem dimmer of the Aac2 was found 
to be stable and active in vivo (Trézéguet et al., 2000). On the other hand, the absence of 
cyt c in the Aac2 wt/CL-V5-His6 strains suggests that, for some reason, these proteins 
completely destabilize the mitochondrial import systems, including the one for cyt c. 
The peculiar transport of cyt c into mitochondria is driven by haem assembly and 
involves the mitochondrial general import pore Tom40p and the receptor Tom22p 
(Diekert et al., 2001; Wiedemann et al., 2003). Following the transport across the 
OMM, apocytochrome c binds to a holocytochrome c synthase (HCCS) in the IMS and 
is trapped inside mitochondria by conversion to holocytochrome c (Dumont et al., 
1991). The TOM complex is both required and sufficient for the import of HCCS to the 
IMS, and the absence of this enzyme prevents the mitochondrial accumulation of 
apocytchrome c (Diekert et al., 1999; Dumont et al., 1988).  
Because the V5-His6 tag affected the function of Aac2p, its use to purify this protein 
and assess the role of oxidative modifications in its ability to permeabilize mitochondria 
was hindered. Isolation of Aac2p was accomplished using a construction that consists of 
a six histidine tag attached to the N-terminal of the Aac2p. Although the expression 
levels of His6-Aac2p were lower than those of the untagged carrier, the presence of an 
N-terminal affinity tag does not significantly affect the protein‟s translocation to 
mitochondrial membranes neither its capacity to transport adenine nucleotides (Bamber 
et al., 2007b). Immunodetection of His6-Aac2p in total protein or mitochondrial 
extracts, from control and acetic acid treated cells, revealed a significant reduction in 
the total amount of carrier after exposure to acetic acid. The same phenomenon was 
observed for several other mitochondrial proteins, including outer and inner membrane 
proteins, and the general protein profile of acetic acid treated mitochondria is 
considerably different from that of control mitochondria. This reduced amount of 
mitochondrial proteins such as Aac2p, Por1p or Cox2p may be in part explained by 
mitochondrial degradation during acetic acid treatment, an event that has already been 
reported (Ludovico et al., 2002; Pereira et al., 2010). On the other hand, some these 
proteins might be specifically regulated during acetic acid induced death. For example, 
cyt c release from mitochondria, triggered by heterologous expression of Bax in yeast, 
has been associated to Cox2p degradation by the mitochondrial AAA-type protease 
Yme1p (Manon et al., 2001). Similarly, the levels of Cox2p were also decreased in 
yeast cells undergoing acetic-acid induced death (Ludovico et al., 2002). In a wider 
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perspective, genes involved in transcription and in mitochondrial functions are essential 
for the adaptation of S. cerevisiae to acetic acid (Mira et al., 2010); Sousa et al., 
unpublished data), and changes in gene expression may also account for the different 
mitochondrial protein profile of control and treated cells. This profile is also evident 
during the determination of protein carbonylation in mitochondria isolated from control 
and treated cells, making it somewhat difficult to analyse the results. Looking at protein 
oxidation in the mitochondrial extracts, it is fair to say that some proteins appear to be 
more carbonylated in the acetic acid treated samples, comparing to control 
mitochondria. Still, the expression levels of these proteins during exposure to acetic 
acid must also be accounted for the analysis of their carbonylation state. Importantly, 
detection of carbonylated proteins in the His6-Aac2p immunoprecipitated samples 
raises some doubts on the hypothesis of an acetic acid-induced Aac2p oxidation. In fact, 
by comparing the His6-Aac2p purified samples, from control and acetic acid-treated 
cells, it is not possible to stress out any increase on protein carbonylation after exposure 
of yeast cells to the acid, even though the Aac2p was present in both purified samples. 
The contribution of ANT to MOMP has generated quite a controversial discussion in 
in the field of cell death. Early studies have identified the ANT as an important 
regulator of mitochondria permeability transition in response to high [Ca
2+
] (Hunter and 
Haworth, 1979), and this carrier was later proposed as an important component of the 
PTP (Bauer et al., 1999; Marzo et al., 1998). The exact contribution of the ANT to cell 
death was thoroughly studied by many different groups in the past decades, yet several 
questions remain to be answered. Oxidative stress was long identified as an activator of 
the PTP (Crompton et al., 1987), an effect attributed to the oxidation/reduction state of 
mitochondrial thiol groups (Costantini et al., 1995, 1996; Petronilli et al., 1994). It was 
later proposed that oxidative stress and thiol crosslinking agents could act on the ANT, 
causing structural modifications that would eventually lead to MMP (Costantini et al., 
2000; Halestrap et al., 1997). Indeed, the crosslinking of ANT‟s cysteine residues might 
stabilize the carrier in a “c-state” conformation (the ADP binding site facing the 
cytosol) (McStay et al., 2002), which is required to sensitize the IMM permeability to 
Ca
2+
 (Lê Quôc and Lê Quôc, 1988). In yeast, the finding that AAC also plays an 
essential role in cell death induced by acetic acid and diamide (a known thiol 
crosslinking agent), raised the possibility of using S. cerevisiae as a model system to 
study the role of this carrier in MMP (Pereira et al., 2007). As for other scenarios of 
cellular demise, acetic acid-induced yeast death is characterized by ROS production, 
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and the AAC was proposed to be a target for oxidative modifications. Our results 
suggest that, in the scenario of acetic acid-induced yeast cell death, the oxidation of 
thiol groups in the Aac2p is unlikely related to the role of this carrier in MOMP. 
Mitochondrial dysfunction associated with a reduction of cytochrome c oxidase (COX) 
activity, and a decrease in the amounts of Cox2p and of cytochromes a+a3 is 
accompanied by ROS accumulation during acetic acid induced apoptosis (Ludovico et 
al., 2002). The results obtained in the context of the present study suggest that ROS 
accumulation is not necessarily the trigger of AAC-mediated MOMP. To rule out this 
hypothesis it should be interesting to test the effect of diamide, a true thiol crosslinking 
agent, on yeast cell death in the presence of a cysteine-less Aac2p, and compare it to 
acetic acid. A different possibility is that the Aac2p could experience other 
modifications than thiol oxidation. Also, it might be worth to study the influence of the 
AAC‟s conformational states in acetic acid-death, by blocking the carrier with specific 
ligands.  
Although the importance of the ANT and its thiol groups in cell death has been 
questioned (Kokoszka et al., 2004), it is undeniable that its counterpart in yeast plays a 
crucial role in some scenarios of cell death (Pereira et al., 2007). And even if it is not 
the case during acetic acid-induced death, post-translational modifications of the ANT 
might actually affect its role in MMP (Queiroga et al., 2010). Several recent reports 
connect the effect of ROS, thiol groups and anti-oxidant defence mechanisms or 
reducing agents with the regulation of PTP opening, thus strengthening the concept of 
oxidation/reduction events as an important mechanism of MMP regulation (Greco et al., 
2011; Singh et al., 2011; Sloan et al., 2012). The finding that a C. elegans orthologue of 
mammalian ANT is a central player of PCD (Shen et al., 2009) suggests a conserved 
dual role for the carrier in cellular physiology, and as for the mechanisms regulating this 
process one may say the game is still on. 
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5. Supplementary Data 
 
5.1. Acetic acid tolerance of wt and CL mutants 
The viability of Aac2 wt and CL exposed to 180 mM of acetic acid was evaluated by 
c.f.u. counting. Cells were grown and treated in medium with glucose or galactose as 
carbon sources and in both cases no significant differences were observed in Aac2 wt 
and CL (Fig. 7). Galactose seems affect the capacity of Aac2 wt and CL cells to respond 
to acetic treatment, since the survival these cultures was lower than that of glucose-
grown cultures (Fig. 7). 
 
Fig. 7 – Cell death of Aac2 wt and Aac2 CL strains during acetic acid treatment. Survival curve of cell 
cultures during acetic acid treatment (180 mM) in synthetic complete media with galactose (left panel) or 
glucose (right panel). Data represent mean ± SD of at least 2 independent experiments. 
 
 
One possible explanation for such occurrence may be related with in the fact that 
dissociation of acetic acid in the cytosol leads to intracellular acidification, acetate anion 
accumulation (Casal et al., 1996) and inhibition of cellular metabolic activity, namely, 
fermentation (Pampulha and Loureiro-Dias, 1989). This event could affect the cell‟s 
energetic capacity, and in the presence of galactose as the sole carbon source it would 
be a very important limiting factor for the cellular reaction to acetic acid stress. This 
idea might find some support on the observation that carbohydrate metabolism genes 
are determinant for maximal tolerance to acetic acid (Mira et al., 2010).  
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5.2. The effect of two anti-oxidants during acetic acid treatment  
To understand if the acetic acid-induced cell death in S. cerevisiae is being regulated 
by ROS, wt cells were incubated with two different anti-oxidants, N-acetylcysteine 
(NAC) and resveratrol, prior to the exposure to acetic acid. NAC is a thiol, a mucolytic 
agent and a precursor of L-cysteine and reduced glutathione. It is also a source of 
sulfhydryl groups in cells, acting as a scavenger of free radicals such as hydrogen 
peroxide and hydroxyl radicals. It can also increase the glutathione levels in cells. NAC 
has been extensively used to investigate the role of ROS in several biological and 
pathological processes, although there is some controversy rising from the ability of 
NAC to act either as a pro-apoptotic or pro-survival agent (Zafarullah et al., 2003). 
Resveratrol (3,4‟,5-trihydroxystilbene) is a phytoalexin found in various plants, 
including grapes, berries and peanuts, as well as in wines (especially red wines). 
Resveratrol has several biological attributes, including antioxidant and anti-
inflammatory activities, anti-platelet aggregation effects, anti-atherogenic properties, 
oestrogen-like growth-promoting effects, growth-inhibiting activities, 
immunomodulation and chemoprevention. Recently, resveratrol has been identified as 
an anti-carcinogenic and anti-ageing agent. However, and depending on the 
concentration, resveratrol can also exhibit pro-oxidant activities, leading to oxidative 
breakage of DNA in the presence of transition metal ions such as copper (de la Lastra 
and Villegas, 2007). 
Both antioxidants were added to the culture medium 1 hour before the addition of 
acetic acid. The effect of NAC (5 mM) or resveratrol (100 μM) in the survival of wt 
cells exposed to different acetic acid concentrations (40, 80 and 160 mM), was tested 
after 3 hours of exposure. In both cases the survival of cells treated in the presence of 
the antioxidant is similar to that of control cells (treated only with the acid), having no 
significant differences between both treatments (Fig. 8). In our experimental conditions, 
it seems that the presence of an anti-oxidant could affect the cell‟s capacity to resist the 
stress induced by lower concentrations (40 mM) of acetic acid. 
It is possible that the concentrations of each anti-oxidant used in this assay, were not 
enough to actually prevent the generation/accumulation of ROS induced by acetic acid 
treatment. To test this hypothesis, ROS accumulation during these experimental 
conditions should be controlled using, for an instance, a fluorescent probe to react with 
superoxide and other oxidative molecules. It should be mentioned that antioxidants such 
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as NAC have already been successfully used to promote yeast survival during acetic 
acid treatment (Guaragnella et al., 2010). 
 
 
Fig. 8 – Cross effect of the antioxidants NAC (5 mM), on the left, and Resveratrol (100 µM), on the 
right, in the acetic acid treatment of Aac2 wt cultures exposed to three different concentrations of acetic 
acid (40, 80 and 160 mM) for 180 minutes. Viability was determined by c.f.u. counting after 48 hours at 
30°C. 100 % survival corresponds to the total c.f.u. number at time zero. Statistical analysis indicates that 
the presence of the antioxidants is not able to promote cell survival upon acetic acid treatment. For cells 
treated with 40 mM of acetic, the combined effect of NAC was in fact deleterious for cell survival (P < 
0.05). Data represent mean ± SD of at least 3 independent experiments.  
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1. Introduction 
 
The contribution of mitochondrial proteins to the different mechanisms of cell death 
has taken a great deal of attention, particularly since mitochondria were found to be 
more than just the cell‟s “power station”, also playing a central role in programmed cell 
death (PCD). One such protein is the Voltage Dependent Anion Channel (VDAC), 
presumably the most abundant protein of the outer mitochondrial membrane (OMM) 
that functions as a low-specificity molecular sieve with a cut-off at approximately 1 
kDa. VDAC is considered to be responsible for the permeability of the OMM to several 
small molecules, and its voltage-dependence regulates the flow of metabolites between 
the cytoplasm and the inner mitochondrial membrane (IMM) (Colombini, 1979). 
Different models have been proposed considering the role of VDAC in mitochondria 
outer membrane permeabilization (MOMP), a determinant step in most scenarios of cell 
death (Desagher and Martinou, 2000). One of these models associates VDAC to the 
opening of the permeability transition pore (PTP), an idea originated from 
electrophysiological studies in which the voltage dependence of the pore resembled that 
of VDAC (Szabo et al., 1993; Szabo and Zoratti, 1993). This hypothesis found some 
support in the work of Beutner and colleagues, who observed that, when reconstituted 
into liposomes, hexokinase-enriched fractions found in mitochondrial contact sites, also 
containing VDAC and the adenine nucleotide translocator (ANT), were able to form 
channels with the conductance expected for the PTP (Beutner et al., 1996). A different 
model, proposes an association between pro-apoptotic Bcl-2 family proteins and VDAC 
as the mechanism responsible for cytochrome (cyt c) release during apoptosis (Shimizu 
et al., 1999). Supporting this idea, Shimizu and colleagues proposed that Bax and Bak 
accelerated the opening of VDAC in reconstituted proteoliposomes, whereas Bcl-xL 
directly interacted with VDAC to close it (Shimizu et al., 1999). An alternative model 
proposes that apoptosis induction favours the closed conformation of VDAC, resulting 
in the inability to exchange cytosolic ADP for mitochondrial ATP, which would inhibit 
the F1F0 ATPase and prevent the flux of H
+
 back into the matrix (Vander Heiden et al., 
1999). Hyperpolarization of the inner mitochondrial membrane (IMM) would then 
promote osmotic swelling of the matrix and subsequent rupture of the outer 
mitochondrial membrane (OMM) (Vander Heiden et al., 1997). On this model, anti-
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apoptotic Bcl-2 family members such as Bcl-xL would prevent cell death by promoting 
VDAC opening and facilitating the ADP/ATP exchange (Vander Heiden et al., 2001). 
Meanwhile, the model of VDAC regulation by Bax was questioned and instead, 
truncated Bid, another pro-apoptotic regulator, was found to modulate voltage gating of 
VDAC by inducing channel closure (Rostovtseva et al., 2004). Nevertheless, it should 
be mentioned that the typical “closed” VDAC conformation actually corresponds to a 
lower-conductivity state with only 50 % reduction in channel conductance and an 
estimated pore radius of 0.9 nm (Colombini et al., 1987; Mannella and Guo, 1990). 
Along with a decrease in pore size, the shift from an open to a “closed” state changes 
the selectivity of the channel lowering its specificity to anions in favour of a more 
cation selective form (Hodge and Colombini, 1997). 
Studies with mitochondria extracted from mice in which the VDAC isoforms were 
genetically inactivated, seriously questioned the contribution of VDAC to MOMP and 
cell death. The first evidences were obtained by Krauskopf and collegues who observed 
that the basic properties of the PTP in VDAC1
−/−
 mitochondria were identical to those 
of wild-type mitochondria, demonstrating that VDAC1 isoform is not required for the 
opening and regulation of PTP (Krauskopf et al., 2006). Additional confirmation was 
obtained in the work of Baines and colleagues, demonstrating that wild-type and 
VDAC-deficient mitochondria or whole cells were still able to undergo mitochondrial 
permeability transition (MPT) induced by Ca
2+
 overload and oxidative stress (Baines et 
al., 2007). Furthermore, the absence of VDAC isoforms did not affected cyt c release, 
caspase cleavage and cell death induced by the pro-apoptotic Bcl-2 proteins Bax and 
Bid (Baines et al., 2007). Such evidences discredited the hypothesis of a VDAC 
mediated cell death mechanism involving the participation of this protein in the PTP or 
the collaboration with the Bcl-2 family proteins (Galluzzi and Kroemer, 2007). 
 Although most of the mammalian apoptotic regulators are absent in yeast, the 
original candidates proposed to build up the scaffold structure of mammalian PTP, 
appear to be conserved among eukaryotic organisms. In fact, Saccharomyes cerevisiae 
possesses three isoforms of the ADP/ATP carrier (AAC1, AAC2 and AAC3), orthologues 
of the mammalian ANTs (Kolarov et al., 1990; Lawson and Douglas, 1988), a VDAC 
gene POR1 (Blachly-Dyson et al., 1997; Mihara and Sato, 1985), and a mitochondrial 
cyclophilin, CPR3 (Matouschek et al., 1995). As for mammalians, a large-conductance 
unselective channel has also been found in yeast mitochondria and was later named 
“yeast PTP” (Jung et al., 1997). The properties of this yeast mitochondrial unselective 
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channel (YMUC) were summarized in a review by Manon and colleagues in 1998, and 
a comparison with the features of mammalian PTP was made (Manon et al., 1998). 
Based on the available knowledge by then, it was concluded that even if YMUC 
presents some functional analogies with mammalian PTP, its regulation was different 
enough to consider YMUC a controversial counterpart of the mammalian PTP (Manon 
et al., 1998). However, recent data indicates that the apparently big differences between 
these two channels might only be due to different sensitivities of yeast and mammalian 
mitochondrial cyclophilin to phosphate and/or Ca
2+
, and Ca
2+
-induced permeability 
transition can be observed in yeast suggesting that the YMUC and mammalian PT may 
be the expression of very similar events (Azzolin et al., 2010; Yamada et al., 2009). The 
exact composition of the YMUC remains to be elucidated, and some evidences argue 
against a putative contribution of the AAC or Porin (Ballarin and Sorgato, 1995; Lohret 
et al., 1996). Nevertheless, the absence of Por1p is enough to alter its voltage 
dependence and desensitize it to Ca
2+
 regulation (Gutierrez-Aguilar et al., 2007; Lohret 
and Kinnally, 1995). 
Interestingly, both AAC and Por1p have been implicated in yeast cell death induced 
by different stimuli. Absence of AAC proteins increased the resistance of yeast cells to 
acetic acid and diamide, preventing acetic acid-induced cyt c release from mitochondria 
(Ludovico et al., 2002; Pereira et al., 2007). On the other hand, deletion of Por1p 
increases the sensitivity of yeast cells to acetic acid, a process that is associated to a 
faster DNA degradation. The Δpor1 mutant yeast is also sensitive to hydrogen peroxide 
and diamide (Pereira et al., 2007), exhibiting mitochondrial network fragmentation and 
increased ΔΨm, two events that are apparently not related to the acetic acid sensitive 
phenotype (Pereira, 2008; Pereira et al., 2007).  
The aim of this work was to study the contribution of the AAC and Por1p, and a 
potential interaction of both proteins, to MMP and yeast cell death, particularly during 
acetic acid-induced death in which these proteins apparently have different regulatory 
roles. To understand the impact of Por1p in AAC-mediated MMP, we studied cyt c 
release from mitochondria of cells lacking Por1p and the three isoforms of the AAC, 
and compared it to wt, Δaac1/2/3 and Δpor1 mitochondria.  
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2. Materials and Methods 
 
2.1. Strains and Growth Conditions 
The yeast strains and plasmids used in this study are listed in Table 1: 
 
Table 3 – List of strains used on the experiments described in the following sections. 
Name Strain/Plasmid Source/Reference 
wt W303-1B (MATα; ura3; trp1; leu2; his3; ade2; canR) 
Gift from Alexander 
Tzagoloff 
Δaac1/2/3 
JL1-3Δ2Δ3 (MATa, ade2, his3; leu2; trp1; ura3; can1; 
aac1::LEU2; Δaac2::HIS3; Δaac3::URA3) 
Postis et al., 2005 
Δpor1 W303-1B; Δpor1::kanMX4 This study 
Δaac1/2/3Δpor1 JL1-3Δ2Δ3; Δpor1::kanMX4 This study 
Atp3 
W303-1B (MATα; ura3; trp1; leu2; his3; ade2; canR 
Δatp3::kanMX4) +  pCM189-ATP3 
Gift from Emmanuel 
Tétaud 
 
Saccharomyces cerevisiae strains W303-1B and JL1-3Δ2Δ3, which is a derivate of 
W303 lacking the three isoforms of the AAC (AAC1, 2 and 3; (Postis et al., 2005)), 
were transformed with a Δpor1::kanMX4 interruption cassette, amplified by PCR from 
genomic DNA of BY4741 Δpor1 EUROSCARF deletion strain (EUROSCARF, 
Institute of Molecular Biosciences Johann Wolfgang Goethe-University Frankfurt, 
Germany), to generate Δpor1 and Δaac1/2/3Δpor1 strains, respectively. Yeast cells 
were transformed by the lithium acetate method (Ito et al., 1983), after which 
transformants were selected in medium containing geneticin (200 µg/µL) and confirmed 
by PCR. In the experiments described below, cells were pre-grown in YPD medium 
(2% Glucose, 1% yeast extract, 1% bactopeptone), transferred to YPGal medium (2% 
Galactose, 1% yeast extract, 1% bactopeptone) and incubated over-night (O.N.) at 30°C 
(200 r.p.m.) until an optical density of 1.5-2.0 was reached (Pereira et al., 2007). A 
Δatp3 strain was transformed with plasmid pCM189-ATP3, containing the ATP3 
sequence under control of a Tet-off promoter and kindly provided by Doctor Emmanuel 
Têtaud (IBGC, Bordeaux), and selected in YNB medium (0.175% YNB, 2% Glucose, 
0.5% (NH4)2SO4, 2% agar) without uracil. The Atp3 strain was pre-grown in synthetic 
complete medium (0.175% YNB, 2% Glucose, 0.5% (NH4)2SO4) without uracil. 
Doxycycline, 10 µg/mL, was used whenever inhibition of ATP3 expression was desired. 
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2.2. Acetic acid treatment  
For acetic acid tolerance and mitochondria extraction assays, acetic acid was added 
at a final concentration of 180 mM to cultures grown over-night until exponential 
growth phase (O.D.640nm = 1.5 – 2.0) in YPGal medium. Survival of wt, Δaac1/2/3, 
Δpor1 and Δaac1/2/3Δpor1 cells to acetic acid treatment was evaluated by c.f.u. 
counting from samples collected at different time points during a 3 hours period,  plated 
onto YPDA (YPD supplemented with 2% Agar; 200 μl from a 1.25x103 cell/mL 
suspension) and grown for 2 days at 30°C. Percentage of viable cells was estimated 
considering 100% survival the number of c.f.u. at time zero minutes. 
 
2.3. Mitochondria Isolation and Western-blot analysis 
For mitochondria isolation, approximately 5 L of wt, Δaac1/2/3, Δpor1 and 
Δaac1/2/3Δpor1 cultures were grown O.N. in YPGal as previously described. Half of 
each culture was used as control (T0), and the remaining was subjected to acetic acid 
treatment (180 mM) for 90 or 180 minutes. Control and acetic acid treated cells were 
converted into spheroplasts by enzymatic digestion with zymolyase (Zymolyase 20T, 
Seikagaku Biobusiness Corporation), disrupted by hand-potter or mechanical 
homogenization, and the mitochondrial fraction recovered after a series of differential 
centrifugations (Law et al., 1995). Mitochondrial suspensions were frozen in liquid 
nitrogen and stored at -80°C. For characterization of the mitochondrial and post-
mitochondrial fractions by Western-blot, 50 μg of proteins were precipitated with TCA, 
and solubilized in 2% SDS before being separated on SDS–PAGE (Laemmli, 1970). 
Proteins were then blotted into PVDF membranes. Characterization of both fractions 
was carried out with antibodies directed against cytochrome c (rabbit polyclonal Anti-
CYC1 antibody; 1:1000, custom-made by Millegen); phosphoglycerate kinase (mouse 
monoclonal Anti-PGK1 antibody; 1:5000, Molecular Probes), and the beta subunit of 
the F1 sector of mitochondrial F1F0 ATP synthase (rabbit polyclonalclonal Anti-ATP2 
antibody; 1:20000, home made by Jean Velours, IBGC, Bordeaux). All protein 
quantifications were performed by the Lowry method (Lowry et al., 1951). 
 
2.4. Redox Spectrophotometry 
For cytochrome quantification, 9.6 mg of thawed mitochondrial proteins were diluted 
in recuperation buffer (0.6 M Mannitol; 10 mM Tris-maleate; 2 mM EGTA; pH 6.8) to 
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a final volume of 1.6 mL, producing a mitochondria suspension with the final 
concentration of 6 mg/mL. The suspension was equally divided into two glass cuvettes 
and the reference and sample cuvettes were oxidized and reduced with potassium 
ferricyanide and sodium dithionite, respectively. Samples were then analysed in a 
double beam spectrophotometer, Varian Cary 4000. Alternatively, 200 μl of a 10 
mg/mL mitochondria preparation were analysed in a micro-plate spectrophotometer. For 
whole cell cytochrome quantification, cells were collected during exponential growth, 
and concentrated in a cellular suspension of 2 mL at ≈ 40 O.D.640nm. This suspension 
was divided in two cuvettes and analyzed in a double beam spectrophotometer, Varian 
Cary 4000. Hydrogen peroxide (2 μl) was used instead of potassium ferricyanide for 
whole cell cytochrome quantifications. Spectra were acquired between 500 and 650 nm 
and cytochromes c+c1, b and a+a3 were quantified by the O.D. at differences 550 nm 
minus 540 nm, 561 nm minus 575 nm, and 603 nm minus 630 nm, respectively (Fig. 1). 
 
 
Fig. 1 - The amounts of cytochromes c and b in isolated mitochondria were measured by redox 
difference spectrophotometry. Mitochondria were diluted in 1.8 mL of recuperation buffer (6 mg/mL) and 
divided by two glass cuvettes, one oxidized with ferricyanide (refrence) and the other reduced with 
sodium dithionite (sample). Difference spectra were acquired in a Varian Cary 4000 spectrophotometer. 
 
2.5. Cell wall resistance evaluated by enzymatic digestion 
Wt, Δaac1/2/3, Δpor1 and Δaac1/2/3Δpor1 cultures were grown O.N. on either YPD 
or YPGal medium, as previously described. Cells were then collected, washed and 
resuspended in PBS to obtain a cellular suspension with an O.D.640nm of 0.5. Zymolyase 
was added to a final concentration of 20 µg/mL and the cellular suspensions incubated 
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at 30°C, with agitation for one hour. Cell wall digestion was followed by periodic 
measures of the suspension‟s absorbance (A800). ΔO.D.800nm was estimated considering 
100% the absorbance measured at time zero minutes. 
 
2.6. Cell wall, osmotic and heat stress assays 
For spot assays, samples from exponentially grown cultures of wt, Δaac1/2/3, Δpor1 
and Δaac1/2/3Δpor1 strains were collected and adjusted to a 1.0 O.D.640nm suspension. 
These samples were diluted 5 times in a 1:10 dilution series, and 5 μl of each dilution 
were plated in YPDA medium supplemented with different stress agents: NaCl (1M), 
KCl (1.5 M), Caffeine (7.5 mM) or Caffeine (7.5 mM) + Sorbitol (1M); or YPGA 
medium (2% glycerol). To test the effect of these stresses in the Δatp3 mutant, 
doxycycline was added to a final concentration of 10 µg/mL. Plates were incubated for 
5 days at 30°C. The growth ability of theses strains in YPDA medium at 37°C, was also 
tested. 
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3. Results 
 
3.1. Acetic Acid tolerance of wt, Δaac1/2/3, Δpor1 and Δaac1/2/3Δpor1 strains 
Pereira and colleagues have previously demonstrated that the absence of the three 
AAC isoforms (AAC1, 2 and 3) increases the resistance of S. cerevisiae to acetic acid, 
while deletion of POR1 greatly sensitizes yeast cells acting as a pro-survival molecule 
(Pereira et al., 2007). The authors also found that AAC proteins are required for acetic 
acid-induced cyt c release from mitochondria to the cytosol (Pereira et al., 2007). 
Considering these observations, we questioned how the absence of both AAC and 
Por1p, two members of the originally proposed pore structure, would affect acetic acid-
induced MOMP. To answer this question, the survival of wt, Δpor1, Δaac1/2/3 and 
Δaac1/2/3Δpor1 strains to acetic acid was evaluated by c.f.u. counting.  
 
Fig. 2 – Survival of S. cerevisiae wt, Δaac1/2/3, Δpor1 and Δaac1/2/3Δpor1 cells during acetic acid 
treatment. Cell cultures were pre-grown in YPD, transferred to YPGal and grown O.N. until an O.D.640nm 
of 1.5-2.0 was reached. Acetic acid was then added to a final concentration of 180 mM. Viability was 
determined by c.f.u. counts at the indicated time points (100 % survival corresponds to the total c.f.u. 
number at time zero). Deletion of Por1p results in higher sensitivity of S. cerevisiae to acetic acid, while 
the absence of the AAC proteins, independently of the presence or absence of Por1p, is responsible for 
increased resistance to the deleterious effects of the acid. Data represent mean ± SD of at least 3 
independent experiments. 
 
The simultaneous absence of AAC and Por1p produces a resistance phenotype 
similar to Δaac1/2/3 (Fig. 2). Both Δaac1/2/3 and Δaac1/2/3Δpor1 strains exhibited a 
high plating efficiency after 3 hours of exposure to acetic acid (approximately 85% and 
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75%, respectively). On the other hand, the Δpor1 strain was more sensitive to acetic 
acid than the wt, exhibiting less than 10% survival against approximately 40% of the wt 
(Fig. 2). It seems that in the absence of both proteins, the resistance phenotype resulting 
from deletion of the AAC isoforms prevails over the sensitivity conferred by Por1p 
deletion, suggesting that the sensitivity resulting from Por1p deletion depends on the 
presence of the AAC proteins. It is possible that Por1p acts on the AAC to regulate 
MOMP during acetic-induced death. 
 
3.2. Mitochondria Isolation and Cytochrome Quantification 
In multicellular organisms, release of cyt c from mitochondria to the cytosol is 
considered a point of no return during apoptosis. Once released, cyt c combines with 
cytosolic Apaf-1 and pro-caspase 9 to form the apoptosome, which activates caspase 9 
thus propagating the death signal (Li et al., 1997). Although these proteins lack obvious 
homologs in yeast, cyt c release from mitochondria is a common event to some 
scenarios of yeast cell death, including deletion of the histone chaperone ASF1/CIA1, 
pheromone- and amiodarone-induced cell death, CDC48 mutation, and also H2O2 or 
acetic acid treatments (Braun et al., 2006; Ludovico et al., 2002; Pereira et al., 2007; 
Pozniakovsky et al., 2005; Yamaki et al., 2001). Pereira and colleagues found that 
MOMP and cyt c release during acetic acid-induced death of S. cerevisiae requires the 
presence of the AAC, an observation that correlates with the increased resistance of the 
Δaac1/2/3 mutant to acetic acid. Since the absence of Por1p sensitized yeast cells to this 
acid and this effect was reversed in the absence of AAC proteins, we decided to 
evaluate the impact of Por1p removal in the AAC-mediated MOMP and cyt c release 
during acetic acid treatment. The content of cytochromes c+c1 and b was evaluated by 
redox spectra of whole cells (Fig. 3A). The higher cyt c/cyt b ratios estimated for 
Δaac1/2/3 and Δaac1/2/3Δpor1 cells might result from slight differences in the content 
of cyt c and/or b in these cells (Fig. 3A and 3B). Mitochondria were extracted from wt 
and Δpor1 cells, before and after a 3 hours exposure to acetic acid (180 mM), and the 
cytochrome content was measured by redox spectrophotometry. Mitochondria from wt 
and Δpor1 untreated cells produced classical spectra, with the estimated cyt c/cyt b 
ratios of 2.35 and 2.12, respectively (Fig. 3C). As for acetic acid-treated cells, 
mitochondria extraction proved to be much more difficult and the mitochondrial mass 
obtained by the end of the procedure was significantly lower. Nevertheless, we were 
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able to quantify the cytochromes in mitochondria from acetic acid-treated wt cells and 
observed a cyt c/cyt b ratio of approximately 1.60, suggesting the release of cyt c during 
this experiment (Fig. 3C). Such result is in agreement with the previously reported by 
Pereira and colleagues (Pereira et al., 2007). The same was not true for Δpor1 cells 
treated with acetic acid, from which the amount of mitochondrial mass obtained was 
very low. The resulting spectra only proved the poor quality of these mitochondria and 
so it was not possible to properly measure the cytochrome content in these samples (Fig. 
3C). 
 
Fig. 3 – Cytochrome quantification in S. cerevisiae wt, Δaac1/2/3, Δpor1 and Δaac1/2/3Δpor1 
mutants. (A) Quantification of cytochromes c+c1 and b in wt, Δaac1/2/3, Δpor1 and Δaac1/2/3Δpor1 
cells, by redox spectra. Cells were collected, resuspended to a final O.D.640nm of 40.0 and divided in two 
cuvettes. The reference cuvette was oxidized with hydrogen peroxide (H2O2), and the sample reduced 
with sodium dithionite. Spectra were acquired in a double beam spectrophotometer, and the content of 
cytochromes c+c1 and b was estimated by the O.D. differences 550 nm minus 540 nm and 561 nm minus 
575 nm, respectively. The Δaac1/2/3Δpor1 mutant apparently possesses less cyt c and b when compared 
with the other strains. Data represent mean ± SD of at least 3 independent experiments. (B) Cyt c/cyt b 
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ratio estimated for wt, Δaac1/2/3, Δpor1 and Δaac1/2/3Δpor1 cells. (C) Redox spectra of wt and Δpor1 
mitochondria isolated from control and acetic acid treated cells. Cells were collected before (control) and 
after the exposure to acetic acid, 180 mM for 3 hours, and the mitochondria preparations obtained after 
enzymatic digestion of the cell wall with zymolyase followed by mechanical disruption of spheroplasts 
and differential centrifugations. For redox spectrophotometry, mitochondria preparations (6 mg/mL) were 
oxidized with ferrycianide and reduced with sodium dithionite. Difference spectra were acquired in a 
double beam spectrophotometer, and the content of cytochromes c+c1 and b was estimated as described 
above. One representative experiment is shown for each mitochondria sample. 
 
Since the Δpor1 strain is particularly sensitive to acetic acid, presenting less than 
10% of plating efficiency after 3 hours of treatment with acetic acid (180 mM), we 
decided to examine cyt c release from mitochondria upon a shorter exposure to acetic 
acid, thus with a higher survival percentage of Δpor1 cells. After 90 minutes of 
treatment with acetic acid (180 mM), Δpor1 strain exhibits a viability of about 50%, and 
therefore mitochondria extractions from wt, Δaac1/2/3, Δpor1 and Δaac1/2/3Δpor1 
were performed after a 90 minutes exposure to the acid. Mitochondria from wt, 
Δaac1/2/3, Δpor1 and Δaac1/2/3Δpor1 control cells produced good spectra, with 
estimated cyt c/cyt b ratios of approximately 2.0 (Fig. 4A and 4B). In spite of a 
recurrent low yield of mitochondrial mass, it also possible to obtain enough 
mitochondria from acetic acid-treated cells to analyse the cytochrome‟s content after 90 
minutes of treatment. During this period, the cytochrome ratio of wt mitochondria 
decreased from an average value of 2.03 to 1.39 (Fig. 4B), while the Δaac1/2/3 
mitochondria presented a slighter variation from 1.71 to 1.55 (Fig. 4B). These 
observations reproduce the results of Pereira and colleagues (Pereira et al., 2007), 
indicating an impaired release of cyt c from Δaac1/2/3 mitochondria. The cyt c/cyt b 
ratio from Δpor1 mitochondria varied from 1.97 in control cells to 1.52 after the 90 
minutes exposure to acetic acid, indicating a rate of cyt c release similar to that observed 
in wt mitochondria. Again, mitochondria extraction from Δpor1 cells treated with acetic 
acid was problematic, and obtaining good mitochondria preparations proved to be truly 
challenging. In some cases, the resulting spectra were not suitable for cytochrome 
quantification. As for the quadruple mutant, the average values obtained for 
mitochondrial cyt c/cyt b ratio in control and acetic acid-treated cells, revealed a small 
variation from 2.12 to 2.03 (Fig. 4B). Therefore, it seems that cyt c release in 
Δaac1/2/3Δpor1 cells might be compromised, as observed in the Δaac1/2/3 mutant. 
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Fig. 4 – Evaluation of mitochondrial cytochrome content from wt, Δaac1/2/3, Δpor1 and 
Δaac1/2/3Δpor1 control and acetic acid treated cells. Cells were collected before and after exposure to 
acetic acid, 180 mM for 90 minutes, and mitochondria isolated after enzymatic digestion of the cell wall 
with zymolyase followed by mechanical disruption of spheroplasts and differential centrifugations. (A) 
Redox spectra from wt, Δaac1/2/3, Δpor1 and Δaac1/2/3Δpor1 mitochondria isolated from control and 
acetic treated cells. 400 µL of mitochondria preparations (10 mg/mL) were divided in two wells from a 
96-well micro-plate, one sample oxidized with ferrycianide and the other reduced with sodium dithionite. 
Difference spectra were acquired between 500 and 650 nm in a in a micro-plate spectrophotometer, and 
the content of cytochromes c+c1 and b was estimated by the O.D. differences 550 nm minus 540 nm and 
561 nm minus 575 nm, respectively. A decrease in the content of cyt c can be observed in mitochondrial 
preparations from wt and Δpor1 acetic acid-treated cells. Mitochondria from Δaac1/2/3 and 
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Δaac1/2/3Δpor1 treated cells seem to retain most of their cyt c. One representative experiment is shown 
for each mitochondria sample. (B) Cyt c/cyt b ratio estimated for wt, Δaac1/2/3, Δpor1 and 
Δaac1/2/3Δpor1 mitochondria from control and acetic acid treated cells (180 mM, 90 minutes). 
Mitochondria from wt and Δpor1 cells exposed to acetic acid present the larger decrease in cyt c/cyt b 
ratios, contrasting with those of Δaac1/2/3 and Δaac1/2/3Δpor1 mitochondria. Data represent mean ± SD 
of at least 3 independent experiments. 
 
3.3. Cytochrome c release evaluated by Western-blot 
To confirm the predicted effects from the absence of AAC, Por1p or both proteins in 
MOMP and cyt c release, mitochondria and their corresponding post-mitochondrial 
fractions were collected, and 50 µg of protein were precipitated for immunodetection of 
cyt c. Western-blot analyses of wt mitochondrial and post-mitochondrial samples 
confirmed the cyt c release predicted by redox spectra analysis. Comparing to control 
samples, there is a significant decrease in the mitochondrial content of cyt c in acetic 
acid-treated wt cells (Fig. 5), as previously described by Pereira and colleagues (Pereira 
et al., 2007). In contrast, the absence of AAC proteins allows mitochondria from treated 
cells to retain most of their cyt c (Fig. 5).  
 
Fig. 5 – Immunodetection of cyt c in wt, Δaac1/2/3, Δpor1, Δaac1/2/3Δpor1 mitochondrial and post 
mitochondrial fractions isolated from control and acetic-treated cells. Cytosolic 3-phosphoglycerate 
kinase (Pgk1) and the beta subunit of the F1 sector of mitochondrial F1F0 ATP synthase (Atp2) were used 
as controls for the post- and mitochondrial fractions, respectively. Cyt c detection on mitochondrial 
extracts suggests that wt and Δpor1 mitochondria readily release cyt c during acetic acid treatement, 
whereas Δaac1/2/3 mitochondria are able to retain a significant amount of this cytochrome. 
Δaac1/2/3Δpor1 mitochondria appear to lose more cyt c than Δaac1/2/3 mitochondria, and possibly to a 
lesser extent than wt mitochondria. One representative experiment is shown. 
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In the set of our results, it was not possible to observe a significant increase of cyt c 
in the post-mitochondrial fractions of Δaac1/2/3 cells. On the other hand, the absence of 
Por1p does not appear to compromise MOMP since the mitochondrial content of cyt c 
decreases after treatment with acetic acid (Fig. 4). Interestingly, we could still observe 
cyt c release from mitochondria of acetic acid-treated Δaac1/2/3Δpor1 cells, in what 
appears to be a lesser extent than the release observed for wt or Δpor1 cells (Fig. 5). 
This observation suggests that MOMP might still occur in the absence of AAC proteins, 
although at a significantly reduced rate, and suggests an important role of Por1p in the 
regulation of this process. In a general manner, the results from Western-blot analysis 
matched the profile of cyt c release obtained by redox spectrophotometry, with an 
exception for Δaac1/2/3Δpor1, which presented some differences between both results. 
These differences might be related to the low content of cyt b in Δaac1/2/3Δpor1 acetic 
acid-treated cells that would affect the estimated cyt c/cyt b ratio in these mitochondria. 
 
3.4. Effect of AAC and Por1p in the resistance of cell wall to enzymatic digestion 
During mitochondria extraction experiments we found that the enzymatic digestion 
of the cell wall from Δaac1/2/3 and Δaac1/2/3Δpor1 cells was much slower and less 
efficient when compared to the other strains. As a consequence less spheroplasts were 
obtained from these strains, which eventually contributed to a lower yield in 
mitochondrial mass. Upon such observations, we decided to evaluate the effects of 
AAC and Por1p deletions on the resistance of the cell wall to enzymatic digestion with 
zymolyase. Cell wall digestion by zymolyase was evaluated through variation of the 
O.D.800nm from cellular suspensions, incubated for 60 minutes at 30°C. Our results 
indicate that Δaac1/2/3 and Δaac1/2/3Δpor1 cells have increased resistance to digestion 
by zymolyase when compared to wt or Δpor1 cells, which show no significant 
differences among them (Fig. 6). For cells grown in the presence of glucose as carbon 
source, Δaac1/2/3 and Δaac1/2/3Δpor1 mutants exhibit a small O.D. variation after a 60 
minutes digestion, reaching values of 62% and 81% of the cells with intact cell wall, 
respectively. In the same conditions, the ΔO.D.800nm of wt and Δpor1 cells is 
considerably higher, decreasing to values of nearly 15% of cell wall integrity. When the 
same cells were grown in YPGal, Δaac1/2/3 and Δaac1/2/3Δpor1 mutants presented no 
significant variation. Once again cells lacking both AAC and Por1p were the most 
resistant to enzymatic digestion of the cell wall, while the resistance of wt and Δpor1 
The role of Por1p in AAC-mediated mitochondria membrane permeabilization (MMP) and release of 
cytochrome c 
 
123 
 
cells slightly increased (≈ 25%) (Fig. 6). These results suggest a direct connection 
between the absence of AAC proteins and the observed changes in cell wall resistance 
to enzymatic digestion, revealing what could be a new aspect of mitochondrial 
signalization.  
 
Fig. 6 – Enzymatic digestion of wt, Δaac1/2/3, Δpor1 and Δaac1/2/3Δpor1 cell wall with zymolyase 
(20 µg/mL). Cells grown O.N. in YPD or YPGal until exponential phase (approximately 1.0 O.D.640nm), 
were collected, washed and resuspended in PBS to a final concentration of 0.5 O.D.640nm. Digestion was 
followed by periodic measures of the suspension‟s absorbance at 800 nm. For each strain, values were 
normalized for the A800nm at time zero, allowing the assessment of cell wall digestion measured as a 
variation in absorbance (ΔO.D.800nm). Digestion of the cell wall from wt and Δpor1 cells is much more 
efficient and faster than that of Δaac1/2/3 and Δaac1/2/3Δpor1 cells, particularly in glucose-grown cells. 
This effect is attenuated by the growth in the presence of galactose instead of glucose. Δaac1/2/3Δpor1 
cells are apparently the most resistant to cell wall digestion by zymolyase. Data represent mean ± SD of at 
least 3 independent experiments. 
 
3.5. Cell wall, osmotic and thermotolerance assays 
Since AAC proteins and mitochondria might be involved in signalling events capable 
of changing the structure of cell wall, particularly evident during acetic acid stress, we 
decided to evaluate the response of the selected strains to other kinds of stresses. For 
such purpose, we tested the ability of wt, Δaac1/2/3, Δpor1 and Δaac1/2/3Δpor1 cells to 
grown under conditions of osmotic, cell wall and heat stress, by dropout assay. 
Exponentially grown cells were collected and resuspended to obtain cellular 
suspensions of 1.0 O.D.640nm, which were further diluted in a series of 1:10 dilutions. 
Samples from each suspension were plated in YPDA supplemented with different stress 
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agents and grown for 5 days at 30°C. Thermotolerance of each strain was tested by the 
ability of yeast cells to grow at 37°C. Growth in YPGA was used as control.  
 
Fig. 7 – Cell wall stress, osmotic stress and thermotolerance of S. cerevisiae wt, Δaac1/2/3, Δpor1 and 
Δaac1/2/3Δpor1 strains. Exponentially grown cells were collected, diluted in a series of 1:10 dilutions 
and plated in YPDA medium, YPDA supplemented with different stress agents, or YPGA. Osmotic stress 
was tested in the presence of 1 M NaCl (upper left panel) or 1.5 M KCl (upper right panel). Response to 
cell wall stress was tested in the presence of 7.5 mM caffeine alone (middle left panel) or 7.5 mM 
caffeine with 1 M sorbitol (middle centre panel). Sorbitol 1M was used as a control (middle right panel). 
Thermotolerance was tested by the capacity of each strain to grown on YPDA medium at 37°C (lower left 
panel). The ability to grow on glycerol was used as control for the respiratory capacity of the tested 
strains (lower right panel). Absence of the AAC proteins seems to increase the cell‟s capacity to tolerate 
osmotic and cell wall stresses, contrasting with the absence of por1, which increases the sensitivity of 
yeast cells to the mentioned stresses. The phenotype resulting from the absence of AAC proteins 
overcomess the sensitivity conferred by Por1 deletion, with an exception for the thermotolerance. One 
representative experiment is presented. 
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Our results suggest that Δaac1/2/3 and Δaac1/2/3Δpor1 cells are more tolerant to 
osmotic stress than wt cells, as observed by growth in the presence of NaCl (1M), and 
particularly KCl (1.5M) (Fig. 7). On the other hand, the absence of Por1p greatly 
sensitizes yeast cells to osmotic stress induced by these agents, a phenotype that is 
completely reversed by the absence of AAC proteins. We also tested the ability of these 
strains to grow in the presence of the cell wall-perturbing agent caffeine (7.5 mM). 
Caffeine is a purine analogue that elicits pleiotropic and varied effects on cells, and used 
to induce cell wall stress for long (Bode and Dong, 2007; Martin et al., 1996). Among 
its known targets, caffeine inhibits Tor1p-regulated cellular functions and the kinase 
activity of the ATR and ATM DNA damage checkpoint kinases, interferes with Sit4-
mediated signalling and ubiquitin-dependent protein sorting, and promotes a dual 
phosphorylation of Mpk1/Slt2p, the mitogen-activated protein kinase from (MAPK) 
from the cell wall integrity (CWI) pathway, preventing the formation of a complex with 
the transcription factor Swi4 (Hood-DeGrenier, 2011; Kuranda et al., 2006; Reinke et 
al., 2006; Sarkaria et al., 1999; Truman et al., 2009). 
 The Δaac1/2/3 and, particularly, Δaac1/2/3Δpor1 mutants were able to grow better 
than the wt strain in the presence of caffeine alone (Fig. 7). Once again, Δpor1 cells 
exhibited a sensitivity phenotype (Fig. 7). The interference of caffeine in cell wall 
stability of wt cells was evident since its deleterious effect on the growth of this strain 
was significantly reversed by osmotic stabilization with sorbitol (Fig. 7). On the other 
hand, only a slight improvement was observed for the other three strains when grown in 
the presence of caffeine and sorbitol (Fig. 7). This observation suggests that AAC and 
Por1p deletions modulate the response of S. cerevisiae to osmotic stress. Sorbitol alone 
had no impact in the growth of these cells (Fig. 7). Finally, we tested the response of wt, 
Δaac1/2/3, Δpor1 and Δaac1/2/3Δpor1 to heat stress, by measuring their growth ability 
at 37°C. Our results demonstrate that wt cells were the fittest to grow under a heat stress 
situation (Fig. 7). Absence of AAC proteins had a minor impact on the thermotolerance 
of S. cerevisiae, while deletion of Por1p greatly sensitized yeast cells (Fig. 7). Unlike 
for osmotic and cell wall stresses, the Δaac1/2/3Δpor1 mutant exhibited decreased 
thermotolerance when compared to the wt strain, a phenotype similar to that of Δpor1 
mutant (Fig. 7). This was the only tested situation in which the effect of Por1p deletion 
overcame that of AAC absence, reinforcing the important role of Por1p inº the 
adaptation of yeast cells to heat stress situations (Blachly-Dyson et al., 1997). 
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The absence of AAC proteins from yeast cells compromises oxidative 
phosphorylation resulting in the incapacity of Δaac1/2/3 mutants to grow on non-
fermentable carbon sources (Gawaz et al., 1990).  
 
 
Fig. 8 - Cell wall stress, osmotic stress and thermotolerance of a S. cerevisiae Δatp3 strain carrying a 
plasmid with the ATP3 sequence under control of a Tet-off promoter, in the presence (Δatp3) or absence 
(ATP3) of doxycycline to inhibit or allow expression of ATP3, respectively. Cells were grown O.N. in 
synthetic complete medium without uracil until exponential phase, collected and diluted in a series of 
1:10 dilutions. Samples were then plated in YPDA medium, YPDA supplemented with different stress 
agents, or YPGA, in the presence or absence of doxycycline (10 mg/mL). Osmotic stress was tested in the 
presence of 1 M NaCl (upper left panel) or 1.5 M KCl (upper right panel). Response to cell wall stress 
was tested in the presence of 7.5 mM caffeine alone (middle left panel) or 7.5 mM caffeine with 1 M 
sorbitol (middle centre panel). Sorbitol 1 M was used as a control (middle right panel). Heat stress was 
tested by the growth capacity on YPDA medium at 37°C (lower left panel). The ability to grow on 
glycerol was used as control for the respiratory capacity, and to validate this system (lower right panel). 
The response of yeast cells in the presence or absence of Atp3p was identical, in the different stress 
situations. One representative experiment is presented. 
 
Considering the results described above, we decided to test if the effect of AAC 
deletion in cell integrity and the osmotic response was correlated to the respiratory 
deficiency of Δaac1/2/3 mutants. For such purpose, we tested the ability of a Δatp3 
mutant, lacking the gamma subunit of the mitochondrial F1F0 ATP synthase, to grow on 
the different stress situations in which the AAC and Por1p mutants were tested. This 
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strain was transformed with a plasmid containing the ATP3 sequence under control of a 
tet-off promoter, allowing us to stop ATP3 expression by growing these cells in the 
presence of doxycycline. This way, we were able to compare the effect of Atp3p 
presence or absence in the capacity of yeast cells to withstand osmotic and cell wall 
stresses and their thermotolerance, thus measuring the impact of energetic metabolism 
in such process. Our results indicate that absence of Atp3p does not affect the cell‟s 
response to NaCl, KCl, caffeine or growth at 37°C, considering the identical behaviour 
observed in the presence (Δatp3) or absence (ATP3) of doxycycline (Fig. 8). Growth on 
YPGA medium was used as control and validated this system since growth was 
inhibited in the presence of doxycycline (Δatp3 mutant) (Fig. 8). Altogether, it seems 
that the increased resistance of Δaac1/2/3 mutants to stress induced by NaCl, KCl and 
caffeine is not correlated to their respiratory deficiency, suggesting a direct role of the 
AAC proteins in such phenomenon. 
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4. Discussion 
 
The mechanisms underlying mitochondria permeabilization have been the subject of 
extensive studies for the last decades. Throughout this period a variety of new concepts 
and ideas were postulated while others were questioned or even discarded. A good 
example of such evolution is the contribution of mitochondrial proteins such as the 
ANT or VDAC to permeability transition (PT) and MOMP. Originally thought to 
compose the scaffold structure of the PTP, the role of ANT and VDAC in cell death is 
still controversial. Genetic and molecular studies have seriously questioned their 
contribution to such an important cellular process, eventually throwing these proteins 
into the backstage of cell death research (Baines et al., 2007; Kokoszka et al., 2004).  
The yeast S. cerevisiae has played an important role towards the understanding of 
mitochondria permeabilization during cell death. Yeast was early considered to be 
devoid of the major regulators of cell death in mammals, such as the Bcl-2 family 
members, and so, it has been was widely used in studies involving, for instance, the 
heterologous expression of the mammalian pro-apoptotic regulator Bax, helping to 
explain mechanistic aspects from its cellular actions (Kissova et al., 2006; Ligr et al., 
1998; Manon et al., 1997; Priault et al., 2002; Priault et al., 2003a; Priault et al., 2003b). 
In addition, and since yeast possesses homologues for the components previously 
ascribed to mammalian PTP including three AAC isoforms, Porin and a mitochondrial 
cyclophilin, it has also been used to understand the involvement of putative components 
of the PTP in Bax-induced cell death (Gross et al., 2000; Kissova et al., 2000; Marzo et 
al., 1998; Priault et al., 1999a; Priault et al., 1999b; Shimizu et al., 2000). Furthermore, 
in the absence of heterologous expression of Bax, yeast cells also exhibit a 
mitochondrial swelling, resulting from the flow of metabolites across the IMM, which is 
capable of inducing structural damage to the mitochondrial membranes (Velours et al., 
1977). Such swelling, considered to be responsible for the rupture of the OMM in some 
scenarios of cell death (Vander Heiden et al., 1997), has been attributed to the opening 
of a large-conductance unselective channel in yeast mitochondria, or YMUC. The size 
and absence of selectivity of YMUC led some researchers to consider it the “yeast PTP” 
(Jung et al., 1997). Nevertheless, the peculiar regulatory properties of this yeast channel 
make it a controversial counterpart of mammalian PTP (Manon et al., 1998), and a 
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putative contribution of AAC and porin has been discarded (Ballarin and Sorgato, 1995; 
Lohret et al., 1996). 
Interestingly, both the AAC and Por1p have been identified as important elements 
during acetic acid-induced cell death and mitochondria permeabilization in S. 
cerevisiae, apparently with opposite effects. The absence of AAC proteins increases the 
resistance of yeast cells to acetic acid-induced death, impairs the mitochondrial release 
of cyt c and delays the outcome of several cellular events associated to an apoptotic-like 
cell death. On the other hand, Por1p deletion results in increased sensitivity to acetic 
acid and accelerates other processes such as DNA degradation and loss of plasma 
membrane integrity (Pereira et al., 2007). A similar effect was found for diamide-
induced stress, again with increased resistance in the absence of AAC proteins and a 
higher sensitivity promoted by POR1 deletion (Pereira et al., 2007). Characterization of 
a Δpor1 mutant revealed that the absence of Por1p affects the dynamics of 
mitochondrial morphology, favouring the fragmentation of the mitochondrial network. 
Also, Δpor1 mutant cells exhibit an increased mitochondrial membrane potential (ΔΨm) 
when compared to wt cells, a phenotype that is not related to the mitochondrial 
fragmentation (Pereira, 2008). A previous work from our group revealed that the 
sensitivity of Δpor1 mutant cells to acetic acid is apparently dependent on the presence 
of AAC proteins, thus suggesting a common pathway for cell death (Cardoso et al., 
2008; Pereira, 2008). Here, we tested the response of S. cerevisiae cells lacking the 
AAC proteins, Por1p or both, to lethal concentrations of acetic acid and measured the 
impact of each mutation on MOMP and consequent release of cyt c, aiming to elucidate 
putative interactions between these proteins. 
Our results confirmed the observations of Pereira and colleagues in which the 
absence of all three AAC isoforms promotes an increased resistance to acetic acid 
treatment, whereas the absence of Por1p sensitizes yeast cells (Pereira et al., 2007). 
When AAC and Por1p are simultaneously absent, yeast cells exhibit an acetic acid-
resistance phenotype, and the survival of Δaac1/2/3Δpor1 closely matches that of the 
Δaac1/2/3 mutant, suggesting that Por1 is not involved in the mechanism responsible 
for the resistance associated to AAC deletion. Accompanying the resistance phenotype, 
cyt c release from mitochondria during acetic acid-induced death is impaired in 
Δaac1/2/3 mutant cells (Pereira et al., 2007). These observations support the hypothesis 
of a possible contribution of AAC and Por1p to the formation of a pore in mitochondria, 
although with apparent distinct effects. Since Por1p is not involved in the resistance 
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phenotype of the Δaac1/2/3 mutant, we decided to evaluate the impact of Por1p, and its 
putative collaboration with the AAC, on MOMP during acetic acid treatment. 
Mitochondria were extracted from the different cell types, before and after exposure 
to acetic acid, to assess MOMP measured by the ability to release cyt c. Our results 
showed that after 3h of treatment, it is very difficult to obtain good mitochondria 
preparations from acetic acid treated cells, and the final outcome in mitochondrial mass 
was considerably lower when compared to control cells. This was particularly evident 
for the Δpor1 mutant, most likely because of its reduced survival capacity (< 10% after 
3 hours). Considering this limitation, we changed our experimental conditions to 
evaluate cyt c release after a shorter exposure to acetic acid (90 min), thus ensuring a 
higher survival of Δpor1 cells (~50%). Importantly, at 90 min of treatment the survival 
propensity of each strain was similar to that observed after 3 hours, again with increased 
survival of Δaac1/2/3 and Δaac1/2/3Δpor1 cells, and lower cell viability of the Δpor1 
mutant. 
After 90 minutes of acetic acid exposure, we could still isolate enough mitochondria 
for redox spectra analysis of cyt c relase from wt, Δaac1/2/3, Δpor1 and 
Δaac1/2/3Δpor1 mitochondria. As expected, acetic acid treatment induced the release of 
cyt c in wt cells, confirmed by a significant decrease (about 30%) on cyt c/cyt b ratio 
and by immunodetection of cyt c in mitochondrial and post-mitochondrial fractions. 
Conversely, the absence of AAC proteins seems to impair this process resulting, at least 
in our experimental conditions, in smaller release (about 10%) of the cyt c. Apart from 
the observation that cyt c was not released form mitochondria in Δaac1/2/3 acetic acid-
treated cells, Pereira and colleagues reported what seems to be a selective degradation 
of this cytchrome along with other mitochondrial proteins (Pereira et al., 2007). This 
may not be the case in our experiments, still it should be noted that the treatment 
periods used in both works are considerably different (90 or 200 minutes), and the 
shorter acid exposure used in this work could be insufficient to discriminate the 
mentioned protein degradation. 
The absence of Por1p does not seem to impair MOMP during acetic acid treatment, 
as suggested by the absence of cyt c from Δpor1 mitochondrial fractions, and the 
variation in cyt c/cyt b ratio observed for this strain (≈ 25%) which is similar to that of 
wt cells. Still, the fragility of Δpor1 mitochondria was a constant limitation during these 
procedures, making it hard to obtain good mitochondrial preparations and to define a 
direct relationship between cause and effect. Interestingly, in the absence of both AAC 
The role of Por1p in AAC-mediated mitochondria membrane permeabilization (MMP) and release of 
cytochrome c 
 
131 
 
and Por1p, cyt c release is still observed in mitochondria isolated from acetic acid-
treated yeast cells. The loss of mitochondrial cyt c in the Δaac1/2/3Δpor1 mutant could 
be classified as greater than that observed in Δaac1/2/3 cells, and similar or slightly 
inferior to the release of cyt c from wt mitochondria. This result is divergent from that 
observed by redox spectrophotometry, in which no significant variance was observed in 
cyt c/cyt b ratio, probably because of the simultaneous decrease in the content of both 
cytochromes (c+c1 and b). The release of cyt c in the absence of both AAC and Por1p 
might lead to a new perspective on the contribution of these proteins to MOMP. 
If MOMP during acetic acid-induced death was completely dependent on the AAC 
proteins, and regulated by Por1p, it would be expected to observe no permeabilization 
of Δaac1/2/3 mitochondria, contrasting to unregulated permeabilization of Δpor1 
mitochondria. Following this hypothesis, if both proteins are removed, the absence of 
AAC proteins should be enough to prevent the uncontrolled MOMP of cells lacking 
Por1p as well. Although the absence of AAC isoforms is able to completely convert the 
sensitive phenotype resulting from Por1p deletion into a resistant one, it is apparently 
insufficient to prevent the release of cyt c from mitochondria of acetic acid treated cells. 
It should be noted, however, that cyt c release and cell death do not necessarily correlate 
with each other.  The contradictory observations from redox spectra and Western-blot 
analyses do not provide a solid answer to the initial question, and two possible scenarios 
might be speculated: either the AAC and Por1p are “just” two regulatory players of a 
more complex mechanism mediating the yeast MOMP, a scenario that has also been 
hypothesized in mammalian cells (Siemen and Ziemer, 2013), or a different mechanism 
could be accountable for the results described above. 
In mammalian cells, the contribution of AAC and Por1p orthologues, ANT and 
VDAC, to MOMP and cyt c release during cell death has been discarded. Mitochondria 
lacking either ANT or VDAC isoforms could still undergo permeability transition 
induced by Ca
2+
, and only a regulatory role was attributed to the ANT (Baines et al., 
2007; Kokoszka et al., 2004). Likewise, the AAC and Por1p are apparently dispensable 
for the YMUC (Ballarin and Sorgato, 1995; Lohret et al., 1996). Considering these 
evidences, it would not be strange to envisage an acetic acid-induced MOMP in the 
absence of these proteins, as well. Nevertheless, the impact from AAC deletion in the 
cell survival of S. cerevisiae to acetic acid treatment cannot be ignored and cyt c release 
is definitely impaired in Δaac1/2/3 cells. In Δaac1/2/3Δpor1 cells the resistance 
phenotype “provided” by the absence of AAC proteins actually overcomes the 
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sensitivity phenotype resulting from Por1p deletion. Therefore, it is challenging to 
explain how two mutant strains, both lacking the AAC proteins and exhibiting identical 
resistance to acetic acid would present different mitochondrial permeabilization. The 
distinctive trait between these two strains is the absence of Por1p a protein that, among 
other functions, has been associated to the maintenance of redox sate, mitochondrial 
DNA import and even cytoskeleton rearrangements (D'Souza-Schorey et al., 1997; 
Galganska et al., 2008; Weber-Lotfi et al., 2009). Additionally, the absence of Por1p, or 
inhibition of this channel with the VDAC inhibitor 4´-diisothiocyano-2,2´-disulfonic 
acid stilbene (DIDS), induces the fragmentation of the mitochondrial network, a 
phenotype that is not reversed by the absence of AAC proteins (Pereira, 2008). This 
contribution of Por1p to mitochondrial morphology might be of outmost importance to 
understand the role of this protein in cyt c release from mitochondria. 
Changes in the dynamics of mitochondria morphology are actually able to modulate 
cell death in several organisms, including yeasts. Accordingly, deletion of yeast‟s 
fission proteins Dnm1p or Mvd1p delays the fragmentation of the mitochondrial 
network and, in case of cells lacking Mvd1p, promotes cell survival following a death 
stimulus or in ageing cells (Fannjiang et al., 2004; Scheckhuber et al., 2007). Other 
proteins associated with cell death in yeast can also contribute to mitochondrial 
morphology. This is the case of Yca1p (yeast caspase 1), a Ca
2+
-dependent cysteine 
protease whose deletion has been associated to a decrease in mitochondria fission of a 
yeast strain lacking LSM4, a gene involved in mRNA decapping whose deletion leads to 
an apoptotic-like cell death, and increased survival in response to different death 
stimuli. (Mazzoni et al., 2005; Mazzoni et al., 2003). An analogy could be established 
for the role of Por1p in yeast cell death. The absence of Por1 affects mitochondrial 
morphology leading to the fragmentation of these organelles and promoting cell death 
associated to cyt c release, somewhat explaining the results obtained for the Δpor1 
mutant, and also the possible loss of mitochondrial cyt c observed in Δaac1/2/3Δpor1 
cells, which are also unable to form mitochondrial networks (Pereira, 2008).   
The increased mitochondrial fragmentation (Pereira, 2008), or reduced osmotic 
stability resulting from the absence of Por1p (Sanchez et al., 2001), could be 
responsible for the observed cyt c release in Δaac1/2/3Δpor1 cells during acetic acid 
treatment, thus explaining an eventual bypass of the impaired MOMP in the absence of 
AAC. Further experimentation could help to clarify this hypothesis. For instance, 
determining the activities of mitochondrial proteins such as the IMS adenylate kinase 
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and the matrix citrate synthase, in mitochondrial and post mitochondrial fractions of 
untreated and acid-treated cells, would help to monitor the integrity of OMM and IMM, 
respectively, and hence to properly evaluate MOMP in each strain. This would allow 
measuring the real impact of AAC, Por1p or both, in cyt c release and to exclude a 
possible contribution from mitochondrial lability and damage resulting from the 
extraction procedure. It should also be interesting to manipulate the dynamics of 
mitochondrial morphology to test its influence in the sensitivity of yeast cells to acetic 
acid, and evaluate the role of mitochondrial fusion/fission proteins in the AAC-
mediated MOMP. Alternatively, S. cerevisiae POR1 has a paralog, POR2, which has 
been demonstrated to complement the inability of Δpor1 cells to grow at 37°C when it 
is overexpressed. In spite of the resemblance with Por1p (50%), Por2p is not a real 
porin and does not seem to significantly contribute for the permeability of the OMM 
(Blachly-Dyson et al., 1997; Lee et al., 1998).  It could be worthy to test the effect of 
Por2p in acetic acid-induced MOMP and cyt c release, particularly since Por2p does not 
seem to have channel properties in yeast mitochondria, and its deletion is associated to 
increased mitochondrial branching without affecting the acetic acid tolerance or ΔΨm of 
yeast cells (Blachly-Dyson et al., 1997; Pereira, 2008). 
The effect of AAC deletion in the acetic acid-induced cell death may also be 
associated to a different process, possibly unrelated to MOMP. Indeed, we observed that 
obtaining spheroplasts from strains lacking the AAC proteins was much harder when 
compared to wt cells, even without any treatment. Upon such observation, we wondered 
if the absence of AAC proteins could somehow promote an increased resistance of yeast 
cells through changes in their cell wall. In fact, the absence of AAC results in increased 
resistance to cell wall digestion by zymolyase, while deletion of Por1p had no effect. 
When both proteins are absent we observed a resistance phenotype similar to that of 
Δaac1/2/3 cells. As for acetic acid treatment, the increased resistance seems to depend 
exclusively on the absence of AAC. Considering these observations, we decided to 
evaluate the response of each strain to several stress conditions by their ability to grown 
in the presence of different stress agents. 
Our results indicate that the absence of AAC proteins increases the resistance of 
yeast cells to osmotic stress and a cell wall disturbing agent. This increased resistance is 
independent of Por1p, since the Δaac1/2/3Δpor1 mutant preserves the phenotype 
resulting from AAC deletion. Δpor1 cells, on the other hand, are more sensitive to both 
kinds of stresses. Recently, it was demonstrated that Por1p and Por2p contribute to the 
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positive control of Snf1 protein kinase, the central activator of respiratory metabolism 
responsible for the transcription of a large set of genes, including many involved in 
mitochondrial functions (Hardie, 2007; Strogolova et al., 2012; Young et al., 2003). 
Snf1p had previously been proposed as an essential element for the adaptation to salt 
stress through the activation of mitochondrial function (Pastor et al., 2009), thus 
accounting, at least in part, for the higher sensitivity of Δpor1 cells. Curiously, the 
absence of AAC does not significantly affect the response to heat stress and in this case 
the sensitivity phenotype resulting from Por1p deletion is also exhibited by the 
Δaac1/2/3Δpor1 mutant. These evidences implicate two different processes; (i) the 
response to heat stress highly influenced by the presence of Por1p and unrelated to the 
AAC, (ii) and a pathway leading to increased resistance to osmotic stress which 
involves alterations in the cell wall integrity and depends on the absence of AAC 
proteins. To test a possible connection between the increased resistances of AAC-less 
cells to osmotic and cell wall stresses and the eventual limitations on ATP production, 
we used a biological system which enabled us to switch off the expression of ATP3. Our 
data suggests that this resistance phenotype, resulting from the absence of AAC, cannot 
be attributed to the impaired respiration and its consequences for the energetic 
metabolism.  
We can conclude that, the absence of AAC proteins leads to increased resistance of 
S. cerevisiae cells to osmotic and cell wall stresses, a process associated to changes in 
the cell wall structure and/or composition. This mechanism does not seem to depend on 
the presence of Por1p. To our knowledge, no direct connection has been established 
between the AAC proteins and the cell wall biogenesis/composition in S. cerevisiae. 
Still, it is possible to find some associations between proteins or processes involved in 
cell wall assembly/remodelling and mitochondria. For instance, the defective cell wall 
of Candida albicans ccr4/pop2 mutants is linked to mitochondrial dysfunction and 
phospholipid imbalance (Dagley et al., 2011). Proteins associated to the cell wall 
integrity pathway, namely Pkc1p, Bck1p and Mkk1, were found to relocate to 
mitochondria of yeast cells treated with farnesol (Fairn et al., 2007). Sun4p and Uth1p, 
two members from the SUN family, are localized in the cell wall and mitochondria 
(Velours et al., 2002). The latter, has been associated to the biogenesis of both 
structures (Camougrand et al., 2000; Ritch et al., 2010). Alternatively, the ADP/ATP 
carrier from Pseudozima antarctica is apparently involved in the biosynthesis of 
mannosylerythriol lipids (Morita et al., 2010). 
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We can further propose that the changes in the cell wall of Δaa1/2/3 strains could be 
a preconditioning favouring the capacity of these cells to respond and survive to acetic 
acid. Different screenings have identified genes associated to cell wall functions, such 
as the synthesis of cell wall components, cell wall assembly or remodelling, and even 
genes required for the mannosylation of proteins, as essential for the resistance of S. 
cerevisiae cells to acetic acid (Sousa et al., 2013, accepted for publication) (Mira et al., 
2010). Additionally, acetic acid treatment induces the activation of two yeast MAP 
kinases; Hog1p MAPK from the osmotic stress signalling pathway, and Slt2p from the 
cell wall integrity (CWI) pathway (Mollapour and Piper, 2006). A recent work from our 
group actually implicates the CWI pathway in the signalling of acetic acid-induced 
death, and blocking this signal transduction renders cells more resistant to the acid 
(Azevedo, 2011). Furthermore, changes in the plasma membrane and cell wall resulting 
from the adaptation of yeast cells exposed to weak acids have also been proposed to 
limit the diffusional entry of the acids (Ullah et al., 2013). It is possible that the cell wall 
changes induced by the absence of AAC proteins actually promote the increased 
resistance of yeast cells to acetic acid. Measuring the uptake of acetic acid in these 
strains should provide important clues on this hypothesis. 
In this work, we assessed the role of AAC and Por1p in MOMP during acetic acid-
induced cell death. Although the exact contribution of each protein to MOMP requires 
further investigations, we found that the presence of Por1p is not necessary for cyt c 
release form mitochondria of acetic acid treated cells. Mitochondria from cells lacking 
both AAC and Por1p are apparently able to undergo acetic acid-induced cyt c release, 
which raises the possibility that AAC proteins may not be indispensable for this process 
as well. In the past few years, the inorganic phosphate carrier (PiC) and the F1F0 ATP 
synthase have been proposed has putative elements of the PTP in yeast mitochondria, 
and it should be interesting to test the impact of both proteins in this working model 
(Giorgio et al., 2013; Leung et al., 2008). It is also possible that the absence of Por1p 
per se weakens mitochondria and compromises their integrity during acetic acid 
treatment. Both scenarios should be explored. Additionally, we reveal a possible 
connection between the AAC proteins and the structure/composition of the cell wall, 
which is well documented as an important element in the resistance of yeast cells to 
different acids. This unexpected link between two very different cellular components 
might also account for the resistance of Δaac1/2/3 strains to acetic acid.  
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1. Introduction 
 
Along with the Bcl-2 family members, sphingolipid metabolism also regulates 
apoptosis, although only recently we began to understand how these particular type of 
lipids mechanistically intersect with Bcl-2 family function (Zhang and Saghatelian, 
2013). Alterations in sphingolipid profiles, in particular ceramide profiles, are a 
common event in many scenarios of apoptosis (Taha et al., 2006a). Furthermore, the 
addition of exogenous ceramide analogs to cells is able to trigger apoptosis (Obeid et 
al., 1993), and the modulation of ceramide production can actually regulate this cell 
death process (see for example: Alphonse et al., 2004; Rodriguez-Lafrasse et al., 2002; 
Taha et al., 2006b). One of the mechanisms proposed for the ceramide control of 
apoptosis is the formation of ceramide channels (Colombini, 2010; Siskind et al., 2006). 
Indeed, ceramides are able to form large stable channels in membranes, a phenomenon 
that seems to be exclusive for this sphingolipid since the biologically inactive 
dihydroceramides cannot form such structures (Siskind and Colombini, 2000). Although 
Bcl-2 family proteins are not required for the assembly of these channels, the anti-
apoptotic members Bcl-xL and CED-9 (the C. elegans Bcl-2 homologue) disassemble 
ceramide channels on isolated rat liver and yeast mitochondria, as well as in planar 
phospholipid membranes (Siskind et al., 2008). On the other hand, the pro-apoptotic 
protein Bax seems to act synergistically with ceramide channels to permeabilize the 
outer mitochondrial membrane (OMM) (Ganesan et al., 2010). The contribution of 
sphingolipid metabolism to cell death, however, is not limited to ceramide. Sphingosine, 
like ceramide, mediates apoptosis whereas sphingosine-1-phosphate promotes cell 
survival and inhibits apoptosis (Cuvillier, 2002; Spiegel and Milstien, 2003). These 
antagonistic roles of closely related sphingolipid species create the concept of the so-
called sphingolipid rheostat, according to which the relative levels of these lipids are 
important determinants of cell fate, and the sphingolipid interconversions enables cells 
to orchestrate different cellular responses (Hannun and Obeid, 2008). Recently it has 
been proposed that mitochondria actively maintain a specific sphingolipid milieu that 
favors Bak/Bax function and apoptosis (Chipuk et al., 2012). Still, a challenge remains 
to determine how specific sphingolipids cooperate with pro- and anti-apoptotic proteins 
in vivo. 
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The connection between sphingolipids and Bcl-2 family members is not restricted to 
the direct interaction of ceramide and these apoptotic regulators in OMM. Ceramide has 
diversified downstream targets including protein kinases and phosphatases, such as 
ceramide activated protein kinases (CAPK), protein kinase C (PKC), mitogen-activated-
protein kinases (MAPKs) and ceramide activated protein phosphatases (CAPPs). 
Several of this kinases and phosphatases can actually modulate the activity of different 
members of the Bcl-2 family through phosphorylation/dephosphorylation events.  
In the past decades, yeast has been extensively used to study the regulation and 
function of different Bcl-2 family proteins. Additionally, the simple and genetic 
tractable unicellular eukaryotic organism S. cerevisiae has also been essential for the 
investigation of sphingolipid metabolism. Together these two features make yeast an 
advantageous model system to further address the connections of Bcl-2 family members 
and sphingolipids. The purpose of this work was to further elucidate the influence of 
shingolipid metabolism on the activity of the pro-apoptotic regulator Bax. For such 
purpose, several S. cerevisiae sphingolipid mutants were tested in response to the 
heterologous expression of Bax. Among these mutants, we focused on the effect of 
ISC1 deletion on the action of different forms of Bax exhibiting distinct functional 
properties and cellular effects. Our data bring a new emphasis to the role of ceramide in 
PCD, and how this sphingolipid might contribute to the action of Bax in yeast cells.  
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2. Materials and Methods 
 
2.1. Strains and Plasmids  
The strains and plasmids used in this work are listed in table 1.  
 
Table 1 – List of strains and plasmids used on this work. 
 
W303 Δisc1 mutant was generated by homologous recombination with 
Δisc1::kanMX4 fragment in S. cerevisiae W303 cells. The transformation products were 
confirmed by PCR, and are referred to as Δisc1. The Bax gene referred ahead is a 
chemically synthesized version of the human Bax cDNA, carrying substitutions at the 
third position of several codons to improve its expression in yeast (Greenhalf et al., 
1996). All BY4742 strains mentioned in table 1 (wt, Δifa38, Δisc1, Δydc1, Δymr1 and 
Δypc1) were transformed with the plasmid pCM189-Bax c-myc (URA3), carrying the 
Bax cDNA, fused to a 5‟-DNA sequence encoding the c-myc epitope 
(EQKLOSEEDLNG), under control of a tet-promoter (as described in Priault et al., 
1999). W303 and Δisc1 cells were subsequently transformed with three different forms 
Name Strain/Plasmids Source/Reference 
BY wt BY4742 (MATα; his3Δ 1; leu2Δ 0; lys2Δ 0; ura3Δ 0) Euroscarf 
BY Δifa38 BY4742 Δifa38 (MATα; his3Δ1; leu2Δ0; lys2Δ0; 
ura3Δ0; YBR159w::kanMX4) 
Euroscarf 
BY Δisc1 BY4742 Δisc1 (MATα; his3Δ1; leu2Δ0; lys2Δ0; 
ura3Δ0; YER019w::kanMX4) 
Euroscarf 
BY Δydc1 BY4742 Δydc1 (MATα; his3Δ1; leu2Δ0; lys2Δ0; 
ura3Δ0; YPL087w::kanMX4) 
Euroscarf 
BY Δypc1 BY4742 Δypc1 (MATα; his3Δ1; leu2Δ0; lys2Δ0; 
ura3Δ0; YBR183w::kanMX4) 
Euroscarf 
BY Δymr1 BY4742 Δypc1 (MATα; his3Δ1; leu2Δ0; lys2Δ0; 
ura3Δ0; YJR110w::kanMX4) 
Euroscarf 
W303 W303 1B (MATα ; ura3-1; trp1Δ 2; leu2-3,112; his3-
11,15; ade2-1; can1-100) 
IBGC - CNRS 
Δisc1 W303 1B (MATα ; ura3-1; trp1Δ 2; leu2-3,112; his3-
11,15; ade2-1; can1-100; ISC1::kanMX4) 
This study 
Bax c-myc pCM189-Bax c-myc Priault et al., 1999 
Bax-wt pYES3-Bax Arokium et al., 2004 
Bax-P168A pYES3-Bax-P168A Arokium et al., 2004 
Bcl-xL 
pYES2-Bcl-xL 
pFL39-Bcl-xL 
Arokium et al., 2004 
Priault et al., 2002 
Empty vector pYES3 Invitrogen 
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of Bax: (i) pCM189-Bax c-myc, containing the above described Bax gene fused to a 
myc epitope (Priault et al., 1999); (ii) pYES3-Bax-P168A, containing a Bax gene in 
which proline 168 was replaced by an alanine under control of the GAL1/10 promoter 
(as described in Arokium et al., 2004); (iii) and pYES3-Bax containing a “wild-type” 
version of the human Bax, and referred to as Bax-wt, under control of the GAL1/10 
promoter (Arokium et al., 2004). W303 and Δisc1 strains were also transformed with 
empty vector pYES3 (TRP1, Invitrogen). For co-expression of Bcl-xL two different 
plasmids, both carrying the cDNA of human Bcl-xL under control of a GAL1/10 
promoter, were used. The vector pYES2-Bcl-xL (URA3) was used to co-express Bcl-xL 
with Bax-wt or Bax-P168A (Arokium et al., 2004), while pFL39-Bcl-xL (TRP1) was 
used to co-express Bcl-xL with Bax c-myc (Priault et al., 2002), in W303 and Δisc1 
strains. Transformations of S. cerevisiae cells with the above mentioned plasmids were 
performed by lithium acetate general protocol (Ito et al., 1983). 
 
2.2. Growth conditions 
The BY mutants transformed with pCM189-Bax c-myc were selected in YNB plates 
(2% glucose) without uracil (-Ura), in the presence of 5 μg/mL of doxycycline to inhibit 
the expression of Bax c-myc. The BY + Bax c-myc mutants were pre-grown in synthetic 
complete medium (SC) with glucose (0.175% yeast nitrogen base w/o amino acids 
(Difco), 0.5% ammonium sulfate, 0.1% potassium phosphate, 2% glucose, with 
dropout) and without uracil (-U), in the presence of 2 μg/mL of doxycycline, thus 
preventing the expression of Bax c-myc .  
W303 and Δisc1 strains transformed with pYES3, pYES3-Bax or pYES3-Bax-P168A 
were selected in YNB plates (2% glucose) without tryptophan (-W), while cells co-
transformed with either of the Bax-containing plasmids and pYES2-Bcl-xL were 
selected in YNB plates (2% glucose) without tryptophan (-W) and uracil (-U). These 
mutants were pre-grown in SC glucose medium (0.175% yeast nitrogen base w/o amino 
acids (Difco), 0.5% ammonium sulfate, 0.1% potassium phosphate, 2% glucose, with 
dropout) without tryptophan (-W), for the strains carrying pYES3, pYES3-Bax or 
pYES3-Bax-P168A alone, or without tryptophan and uracil (-UW) for the strains co-
transformed with pYES2-Bcl-xL.  
W303 and Δisc1 cells transformed with pCM189-Bax c-myc alone, or together with 
pFL39-Bcl-xL were selected in YNB plates (2% glucose) without uracil (-U) or without 
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uracil and tryptophan (-UW), respectively, both supplemented with doxycycline (5 
µg/mL) to prevent Bax c-myc  expression. These mutants were pre-grown in SC glucose 
medium (0.175% yeast nitrogen base w/o amino acids (Difco), 0.5% ammonium sulfate, 
0.1% potassium phosphate, 2% glucose, with dropout) without uracil (-U), for the 
strains carrying pCM189-Bax c-myc alone, or without uracil and tryptophan (-UW) for 
the strains co-transformed with pFL39-Bcl-xL. Doxycycline (2 µg/mL) was added to 
prevent Bax c-myc expression. For mitochondria extractions, cells were transferred to 
SC lactate medium (2% DL-Lactate, pH adjusted to 5.5 with NaOH) without uracil or 
without uracil and tryptophan, accordingly. Expression of Bax c-myc was induced after 
transferring the cells into fresh medium supplemented with 0.1 µg/mL of doxycycline. 
Co-expression of Bcl-xL was induced by the addition of 0.5% galactose to the medium. 
 
2.3. Survival assays of Bax c-myc mutants 
To test the viability of BY + Bax c-myc mutants, cells were pre-grown as mentioned 
above, collected, washed and transferred to SC lactate -U medium (2% DL-Lactate, pH 
adjusted to 5.5 with NaOH), supplemented with 2 μg/mL of doxycycline. To induce 
Bax c-myc expression, exponentially grown cells were collected, washed twice with 
sterile water, and transferred to fresh SC lactate -U medium with 0.1 or 0.2 μg/mL of 
doxycycline, to have a 0.5 O.D.640nm culture. For each strain, a control with 2 μg/mL of 
doxycycline was also prepared. These cultures were then incubated for 14h at 30°C, 
after which a sample of each culture was extracted, diluted, and plated in YPDA (1% 
yeast extract, 1% bactopeptone, 2% Glucose, 2% Agar) supplemented with 10 µg/mL of 
doxycycline (250 cells per plate). The number of c.f.u. was counted after 48h incubation 
at 30°C, and the c.f.u. values obtained in control cultures were used as reference. 
Expression of Bax-c-myc was confirmed by WB. 
 
2.4. Mitochondria Isolation and Western-blot analysis 
For mitochondria extraction, BY wt and BY Δisc1 + Bax c-myc strains were pre-
grown in SC glucose -U medium, and then transferred to SC medium with glycerol 
(2%) and ethanol (2%) as carbon sources and without uracil, to obtain fully 
differentiated mitochondria. Bax c-myc expression was achieved as described above. 2 
L cultures (1.0 O.D.640nm) were incubated for 14 hours at 30°C, prior to mitochondria 
extraction. W303 and Δisc1 cells transformed with pYES3, pYES3-Bax or pYES-Bax-
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P168A were grown in SC lactate -W medium (2% DL-Lactate, pH adjusted to 5.5 with 
NaOH). Cells co-transformed with pYES2-Bcl-xL were grown in SC lactate -UW 
medium. Expression of Bax, Bax-P168A and Bcl-xL in these strains was accomplished 
by the addition of 0.5% galactose to the culture medium. 2 L cultures were set at 0.5 
O.D.640nm an incubated for 14 hours. 
Cells were collected, converted into spheroplasts by enzymatic digestion with 
zymolyase (Zymolyase 20T, Seikagaku Biobusiness Corporation), disrupted by hand-
potter or mechanical homogenization, and the mitochondrial fraction recovered after a 
series of differential centrifugations (adapted from Law et al., 1995). Mitochondrial 
suspensions were frozen in liquid nitrogen and stored at -80 °C. For characterization of 
the mitochondrial and post-mitochondrial fractions by Western-blot, 50 μg of proteins 
were precipitated with TCA, washed with acetone, and solubilized in 2% SDS before 
being separated on SDS–PAGE (adapted from Laemmli, 1970). When referred, the 
microsomal fraction was isolated after centrifuging the post-mitochondrial fraction at 
100,000 g. Protein samples were then blotted on PVDF membranes (hybond-P; 
Amersham). Characterization of the different cellular fractions was carried out with 
antibodies directed against mitochondrial cytochrome c (rabbit polyclonal anti-CYC1 
antibody; 1:1000, custom-made by Millegen) and cytochrome c oxidase subunit II 
(mouse monoclonal anti-COX2 antibody; 1:1000, Molecular Probes); cytosolic 
phosphoglycerate kinase (mouse monoclonal anti-PGK1 antibody; 1:5000, Molecular 
Probes); and the endoplasmic reticulum protein dolichol phosphate mannose synthase 
(mouse monoclonal anti-DPM1, Molecular Probes). Immunodetection of Bax and Bcl-
xL was performed with the antibodies anti-Bax (N20) (rabbit polyclonal from Santa-
Cruz) and anti-Bcl-xL (rabbit polyclonal, BD Transduction Laboratories). 
 
2.5. Carbonate treatment 
For carbonate extraction, 1 mg of protein from freshly isolated mitochondria (before 
storage at -80 °C) was resuspended in Hepes 1 mM buffer and incubated with Na2CO3 
(0.1 M, pH 10.0) or Triton X-100 (1%) for 10 minutes at 4 °C, to remove loosely bound 
or integrated proteins respectively. Samples were then centrifuged for 15 minutes at 
100,000 g.  Both pellet and supernatant were collected, and the proteins precipitated 
with TCA, as described above, prior to Western-blot analyses. 
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2.6. Redox Spectrophotometry 
For cytochrome quantification, 10 mg of thawed mitochondrial proteins were diluted 
in recuperation buffer (0.6 M Mannitol; 10 mM Tris-maleate; 2 mM EGTA; pH 6.8) to 
a final volume of 1.6 mL, producing a mitochondria suspension with the final 
concentration of 6.24 mg/mL. The suspension was equally divided into two glass 
cuvettes and the reference and sample cuvettes were oxidized and reduced with 
potassium ferricyanide and sodium dithionite, respectively. Samples were then analyzed 
in a double beam spectrophotometer, Varian Cary 4000. Alternatively, 200 μl of a 10 
mg/mL mitochondria preparation were analyzed in a micro-plate spectrophotometer. 
For whole cell cytochrome quantification, cells were collected during exponential 
growth, and concentrated in a cellular suspension of 2 mL at ≈ 40 O.D.640nm. This 
suspension was divided in two cuvettes and analyzed in a double beam 
spectrophotometer, Varian Cary 4000. Difference spectra were acquired between 500 
and 650 nm and cytochromes c+c1, b and a+a3 were quantified by the O.D. differences 
550 nm minus 540 nm, 561 nm minus 575 nm, and 603 nm minus 630 nm, respectively. 
 
2.7. PI staining 
Propidium Iodide (PI) exclusion in W303 and Δisc1 cells expressing Bax c-myc or 
co-expressing Bax c-myc and Bcl-xL, was monitored by flow cytometric analysis. Cells 
were transferred to SC lactate medium -U or -UW, accordingly, grown to exponential 
phase, collected, washed and transferred into fresh medium containing 0.1 μg/mL of 
doxycycline and 0.5% galactose, to induce Bax c-myc and Bcl-xL expression. Control 
cultures were prepared with 2 μg/mL of doxycycline. Cells were harvested after 14h and 
40h, washed and resuspended in PBS (137 mM NaCl; 2.7 mM KCl; 100 mM 
Na2HPO4; 2 mM KH2PO4; pH 7.4) containing 4 μg/ml of PI (Sigma). The samples 
were incubated for 10 minutes at room temperature, in the dark, before analyzed. The 
survival of each strain after 14 hours was also tested by c.f.u. counting, as described 
previously. Flow cytometric analysis was performed in an Epics® XLTM 
(BeckmanCoulter) flow cytometer equipped with an argon-ion laser emitting a 488 nm 
beam at 15 mW. Red fluorescence was collected through FL-4 (660/700 nm) sensor. 
The obtained data were further analyzed by Flowing Software version 2.5.0. 
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3. Results 
 
3.1. Screening sphingolipid mutants for resistance to the action of Bax c-myc 
To understand how sphingolipids might influence the action of human apoptotic 
regulators of the Bcl-2 family, namely Bax, using the yeast S. cerevisiae as a model 
system, we started by screening a set of selected strains, mutated in genes involved in 
sphingolipid metabolism. This set, obtained from the EUROSCARF collection, 
included the following mutants: Δifa38 (missing the major microsomal 3-ketoreductase 
of the elongase system of enzymes required for the synthesis of very long-chain fatty 
acid; accumulates high levels of dihydrosphingosine, phytosphingosine and medium-
chain ceramides) (Beaudoin et al., 2002; Han et al., 2002), Δisc1 (missing a inositol 
phosphosphingolipid phospholipase C that can be localized in the mitochondrial 
membrane and hydrolyzes complex sphingolipids to yield both phyto- and 
dihydroceramides) (Sawai et al., 2000), Δydc1 and Δypc1 (lacking the alkaline 
dihydroceramidase and phytoceramidase, respectively, that are responsible for the 
cleavage of dihydro- and phytoceramide into the corresponding sphingoid bases (Mao et 
al., 2000a, 2000b), and Δymr1 (which lacks a phosphatidylinositol 3-phosphate (PI3P) 
phosphatase, involved in several protein sorting pathways (Taylor et al., 2000). All the 
mentioned strains were transformed with plasmid pCM189 carrying Bax c-myc under 
control of a tet-off expression system. The presence of a c-myc epitope in the C-terminal 
of Bax results in an active conformation of this protein with enhanced insertion in the 
mitochondrial membrane that very efficiently induces yeast cell death (Greenhalf et al., 
1996; Manon et al., 1997). Full Bax expression is observed after 14h incubation in 
inducible conditions (Fig. 1A). Therefore, the survival of BY mutants (wt, Δifa38, 
Δisc1, Δydc1, Δymr1, Δypc1) expressing Bax c-myc was evaluated by c.f.u. counting, 
following a period of 14 hours in the absence of doxycycline, to induce Bax c-myc 
expression. Control cultures were prepared in the same way, and 2 μg/mL of 
doxycycline were added, to inhibit Bax expression. Under these conditions, Bax c-myc 
induced a high rate of cell death and only a residual amount of cells were able to retain 
their plating efficiency. No differences were observed among the different strains, 
which presented survival values below 10% (data not shown). 
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Fig. 1 – Tolerance of sphingolipid metabolism mutants to the action of Bax c-myc. A) Representative 
Western-blot for detection of Bax c-myc in cultures grown with or without doxycycline. Samples were 
collected at 0, 4, 8, 12 and 24 hours. Porin (Por1p) from the outer mitochondrial membrane was used as 
control. Full Bax expression is obtained after 12 hours incubating in the absence of doxycycline. In the 
presence of 2 µg/mL doxycycline, there is no expression of Bax c-myc. B) Tolerance of BY4742 wt, 
Δifa38, Δisc1, Δydc1, Δymr1 and Δypc1 strains to the action of Bax c-myc. Cultures were incubated in the 
presence of 0.1 µg/mL or 0.2 µg/mL of doxycycline to allow Bax c-myc expression and 2 µg/mL to 
prevent it. Samples were collected after a 14h incubation, plated onto YPDA with 10 µg/mL of 
doxycycline, and the c.f.u. counted after 2 days incubating at 30°C. Survival was estimated using the 
c.f.u. obtained for control cultures as reference. When the mutants were incubated in the presence of 0.1 
µg/mL of Doxycycline, Δisc1 and Δifa38 strains exhibited an increased tolerance to the action of Bax c-
myc, compared to the wild-type BY4742 (*** P < 0.001). Δisc1 mutant retained this tolerance phenotype 
when incubated in the presence of 0.2 µg/mL of doxycycline (* P<0.05). 
 
Considering the high effectiveness of Bax c-myc in killing yeast cells, we decided to 
incubate each strain for 14h in the presence of 0.1 or 0.2 μg/mL of doxycycline, which 
should enable moderate expression levels of this pro-apoptotic regulator. Under these 
conditions, we observed a different response among the BY-sphingolipid mutants. In 
the presence of 0.1 μg/mL of doxycycline, the survival of the BY wt strain is slightly 
higher than 10%, a value similar to the ones obtained for BY Δydc1, Δymr1 and Δypc1 
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mutants (Fig. 1B). The BY Δifa38 and Δisc1 mutants, however, have an increased 
resistance to the action of Bax c-myc, with 20% and 30% survival, respectively (Fig. 
1B). When Bax c-myc expression was induced in the presence of 0.2 μg/mL of 
doxycycline, the survival of BY wt practically doubled compared to the induction with 
0.1 μg/mL of doxycycline (Fig. 1B). The same was true for BY Δydc1, Δymr1 and 
Δypc1 mutants whose survival was similar to that of the wt strain (Fig. 1B). Curiously, 
the survival of either BY Δifa38 and Δisc1 mutants was not significantly improved in 
the presence of a higher concentration of doxycycline, and the resistance phenotype of 
BY Δifa38 was no longer evident. Nevertheless, the BY Δisc1 mutant exhibited the 
highest survival to the action of Bax c-myc (Fig. 1B). These observations suggest that 
the physiological changes resulting from the absence of Isc1p may affect the action of 
the human pro-apoptotic regulator Bax. Therefore, we focused on the role of Isc1p on 
the activity of the pro-apoptotic regulator Bax. 
Isc1p, a yeast homologue of the mammalian neutral sphingomyelinases, shares 
significant structural and functional homology with mammalian neutral 
sphingomyelinases, and its activity is not limited to yeast complex sphingolipids since it 
can also hydrolyze sphingomyelin, the mammalian counterpart of these complex 
sphingolipids which does not exist in yeast (Sawai et al., 2000). Isc1p has also been 
associated to essential cell processes including growth, cell division, sporulation, ion 
protection, heat shock response, genotoxic protection, oxidative stress response, and 
aging (reviewed in (Matmati and Hannun, 2008).  Although it is usually localized to the 
ER, Isc1p is activated and translocates to mitochondria in the post-diauxic growth phase 
(Vaena de Avalos et al., 2004). Isc1p also influences mitochondrial related functions, 
such as the regulation of cellular redox homeostasis (Almeida et al., 2008; Kitagaki et 
al., 2007). Furthermore, loss of Isc1p leads to a shortening in chronological life span, 
associated to the modulation of iron metabolism and apoptosis (Almeida et al., 2008), 
an effect that is directly associated to the altered sphingolipid profile (Barbosa et al., 
2011). 
 
3.2. Bax c-myc addressing to mitochondria and cyt c release 
Since Bax c-myc is already an active form of Bax (Priault et al., 2003), we wondered 
if the increased survival observed for BY Δisc1 mutant could be related to a reduced 
addressing of Bax c-myc to OMM of these cells. To test this hypothesis, mitochondria 
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of BY wt and Δisc1 were extracted after 14h incubating in Bax-expressing conditions, 
and 1 mg of freshly isolated mitochondria was submitted to carbonate extraction. This 
treatment removes proteins that are loosely bound to the mitochondrial membrane, 
leaving only the proteins that are fully inserted. The carbonate treated mitochondria and 
corresponding supernatant fraction were processed for western-blot analysis.  
 
Fig. 2 – Bax c-myc addressing to, and permeabilization of BY wt and Δisc1 mitochondria. Cells 
transformed with Bax c-myc were grown for 14 hours in the absence of doxycycline, enabling full Bax c-
myc expression. A) Bax c-myc addressing to mitochondria was assessed by Western-blot, after treatment 
of mitochondria (1 mg) with sodium carbonate (Na2CO3, 0.1 M, pH 10.0) to evaluate the insertion of Bax 
c-myc in the OMM. The mitochondrial fractions (CO3 Mit), recovered by high speed centrifugation, and 
corresponding supernatants (CO3 SN) were evaluated for the presence of Bax. Bax c-myc and Cox2p 
were also detected in isolated mitochondria (Mit) and total protein extracts (T). B) Cytochrome spectra 
from BY wt and Δisc1 + Bax c-myc isolated mitochondria. The ISC1 mutation did not disturbe the action 
of Bax c-myc, which efficiently permeabilized the mitochondrial membrane of both strains. A 
representative spectrum from each strain is shown. C) Cyt c/cyt b ratios from BY wt and Δisc1 
mitochondria (0.82 and 0.70, respectively). A small difference is observed, probably resulting from a 
decreased cyt c content of Δisc1 cells. (Data represent the mean of at least 3 independent experiments and 
the corresponding) 
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Bax c-myc is mostly localized to the OMM of both strains, and the carbonate 
extraction did not reveal any significant differences (Fig. 2A). Bax c-myc seems to be 
equally inserted in the OMM of Δisc1 cells when compared with the BY wt cells, since 
no difference was found between the pellet and the supernatant of carbonate-treated 
mitochondria of both strains (Fig. 2A). Since there are no differences in the insertion of 
Bax c-myc in the OMM of both cell types, we evaluated its capacity to permeabilize 
mitochondria, by redox spectrophotometry. Bax c-myc was able to induce a significant 
release of cyt c from mitochondria of BY wt and Δisc1 cells, as observed by the small 
cyt c peak on both spectra and reduced cyt c/cyt b ratios (Fig. 2B and C). A small 
difference was observed since the cyt c/cyt b ratio of BY Δisc1 mutant (0.70) is inferior 
to that of BY wt mitochondria (0.82) (Fig, 2C). A similar difference was also observed 
in spectra obtained from whole cells (not shown), indicating that Δisc1 mutant could 
already have a decreased amount of cyt c. 
 
3.3. Effect of Δisc1 mutation in Bax-wt addressing and activity 
The absence of Isc1p results in altered mitochondrial sphingolipid profile with a 
decrease in α-HO C26-phytoceramides, and an accumulation of other species such as α-
HO C14-phytoceramide and non-HO C26-phytoceramides (Kitagaki et al., 2007). The 
altered sphingolipid profile of Δisc1 cells has been associated to the activation of a yeast 
type 2A ceramide-activated protein phosphatase (CAPP), suggesting that Isc1p might 
act as its upstream regulator (Barbosa et al., 2011). Importantly, the mammalian protein 
phosphatase 2A (PP2A) was found to regulate the phosphorylation state of Bax in 
response to ceramide (Xin and Deng, 2006). To test if the absence of Isc1p could lead to 
the activation of Bax, we evaluated the capacity of Bax-wt to insert in the mitochondrial 
membrane and induce the release of cyt c. W303 and Δisc1 cells were grown in SC 
lactate -W for 14 hours in the presence of 0.5% galactose to induce the expression of 
Bax. Our observations suggest that Bax-wt has a microsomal localization rather than a 
mitochondrial one, which is consistent with the inactive conformation of this protein 
(Fig. 3A). No significant differences are apparent in the cellular localization of Bax-wt 
in W303 and Δisc1 strains (Fig. 3A). The redox spectra are also identical for both cell 
types, and the cyt c/cyt b ratios (1.57 and 1.45, respectively) are identical to those 
observed for mitochondria from control cells (without Bax expression). 
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Fig. 3 – Expression of Bax-wt, or co-expression of Bax-wt and Bcl-xL, in W303 wt and Δisc1 cells. 
Western-Blot and redox spectra analysis of W303 wt and Δisc1 mitochondria preparations from cells 
expressing Bax-wt, A) and B), or co-expressing Bax-wt and Bcl-xL, C) and D). Cells were grown for 14h 
in the presence of 0.5% galactose to enable Bax and Bcl-xL expression. A) Western-blot detection of Bax-
wt in total protein extracts (T), isolated mitochondria (Mit), microsomes (Micr) and the post-
mitochondrial fraction (SN). Cox2, Dpm1 and Pgk1 were used as controls for mitochondria, microsomal 
and post-mitochondrial fractions, respectively. When expressed alone, Bax-wt is mostly localized in the 
microsomal fraction. B) Cytochrome spectra of W303 and Δisc1 mitochondria isolated from cells 
expressing Bax-wt. Bax-wt does not induce the release of cyt c from mitochondria of both strains. C) 
Western-blot detection of Bax-wt and Bcl-xL in the equivalent cellular fractions as in A. Bcl-xL is mostly 
localized in the mitochondrial and microsomal fractions of W303 and Δisc1 cells, and promotes the 
addressing of Bax-wt to mitochondria. D) Cytochrome spectra of W303 and Δisc1 mitochondria isolated 
from cells co-expressing Bax-wt and Bcl-xL. The increased mitochondrial localization of Bax-wt is not 
associated with the activation of this protein, since no cyt c is released from mitochondria of either strain. 
 
Simultaneously, we tested the effect of Bcl-xL co-expression in W303 and Δisc1 
strains. Cells carrying Bax-wt and Bcl-xL were transferred to SC lactate -UW, 
supplemented with 0.5% galactose to induce the expression of both proteins. 
Mitochondria were extracted after 14h incubation. The cellular localization of Bcl-xL 
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seems to be divided between the mitochondrial and the microsomal fractions, and the 
co-expression of this protein actually increases the amount of Bax-wt localized in 
mitochondria from both W303 and Δisc1 cells (Fig. 3C), an effect that has been 
observed before (Renault et al., 2013). Redox spectra indicate that no cyt c was released 
from W303 and Δisc1 mitochondria under these conditions as well, and cyt c/cyt b 
ratios of mitochondria co-expressing Bax-wt and Bcl-xL are identical to those of cells 
expressing Bax-wt alone (Fig. 3D). These data are consistent with the nearly inactive 
state of Bax-wt, a condition that is apparently not affected by the absence of Isc1p. 
  
3.4. Effect of Δisc1 mutation on the action of Bax-P168A mutant 
So far, the higher survival of Δisc1 cells to the action of Bax c-myc cannot be 
attributed to a reduced addressing/insertion of this form of Bax in the OMM or impaired 
cyt c release, and the absence of Isc1p does not seem to change the inactive state of a 
wild-type Bax as well. Since Bax c-myc is a highly active form of Bax, in matters of 
addressing to and permeabilization of mitochondria, we tested the effect of Δisc1 
mutation in the action of Bax-P168A mutant protein. Proline 168 is localized in region 
between helixes α8 and α9, and is assumed to play an important role in the 
conformational change responsible for the movement of α9, which is required for the 
mitochondrial addressing/insertion of Bax. The substitution of proline 168 for an 
alanine facilitates a conformational change that mimics the physiological active form of 
Bax that is addressed to mitochondria and permeabilizes the OMM (Arokium et al., 
2004). W303 and Δisc1 cells carrying the pYES3-Bax-P168A were grown in SC lactate 
-W for 14h, in the presence of 0.5% galactose to induce Bax-P168A expression. Bax-
P168A is found in the mitochondrial fractions of both strains, and is not significantly 
removed by carbonate treatment in either case, which is expected for a protein inserted 
in the mitochondrial membrane (Fig. 4A). It also has the capacity to induce cyt c release 
from mitochondria of W303 and Δisc1 cells, as revealed by redox spectra (Fig. 4B). The 
resulting cyt c/cyt b is identical for both strains (1.15 and 1.14) and, unlike the 
experiments with Bax c-myc and Bax-wt, not even a small difference is observed. 
The influence of Δisc1 mutation in the action of Bcl-xL was also tested. W303 and 
Δisc1 cells transformed with pYES3-Bax-P168A and pYES2-Bcl-xL were grown in SC 
lactate -UW for 14h. Expression of both proteins was induced in 0.5% galactose. Once 
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again, Bcl-xL is localized in the mitochondrial fraction of W303 and Δisc1 cells, and its 
insertion is not affected by Isc1p mutation (Fig. 4C).  
 
Fig. 4 – Expression of Bax-P168A, and co-expression of Bax-P168A and Bcl-xL, in W303 wt and 
Δisc1 cells, grown for 14h in the presence of 0.5% galactose to enable the expression of both proteins. 
Western-Blot and redox spectra analysis of W303 wt and Δisc1 mitochondria preparations from cells 
expressing Bax-P168A, A) and B), or co-expressing Bax-P168A and Bcl-xL, C) and D). A) Western-blot 
detection of Bax-P168A in total protein extracts (T), isolated mitochondria (Mit) or mitochondria treated 
with sodium carbonate, and respective supernatant, to evaluate the insertion of Bax-P168A in the OMM 
(CO3 Mit and CO3 SN). Cox2 was used as control. Bax-P168A is localized in mitochondria and properly 
inserted in the OMM. B) Cytochrome spectra of W303 and Δisc1 mitochondria isolated from cells 
expressing Bax-P168A, which efficiently induces the release of cyt c. The action of Bax-P168A does not 
seem to be affected by the ISC1 mutation. C) Western-blot detection of Bax-P168A and Bcl-xL in total 
protein extracts (T), isolated mitochondria (Mit) or mitochondria treated with sodium carbonate (CO3 
Mit) and respective supernatant (CO3 SN). Bax-P168A and Bcl-xL are localized in mitochondria and 
inserted in the OMM of both strains. D) Cytochrome spectra of W303 and Δisc1 mitochondria isolated 
from cells co-expressing Bax and Bcl-xL. The absence of Isc1p does not affect the pro-survival role of 
Bcl-xL, which is able to prevent Bax-P168A-induced mitochondria permeabilization and cyt c release. 
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Co-expression of Bcl-xL does not change the capacity of Bax-P168A to insert itself 
in the OMM of either strain (Fig. 4C). Furthermore, Bcl-xL successfully prevented cyt c 
release from W303 and Δisc1 mitochondria, as demonstrated by the redox spectra and 
the cyt c/cyt b ratios obtained for both strains (1.55 and 1.39, respectively). It seems fair 
to say that the antagonizing activity of Bcl-xL, towards the pro-apoptotic regulator Bax, 
is not affected by the physiological changes resulting from the absence of Isc1p. 
 
Fig. 5 – Graphic representation of the cyt c/cyt b ratio of W303 wt and Δisc1 mitochondria isolated 
from cells without Bax or Bcl-xL (control), and cells expressing Bax-wt, Bax-P168A, or co-expressing 
these forms of Bax with Bcl-xL. W303 and Δisc1 control mitochondria show a cyt c/cyt b ratio of 1.45 
and 1.27, respectively. Mitochondria from cells expressing Bax-wt exhibit a cyt c/cyt b ratio of 1.57 and 
1.45, supporting the fact that this protein has an inactive conformation and therefore cannot induce cyt c 
release. Bax-P168A, which has an active conformation, is able to induce cyt c release, and ratios of W303 
and Δisc1 mitochondria from cells expressing this form of Bax are very similar; 1.22 and 1.18, 
respectively. Co-expression with Bcl-xL prevents this process resulting in cyt c/cyt b ratios identical to 
those observed for control or Bax-wt expressing cells, 1.55 and 1.39. In all the conditions tested the 
differences observed between W303 and Δisc1 cells are not statistically significant. 
 
Comparing the cyt c/cyt b ratios of mitochondria isolated from W303 and Δisc1 cells 
expressing different forms of Bax, co-expressing Bcl-xL, or carrying an empty vector 
allowed us to evaluate the impact of Isc1p in the action of these apoptotic regulators, 
measured by the capacity to induce cyt c release. Bax-wt is able to induce only a 
marginal cyt c release from W303 or Δisc1 mitochondria, when we compare the ratios 
of these cells with those of W303 and Δisc1 cells transformed with pYES3 empty vector 
(Fig. 5). Co-expression of Bcl-xL with this form of Bax has no effect in the 
mitochondrial cyt c/cyt b ratios. Expression of Bax-P168A lowered the cyt c/cyt b ratios 
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from W303 and Δisc1 mitochondria, which is consistent with cyt c release. This effect 
can be prevented by co-expression of Bcl-xL, which restores the cyt c/cyt b ratios of 
both types of mitochondria to values identical to those observed for control and for Bax-
wt or Bax-wt + Bcl-xL expressing cells (Fig. 5). Though a small difference between the 
ratios of W303 and Δisc1 mitochondria is observed in most of the tested conditions 
referred above, presumably due to a lower content of cyt c in Δisc1 cells, it is no longer 
distinguishable after 14h expressing Bax-P168A. 
 
3.5. Bax-induced loss of plasma membrane integrity in W303 and Δisc1 cells 
A work from Camougrand and colleagues revealed that, in yeast cells, the Bax-
induced loss of platting efficiency is associated with the maintenance of plasma 
membrane integrity (Camougrand et al., 2003). Moreover, yeast cells expressing Bax 
display autophagic features, and the selective degradation of altered mitochondria seems 
to be crucial for a regulated death in which mitochondria remained relatively organized 
in the form of orderly distributed spots and plasma membrane intigrety is maintained 
(Kissová et al., 2006). Since we did not observed any major differences in Bax 
addressing to mitochondria or its capacity to induce mitochondrial cyt c release in the 
absence of Isc1p, we decided to evaluate the loss of plasma membrane integrity in cells 
expressing Bax c-myc, through their ability to exclude propidium iodide (PI). For this 
experiment, the W303 and Δisc1 cells expressing Bax c-myc alone, or co-expressed with 
Bcl-xL, were used. 
Expression of Bax c-myc in W303 and Δisc1 revealed a survival profile identical to 
that of the BY4742 counterparts, in which the absence of Isc1p promotes an increased 
resistance to the action of Bax (Fig. 6A). The loss of platting efficiency in both strains 
could be rescued by co-expression with Bcl-xL, supporting the idea that the anti-
apoptotic role of this protein is not affected by the absence of Isc1p (Fig. 6A). In spite 
of a higher resistance to Bax c-myc the percentage of cells with compromised 
membrane integrity (PI positive cells) is significantly higher in the Δisc1 mutant. After 
14h expressing Bax c-myc, about 20% of W303 cells are stained with PI, contrasting 
with almost 40% registered for the Δisc1 mutant (Fig. 6B). This difference subsists after 
a 40h incubation in inducible conditions (Fig. 6B). Co-expression of Bcl-xL successfully 
prevented the loss of plasma membrane integrity of W303 and Δisc1 cells (Fig. 6B). 
Although the deletion of Isc1p is able to promote some level of resistance of yeast cells 
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to the action of Bax on cell viability, death in Δisc1 cells is accompanied by an 
increased loss of plasma membrane integrity. 
Fig. 6 – Expression of Bax c-myc or co-expression of Bax c-myc and Bcl-xL in W303 wt and Δisc1 
cells. A) Survival of W303 and Δisc1 cells to the action of Bax c-myc, in the absence or presence of Bcl-
xL. Cells were grown in the presence of 0.1 µg/mL of doxycycline and 0.5% galactose to induce the 
expression of Bax c-myc and Bcl-xL, respectively. Cells were collected after 14h incubation and platted 
onto YPDA containing 10 µg/mL of doxycycline, thus stopping the expression of Bax c-myc. c.f.u. were 
counted after two days incubating at 30°C. The survival of W303 and Δisc1 expressing Bax c-myc is 
similar to that observed for the BY4742 strains, and the absence of Isc1p favors cell survival. Bcl-xL 
reverts Bax-induced loss of platting efficiency in both strains. B) Plasma membrane integrity, assessed by 
the ability to exclude PI, of W303 wt and Δisc1 cells expressing Bax c-myc alone or co-expressed with 
Bcl-xL. Cells were cultured as described above, and samples collected after 14 and 40h incubation. Cells 
were resuspended in PBS containing PI, incubated for 10 minutes protected from light. PI staining was 
evaluated by flow cytometry. In Δisc1 cells the loss of plasma membrane integrity is higher than in W303 
cells (*** P<0.001). This effect is prevented by co-expression of Bcl-xL. A control using cultures grown 
in the presence of 2 µg/mL of doxycycline, inhibiting Bax c-myc expression was performed (insert). 
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4. Discussion 
 
Although the interplay between sphingolipids and members of the Bcl-2 family in 
the regulation of apoptosis has been extensively studied the connections between these 
two distinct types of known apoptotic regulators have not been completely clarified. To 
obtain further insights into the role of sphingolipid metabolism in cell death regulation 
by Bcl-2 family proteins we exploit the yeast S. cerevisiae. We were particularly 
interested to determine the impact of sphingolipid manipulation on the action of the 
human pro-apoptotic regulator Bax. The pathways and enzymes responsible for 
sphingolipid metabolism are highly conserved among fungi, plant and animal 
kingdoms, and model organisms such as S. cerevisiae greatly contributed to our 
understanding of the sphingolipids‟ biology. In fact sphingolipid studies in yeast have 
allowed the identification and cloning of most of the known enzymes of sphingolipid 
metabolism, which eventually led to the identification of their mammalian orthologues. 
It also uncovered cellular targets of sphingolipids which include pathways of stress and 
cell regulation such as cell cycle, heat stress, ubiquitin-mediated proteolysis, 
endocytosis, and protein trafficking (Obeid et al., 2002). In this work, three different 
forms of human Bax, namely Bax c-myc , Bax wild-type (Bax-wt) and Bax-P168A were 
heterologously expressed in both wild type and yeast mutant cells deficient in 
sphingolipid metabolism enzymes, alone or together with Bcl-xL. Expression of Bax-wt, 
a nearly inactive form localized in the cytosol, has almost no effect on yeast growth, 
whereas Bax-P168A and Bax c-myc are active forms localized in mitochondria and 
capable of inducing MOMP. Using these different forms of Bax allowed us to study the 
impact of enzymes from sphingolipid metabolism in the distinct steps of Bax activation.  
Expression of a Bax c-myc protein in the S. cerevisiae mutants (Δifa38, Δisc1, Δydc1, 
Δypc1, and Δymr1), allowed the identification of Isc1p as involved in Bax-induced cell 
death. In fact, Isc1p is crucial for a normal mitochondrial function, and actually 
regulates the sphingolipid profile of these organelles (Kitagaki et al., 2007), evidences 
that qualify Isc1p as a potential candidate for the regulation of Bcl-2 family members. 
The presence of a c-myc tag added to the C-terminal of Bax promotes the mitochondrial 
localization of this protein and induces cyt c release from mitochondria and yeast cell 
death (Priault et al., 1999, 2003).  
Considering that the sphingolipid profile of mitochondria from Δisc1 cells is 
significantly different from that of wt cells, and that mitochondrial sphingolipids are 
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determinant for the action of Bax, we tested the ability of Bax c-myc to insert in the 
OMM and induce cyt c release. Our hypothesis was that the sphingolipid alterations 
resulting from Isc1p absence could affect the addressing/insertion of Bax in 
mitochondria and impair cyt c release. Comparison of mitochondria samples from Δisc1 
and wt cells expressing Bax c-myc, however, revealed no obvious differences. In both 
strains Bax c-myc is equally capable of inserting in OMM as revealed by carbonate 
treatment. The capacity of this protein to trigger cyt c release is not impaired in the 
absence of Isc1p either. In fact, redox spectra of mitochondria from both cell types 
clearly demonstrate the cyt c/cyt b ratio of Δisc1 + Bax c-myc mitochondria is even 
lower than that of wt mitochondria. This difference in not attributed to a facilitated cyt c 
release from Δisc1 mitochondria, since an identical difference between wt and Δisc1 cyt 
c/cyt b ratios was also observed in spectra of whole cells and mitochondrial preparations 
from control experiments. Since Isc1p has a role in mitochondrial function, the 
observed difference might be explained by the observed reduced cyt c content of Δisc1 
cells in accordance with previous studies (Rego et al., 2012). In addition, loss of Isc1p 
has previously been associated to reduced levels of mitochondrial cytochrome oxidase 
(COX) and decreased capacity to grow on non-fermentable carbon sources (Vaena de 
Avalos et al., 2005). 
An identical analysis was performed with the two other different forms of Bax; a 
native Bax (Bax-wt), and a mutant of native Bax in which proline 168 was substituted 
by an alanine (Bax-P168A). These two proteins have distinct physiological behaviors. 
Native Bax is inactive and mostly cytosolic, waiting for an activation signal that 
eventually triggers its translocation to mitochondria and subsequent activation (Hsu et 
al., 1997). Additionally, a small population of native Bax can also be found in the 
endoplasmic reticulum (ER) (Zong et al., 2003). On the other hand, the P168A mutant 
of native Bax is strongly addressed to mitochondria of yeast cells, inserted in the OMM 
and has the capacity to promote cyt c release (Arokium et al., 2004). Since native Bax 
and Bax P168A have different intracellular localization and activity, the impact of Isc1p 
deletion in mitochondrial addressing/insertion and in cyt c release could be different.  
Bax activity is also modulated by phosphorylation/dephosphorylation, which can be 
regulated by ceramide. For instance, mammalian protein phosphatases 1 (PP1) and 2A 
(PP2A) are ceramide-activated protein phosphatases (CAPPs) that bind to ceramide and 
regulate two distinct signaling pathways (Chalfant et al., 1999, 2004).  Ceramide-
activated PP2A can actually regulate the phosphorylation state of Bax, and the PP2A-
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mediated Bax dephosphorylation is responsible for a conformational change that 
promotes its insertion and oligomerization in the OMM and also disrupts the Bcl-2/Bax 
association, liberating the pro-apoptotic regulator from this heterodimeric complex (Xin 
and Deng, 2006). Recently, Isc1p has been proposed as an upstream regulator of Sit4p, 
whose activation is implicated in mitochondrial dysfunction associated to shortened 
lifespan and oxidative stress sensitivity of Δisc1 mutants (Barbosa et al., 2011). Sit4p is 
a PP2A-like protein phosphatase that shares structural homology to the catalytic subunit 
of mammalian PP2A, and functional homology with the mammalian protein 
serine/threonine phosphatase 6 (PP6) (Arndt et al., 1989; Bastians and Ponstingl, 1996). 
Moreover, Sit4p has been considered a component of a yeast ceramide-activated protein 
phosphatase, and is actually involved in ceramide stress response in yeast (Nickels and 
Broach, 1996; Woodacre et al., 2013). Although, there are no reports on a possible 
connection between mammalian PP6 and the Bcl-2 family members, this phosphatase 
regulates the sensitivity of glioblastoma cells to radiation (Shen et al., 2011). It seems, 
therefore, plausible to assume that the changes on sphingolipid profile of Δisc1 cells, 
namely the decreased amount of α-HO C26-phytoceramides and the increase of its non-
HO form, could modulate a cellular response capable of affecting the action of the 
nearly inactive or less active forms Bax-wt and Bax P168A, respectively. 
 According to our results, Bax-wt is mostly localized to the microsomal and cytosolic 
fractions of wt and Δisc1 cells, and barely found in mitochondria. These observations 
are consistent with the inactive status of Bax, and suggest that the absence of Isc1p does 
not contribute to Bax activation. Furthermore, redox spectra and cyt c/cyt b ratios 
indicate that there is no cyt c release under these conditions. Indeed, the small difference 
between the ratios of both strains is identical to that observed upon expression of Bax c-
myc and might be equally explained. Considering these findings we can say that the 
sphingolipid profile resulting from the absence of Isc1p does not change the inactive 
state of native Bax. Co-expression of Bax-wt with the anti-apoptotic regulator Bcl-xL 
enhanced the translocation of Bax to mitochondria of both cell types. Although it may 
seem a contradictory idea, given that Bcl-xL promotes cell survival by blocking Bax-
induced MOMP, its ability to promote Bax mitochondrial localization while inhibiting 
cyt c release has already been observed in HeLa cells and yeast cells expressing these 
human proteins (Llambi et al., 2011; Renault et al., 2013). Redox spectra of 
mitochondria isolated from W303 or Δisc1 cells co-expressing Bax-wt and Bcl-xL, 
confirmed the absence of cyt c release, even if Bax is more addressed to mitochondria. 
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Once more, a slight difference between the cyt c/cyt b ratios of both strains was 
observed, and the values were identical to those detected under conditions where only 
Bax-wt was expressed. 
Our results show that the absence of Isc1p does not affect the activity of Bax- c-myc 
neither of native Bax. The impact of Isc1p deletion on the action of a pre-active mutant 
Bax-P168A form was then tested. Results demonstrated that Bax-P168A is addressed to 
mitochondria and inserted in the OMM, definitely excluding the hypothesis of impaired 
insertion of Bax in mitochondria of Δisc1 cells. Bax-P168A also induces mitochondrial 
cyt c release in both strains, consistent with an active state. Interestingly, the cyt c/cyt b 
ratios of W303 and Δisc1 cells expressing Bax-P168A are pretty much identical 
(approximately 1.22 and 1.18, respectively). This means that the small differences 
between the wt and Δisc1 cyt c/cyt b ratios observed in cells expressing Bax c-myc, 
Bax-wt, co-expressing Bax-wt and Bcl-xL or carrying an empty vector (with a 
magnitude between 0.12 and 0.19), are practically non-existent in the presence of Bax-
P168A (with a mean difference of 0.04). Co-expression of Bcl-xL, which does not 
change the mitochondrial localization of Bax-P168A, is able to prevent Bax-induced cyt 
c release, and the ratios of W303 and Δisc1 cells under these conditions (1.55 and 1.39, 
respectively), are similar to those of control, Bax-wt or Bax-wt + Bcl-xL cells. Restoring 
the cyt c/cyt b ratios to values consistent with the absence of cyt c release also restores 
the difference between W303 and Δisc1 ratios. These findings suggest that cyt c release 
might be somehow delayed in Δisc1 cells, but such hypothesis would require further 
experimentation. The lower amount of cyt c in Δisc1 cells may not be a limiting factor 
in this case, since upon expression of Bax c-myc both wt and Δisc1 mitochondria loose 
high amounts of cyt c, and the final difference between the ratios of both strains was 
still present. It should be worthy to test a shorter time of incubation in conditions were 
Bax is expressed. If the absence of Isc1p somehow affects Bax-P168A-induced cyt c 
release, this effect should be measurable shortly after Bax expression as well. 
Since the increased survival observed for Δisc1 cells expressing active forms of Bax 
could not be easily correlated to defects on Bax addressing and insertion in the OMM, 
neither to changes of the activation state of Bax, we tried to characterize the process of 
cell death in the absence of Isc1p. Interestingly, the delayed Bax-induced cell death of 
Δisc1 cells is followed by increased loss of plasma membrane integrity, when compared 
to wt cells. This curious result is not entirely surprising since a similar situation has 
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previously been described for Bax-induced cell death in a yeast strain lacking the UTH1 
gene (Kissová et al., 2006). 
The yeast Δuth1 mutant was previously identified in a screen for extended longevity 
and discovered to be resistant to the action of Bax. Shortly after, it was found to be 
required for mitochondrial autophagy, also known as mitophagy (Camougrand et al., 
2003; Kissová et al., 2004). Importantly, the absence of Uth1p does not affect the 
mitochondrial localization of Bax c-myc, nor its ability to induce MOMP and cyt c 
release (Camougrand et al., 2003). Later on, Kissova and colleagues observed that, 
unlike wt cells, the Δuth1 mutant was unable to maintain plasma membrane integrity 
upon expression of Bax c-myc. They describe the slow loss of Δuth1 platting efficiency 
as a necrotic form of cell death similar to that observed for acute stresses, and propose 
that the “apparent” resistance of Δuth1 to the effects of Bax c-myc  is actually caused by 
the slow kinetics of this form of cell death, contrasting with a regulated loss of 
proliferation capacity (Kissová et al., 2004). It was also observed that Bax c-myc 
induces the fragmentation of the mitochondrial network, a common and early, but not 
exclusive, event during mammalian apoptosis, although differently in wt and Δuth1 
strains. Mitochondria from wt cells expressing Bax c-myc were fragmented into 
relatively organized punctuated structures with a somewhat ordered distribution, while 
Δuth1 mitochondria were fragmented into disorganized structures of different sizes and 
random cellular distribution (Kissová et al., 2004). Moreover, mitochondrial 
degradation was impaired in Δuth1 cells suggesting the inactivation of mitophagy in the 
absence of Uth1p. The authors concluded that mitophagy is required for a rapid and 
regulated form of cell death, probably through the elimination of mitochondria damaged 
by the action of Bax, thus preventing a necrotic-like cell death (Kissová et al., 2004).  
The resemblances shared by the effect of Isc1p deletion on the action of Bax, and 
that described for a yeast Δuth1 mutant under identical circumstances, are tempting 
enough for us to establish a possible parallelism between both mutations. We did 
observed an increased resistance of Δisc1 cells to the effects of an active Bax that 
cannot be correlated to the insertion of this pro-apoptotic protein in the OMM, and may 
be independent of its ability to induce mitochondrial cyt c release. Nevertheless, this 
resistance phenotype is accompanied by increased loss of plasma membrane integrity. 
The absence of Isc1p drastically changes the mitochondria morphology of yeast cells 
from the thread-like network, typical of wt cells, into what appears to be randomly 
distributed aggregates, even in the absence of any stress. Importantly, mitochondrial 
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degradation is also compromised in Δisc1 cells during acetic acid treatment, and the 
absence of Isc1p increases the survival of yeast cells to acetic acid-induced death (Rego 
et al., 2012). Relevant for this line of evidences, recent studies associate sphingolipid 
metabolism, particularly ceramides, to mitochondria dynamics and mitophagy (Parra et 
al., 2008; Sentelle et al., 2012; Smith et al., 2013). Therefore, it should be enlightening 
to evaluate mitochondria degradation in Δisc1 cells expressing an active form of Bax, 
and test the effect of this particular mutation in the ability of yeast cells to remove 
damaged mitochondria. 
Recently, Chipuk and colleagues described that hexadecenal, a product of the 
irreversible cleavage of sphingosine-1-phophate, can associate with Bax to promote its 
activation (Chipuk et al., 2012). In yeast sphingolipid metabolism, the phosphate lyase 
Dpl1p is responsible for the cleavage of both dihydro- and phytosphingosines-1-
phosphate (Saba et al., 1997). Manipulation of Dpl1p should provide an interesting 
opportunity to test and eventually validate this kind of in vivo studies in yeast. It should 
also be interesting to expand this approach to other proteins involved in sphingolipid 
metabolism. For instance, yeast cell lacking LAG1, a catalytic subunit of ceramide 
synthase, have altered mitochondria morphology and exhibit increased resistance to 
acetic acid associated to impaired mitochondrial degradation, somewhat similar to Δisc1 
cells (Rego et al., 2012). Overexpression of Ydc1, another protein of interest, has been 
associated to mitochondrial fragmentation and cell death (Aerts et al., 2008). This 
system could also be applied to study the effects of exogenously added sphingolipids in 
yeast cells transformed with mammalian Bax.  
The sphingolipid metabolism and the Bcl-2 family function might intersect at 
different levels of cell death regulation. Among these, sphingolipid signaling has been 
shown to regulate several members of the Bcl-2 family by interfering with signaling 
cascades, or even through the regulation of DNA splicing. It has also been proposed that 
a specific milieu of sphingolipids is required for the proper function of Bcl-2 family 
members in mitochondria (Chipuk et al., 2012). Finally, ceramides are able to form 
lipidic channels which can be disassembled by anti-apoptotic Bcl-2 proteins such as 
Bcl-xL, or enlarged/stabilized by the pro-apoptotic Bax (Ganesan et al., 2010; Siskind et 
al., 2008). Our work demonstrates that genes involved in sphingolipid metabolism can 
interfere with the effects of Bax in yeast. The absence of Isc1p increased the tolerance 
of yeast cells to the action of an active recombinant form of Bax, a phenomenon that is 
not associated with reduced addressing or insertion of this pro-apoptotic regulator in 
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OMM. It is possible that changes in the mitochondrial sphingolipid profile could affect 
the dynamics of Bax-induced cyt c release, but the mechanism behind such hypothesis 
remains unknown and further testing is required to validate this scenario. Alternatively, 
the resistance phenotype of Δisc1 cells could be related to a direct effect of this 
mutation in the regulation of mitophagy. This work provides another insight on the vital 
action of sphingolipids as modulators of the cell death processes, emphasizing the 
valuable contribution of yeast as a model to understand the physiology of life and death.  
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1. Concluding Remarks and Future Perspectives 
 
Mitochondria hold the power to determine life and death of each eukaryotic cell. 
More than “just” containing all the essential elements to generate significant amounts of 
energy and promote life, mitochondria also encloses proteins that can potentially change 
the biological balance and promote cell death. The mechanisms and pathways that 
involve mitochondria permeabilization and the commitment to cell death are complex 
and far from fully comprehended. 
Several years ago, it was suggested that the adenine nucleotide translocator (AAC in 
yeast) was involved in cell death by participating in the formation of an inner membrane 
pore, the PTP (Halestrap and Davidson, 1990). Other studies established a possible 
collaboration between the ANT and the Bcl-2 family members, major regulators of cell 
death in mammals (Marzo et al., 1998). In both cases the contribution of the ANT was 
questioned, and its role in cell death was doubted. While studying the contribution of 
putative components of  the PTP to cell death induced by acetic acid in S. cerevisiae, 
Pereira and colleagues revealed an important role of the AAC, the yeast homologue of 
mammalian ANT, in mediating both MOMP and cell death (Pereira et al., 2007). 
Considering that: i) yeast is deprived of the major regulators of mammalian cell 
death, the Bcl-2 family members (only recently a BH3-only protein was identified), ii) 
acetic acid can trigger different cell death phenotypes and is accompanied by ROS in 
yeast production, iii) ROS are known sensitizers of the PTP and mediators of cell death, 
iv) the thiol groups are preferentially oxidized by ROS, and the AACs are particularly 
sensitive to their action, v) binding of compounds to the cysteine residues of the AAC 
locks the translocator in specific conformations, and vi) absence of the AAC protects 
cells from acetic acid-induced death, we decided to test the contribution of AAC 
cysteine residues to cell death in yeast. Our most relevant observations were: 
 
- The cysteine residues of Aac2p do not influence acetic acid-induced yeast cell 
death; 
- Yeast cells containing an Aac2p protein lacking the four cysteine residues, 
responds in a similar manner to Aac2p wild-type cells in respect to ROS 
production, loss of plasma membrane integrity and MOMP; 
- The Aac2p is not particularly oxidized following acetic acid treatment. 
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In light of this evidence we can exclude the contribution of the Aac2p cysteine 
residues to acetic acid-induced MOMP. It has been proposed that oxidative stress-
mediated crosslinking of thiol groups locks Aac2p in the “c” conformation, which 
would then favour the binding of CyP-D, over ADP, greatly sensitizing the 
mitochondrial PTP to Ca
2+
 (Crompton et al., 1987; McStay et al., 2002). If acetic acid 
induces an identical conformational change in Aac2p, and Aac2p is involved in PTP 
opening, we should observe changes in cytochrome c release. Moreover, analysis of 
protein carbonylation does not suggest that this carrier is particularly oxidized during 
acetic acid treatment. Definite evidence for this hypothesis could be provided by mass 
spectrometry analysis. Nevertheless, diamide, a true pro-oxidant agent, should offer a 
more suitable stimulus to test the putative participation of Aac2p, its thiol groups and 
conformational changes, in PTP opening. Like for acetic acid, yeast cells lacking the 
three AAC isoforms exhibit increased tolerance to diamide treatment (Pereira et al., 
2007). Recently, the inorganic phosphate carrier (PiC) and the FOF1 ATP synthase have 
been suggested as components of the mammalian PTP (Alcala et al., 2008; Giorgio et 
al., 2013; Leung et al., 2008). Therefore, it should be interesting to test the putative 
contribution of both proteins to the acetic acid-induced cytochrome c release, and yeast 
provides excellent genetic tools to do so. Finally, the addition of a V5-His6 double tag 
to the C-terminus of Aac2p had major implications for normal mitochondrial functions, 
in particular for energetic metabolism. This construction was found in mitochondria but 
fails to restore the respiratory competence of Δaac1/2/3 cells. This effect is associated 
with a drastic loss of cytochrome c. One hypothesis is that the TOM-TIM-mediated 
translocation of Aac2p to mitochondria is affected by the presence of the double tag, 
and that this protein could actually destabilize the mitochondrial protein import systems. 
It would be worthwhile to isolate mitoplasts from cells expressing Aac2p and V5-His6 
double tagged Aac2p, and compare the levels of the carrier with those of whole 
mitochondria, to confirm a proper addressing to the IMM. In conclusion, Aac2p 
participates in acetic acid-induced cytochrome c release from mitochondria, but this 
effect does not depend on its cysteine residues and possible on oxidative stress as well. 
Yeast cells lacking another putative component of the mitochondrial PTP, Por1 
(VDAC), were found to be more sensitive to acetic acid than wild-type cells. This effect 
could be completely converted into a resistance phenotype by the simultaneous absence 
of the AAC proteins, suggesting a shared pathway to the promotion of cell death, in 
which Por1p could have a regulatory effect over an AAC-mediated pore formation 
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(Pereira et al., 2007). This relation was tested by comparing the impact of each protein, 
alone or combined, in the capacity of mitochondria to undergo acetic acid-induced 
cytochrome c release. We observed that: 
 
- Acetic acid has increased cytotoxicity in yeast strains lacking Por1p, which 
apparently possess debilitated mitochondria, difficult to isolate; 
- Absence of Por1p does not impair acetic acid-induced cytochrome c release 
from mitochondria; 
- Absence of AAC proteins impairs mitochondrial cytochrome c release 
induced by acetic acid; 
- When both AAC and Por1p are absent mitochondria apparently can still 
release cytochrome c; 
- Absence of AAC contributes to increased cell wall resistance, while Por1 
deletion has no significant effect; 
- AAC and Por1p are, like for acetic acid, implicated in the resistance of yeast 
cells to osmotic and cell wall stresses (the absence of AACs increases  
resistance while absence of Por1p sensitizes cells); 
- Absence of AAC reverts the sensitivity of Δpor1 cells to osmotic and cell 
wall stress, but does not rescue the decreased thermotolerance resulting from 
Por1 deletion; 
- The effect of AAC‟s absence in the resistance of yeast to osmotic and cell 
wall stresses does not seem to depend on the bioenergetic limitations of 
Δaac1/2/3 strains. 
 
These results indicate that both the AAC proteins and Por1p can influence the yeast 
cell‟s response to the acetic acid insult. It is possible that these proteins act in the same 
pathway mediating yeast cell death, with AAC as a facilitator of mitochondrial 
cytochrome c release and Por1p as negative regulator. Nevertheless, both proteins seem 
to mediate different physiological processes. Indeed, Por1p is required for 
mitochondrial stability, normal mitochondria dynamics, and for the capacity of yeast 
cells to cope with osmotic and cell wall stress as well as growth at over-optimal 
temperatures. In future experiments with mitochondria isolated from these strains, it 
will be important to control the inner mitochondria membrane integrity, in order to 
ensure that the observed cytochrome c release truly reflects MOMP. Although localized 
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to the IMM, the AAC is able to influence the cell wall resistance of yeasts, which could 
suggest its involvement, direct or not, in signalling events. The mechanism by which the 
AAC influences the cell wall resistance of yeast, however, remains uncertain. 
In a considerably different approach, we exploited the potential of yeast as a model 
system to study the influence of sphingolipid metabolism on the action of human 
apoptotic regulators. Sphingolipids are widely recognized as crucial signalling 
molecules in a variety of cellular processes, including the pathways of cell death 
(Hannun and Obeid, 2008), and can directly influence the action of the Bcl-2 family 
proteins, particularly that of the pro-apoptotic regulator Bax (addressed in Chapter 1 – 
“Sphingolipids in cell death signalling“). The conservation in yeast of the sphingolipid 
metabolism in yeast, in combination with the ability to express of different forms of 
human Bax, namely the native form of Bax (nearly inactive form localized in the 
cytosol), the pre-active Bax P168A and the active Bax c-myc (both localized in 
mitochondria), provides an advantageous approach to identify which enzymes 
ofinvolved in sphingolipid metabolism play a roleinvolved in the distinct steps of 
human Bax activation.A screen with a set of yeast strains mutated in sphingolipid 
metabolism enzymes, revealed a possible contribution of Isc1p, responsible to the 
degradation of complex sphingolipids into ceramides, for the regulation of Bax c-myc-
induced loss of cell viability. From the heterologous expression of different forms of 
Bax in Δisc1 yeast cells, we can conclude that: 
 
- The resistance of Δisc1 cells to the action of Bax c-myc, cannot be attributed 
to reduced addressing and/or insertion of this active form into the OMM; 
- The resistance of Δisc1 cells to the action of Bax c-myc cannot be attributed 
to changes in cytochrome c release; 
- The resistance phenotype observed in Δisc1 cells expressing Bax c-myc, is 
likely related to the consequences of Bax c-myc effects in mitochondria; 
- This resistance phenotype of Δisc1 cells is probably related to the regulation 
of mitophagy. 
- Absence of Isc1p does not influence the activation of Bax-wt with respect to 
addressing/insertion into mitochondria or induced cytochrome c release; 
- Absence of Isc1p does not influence the function of the pre-active form Bax-
P168A with respect to addressing/insertion into mitochondria, though a 
slight delay in cytochrome c release is apparent 
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Our results suggest that sphingolipids, and genes involved in sphingolipid 
metabolism, have the ability to regulate the effects of Bax in yeast cells. In fact, the 
absence of Isc1p improved the viability of yeast cells expressing an active form of Bax. 
This effect, however, does not seem to be related with the regulation of Bax action in 
mitochondria, i.e. its ability to be addressed and inserted in the OMM, or to induce 
cytochrome c release when fully activated. Rather it seems to depend on downstream 
events. Supporting this hypothesis, we provide evidences suggesting that the increased 
viability of Δisc1 somewhat resembles that of a Δuth1 mutant, in which mitophagy is 
severely compromised and cell death progression changes from that observed for wild-
type cells. From our experiments, we cannot completely discard an effect of Isc1p 
deletion on the dynamics of Bax-induced cytochrome c release, and kinetics of 
cytochrome c release could be performed to validate this scenario. Nevertheless, it 
might be worth exploring a possible contribution of Isc1p to the process of mitophagy. 
Yeast has been extensively, and successfully, used as a model to study the role of 
proteins and evolutionary conserved systems involved in cell death. Here, once more, 
the yeast S. cerevisiae has proven its great value providing interesting clues to different 
biological processes. Consisting of an epistemological approach, this work represents 
another small step towards the understanding of the vast and highly complex network of 
biological events that strongly control cell death, a natural element of life. 
 
 
 
“Life is pleasant. Death is peaceful. It's the transition that's troublesome.” 
 Isaac Asimov 
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